NUR MACROPRINTERS LTD
F-1, 1998-10-26
PRINTING TRADES MACHINERY & EQUIPMENT
Previous: KERAVISION INC /CA/, 8-K, 1998-10-26
Next: FDH INC, 10QSB, 1998-10-26




    As filed with the Securities and Exchange Commission on October 26, 1998
                                             Registration Statement No. 333-____
================================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                       ----------------------------------
                                    FORM F-1
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933

                       ----------------------------------
                             NUR MACROPRINTERS LTD.
             (Exact name of registrant as specified in its charter)

      Israel                          3555                    Not Applicable    
  (State or other               (Primary Standard            (I.R.S. Employer   
   jurisdiction             Industrial Classification     Identification Number)
of incorporation or               Code Number)           
   organization)            
                       ----------------------------------

                              5 David Navon Street
                         Moshav Magshimim 56910, Israel
                              (011) 972-3-908-7676
   (Address and telephone number of Registrant's principal executive offices)

                              CT Corporation System
                                  1633 Broadway
                            New York, New York 10019
                                 (212) 246-5070

            (Name, address and telephone number of agent for service)

                       ----------------------------------
                                    Copy to:
                             Rubi Finkelstein, Esq.
                       Orrick, Herrington & Sutcliffe LLP
                              30 Rockefeller Plaza
                            New York, New York 10112
                                 (212) 506-5000
                              (212) 506-3730 (Fax)
                       ----------------------------------

Approximate date of commencement of proposed sale to the public: 

From time to time after the effective date of this Registration Statement.

      If the only securities being registered on this Form are to be offered
pursuant to dividend or interest reinvestment plans, please check the following
box: |_|

      If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, check the following box: |X|

      If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. |_|

      If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |_|

      If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. |_|

                         CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
=====================================================================================================================
    Title of Each Class of         Amount to be         Proposed Maximum       Proposed Maximum        Amount of
          Securities                Registered         Offering Price Per     Aggregate Offering    Registration Fee
       to be Registered                                     Share(1)               Price(1)
- - - - - - ---------------------------------------------------------------------------------------------------------------------
<S>                               <C>                         <C>                <C>                   <C>      
Ordinary Shares nominal value     4,000,000 Shares            $2.375              $9,500,000.00        $2,641.00
NIS 1.0 per share
- - - - - - ---------------------------------------------------------------------------------------------------------------------
Ordinary Shares Issuable Upon     555,000 Shares              $2.375              $1,318,125.00          $366.44
Exercise of Warrants
- - - - - - ---------------------------------------------------------------------------------------------------------------------
Ordinary Shares Issuable Upon     1,342,339 Shares            $2.375              $3,188,055.13          $886.28
Exercise of Options
- - - - - - ---------------------------------------------------------------------------------------------------------------------
Total Registration Fee                                                           $14,006,180.13        $3,893.72
- - - - - - ---------------------------------------------------------------------------------------------------------------------
</TABLE>

(1)   Estimated solely for the purpose of calculating the registration fee based
      upon the average of the closing bid and ask prices for the Ordinary Shares
      on October 20, 1998 on the Nasdaq National Market, in accordance with Rule
      457(c).

                       ----------------------------------

      The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933, as amended, or until this Registration Statement
shall become effective on such date as the Commission, acting pursuant to said
Section 8(a), may determine.
================================================================================

<PAGE>

                             NUR MACROPRINTERS LTD.

             Cross-Reference Sheet Showing Location in Prospectus of
               Information Required by Items in Part I of Form F-1

Registration Statement Item Number             Caption or Location in Prospectus
and Caption
                                                                    
1.    Front of Registration Statement
      Outside Front Cover of Prospectus.....   Cover page

2.    Inside Front Cover and Outside
      Back Cover Pages of Prospectus........   Inside Front and Outside Back;
                                               Back Cover Pages

3.    Summary Information and Risk
      Factors...............................   Prospectus Summary; Risk Factors

4.    Use of Proceeds.......................   Use of Proceeds

5.    Determination of Offering Price.......   Not Applicable

6.    Dilution..............................   Not Applicable

7.    Selling Security Holders..............   Selling Shareholders

8.    Plan of Distribution..................   Plan of Distribution

9.    Legal Proceedings.....................   Business-Legal Proceedings

10.   Directors, Executive Officers,
      Promoters and Control Persons.........   Management

11.   Security Ownership of Certain
      Beneficial Owners and Management......   Principal Shareholders

12.   Description of Securities.............   Description of Ordinary
                                               Securities

13.   Interest of Named Experts and
      Counsel...............................   Experts; Legal Matters

14.   Disclosure of Commission Position
      on Indemnification for Securities
      Act Liabilities.......................   Commission Position on
                                               Indemnification for
                                               Securities Act Liabilities

15.   Organization Within Last Five
      Years.................................   Not Applicable

16.   Description of Business...............   Business

17.   Management's Discussion and
      Analysis or Plan of
      Operation.............................   Management's Discussion and
                                               Analysis of Financial Condition
                                               and Results of Operations

18.   Description of Property...............   Business--Facilities

19.   Certain Relationships and Related
      Transactions..........................   Certain Transactions 

20.   Market for Common Equity and
      Related Stockholder Matters...........   Risk Factors; Market for Common
                                               Equity; Dividend
                                               Policy; Principal Shareholders

21.   Executive Compensations...............   Management

22.   Financial Statements..................   Financial Statements

23.   Changes in and Disagreements with
      Accountants on Accounting and
      Financial Disclosure..................   Not Applicable

<PAGE>

                  SUBJECT TO COMPLETION, DATED OCTOBER 26, 1998

Information contained herein is subject to completion or amendment. A
registration statement relating to these securities has been filed with the
Securities and Exchange Commission. These securities may not be sold nor may
offers to buy be accepeted prior to the time the registration statement becomes
effective. This prospectus shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of these securities
in any State in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any such State.

                                                              Shelf Registration
                                                          Preliminary Prospectus

                             NUR MACROPRINTERS LTD.
                                  NASDAQ: NURTF


                            5,897,339 Ordinary Shares



NUR Macroprinters, Ltd                  We develop, sell, and service digital  
5 David Navon Street                    color printers for the printing of     
Moshav Magshimim 56910                  large images such as billboards,       
Israel                                  posters, and banners. Our primary      
                                        customers include commercial printers, 
                                        design firms, and billboard companies. 
                                        
The Offering
o Ordinary shares          4,000,000    We are registering stock currently      
o Ordinary shares                       owned by shareholders of the company to 
  issuable upon exercise                enable them to sell the stock on the    
  of warrants                555,000    open market. We will not receive any    
o Ordinary shares                       money from this offering.               
  issuable upon exercise                
  of options               1,342,339
                           ---------

Total Ordinary shares      5,897,339
                           =========

                       ----------------------------------

This Investment Involves a High Degree of Risk. You Should Purchase Shares Only
If You Can Afford a Complete Loss. See "Risk Factors" Beginning on Page 8.

Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved these securities, or determined if this
Prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.

We will request that the Securities Authority of the State of Israel grant us an
exemption from Israel's publication requirements applicable to this Prospectus.
The granting of such exemption, which is anticipated, should not be construed as
a determination that this Prospectus is truthful or complete or as an opinion on
the quality of the securities offered in this Prospectus.

                                October __, 1998
<PAGE>

                               PROSPECTUS SUMMARY

      This summary highlights information contained elsewhere in this
prospectus. It is not complete and may not contain all of the information you
should consider before investing in our stock. Therefore, you should read the
entire prospectus carefully.

                             Nur Macroprinters Ltd.

Introduction
- - - - - - ------------

      Nur Macroprinters Ltd., an Israeli company, formerly Nur Advanced
Technologies Ltd., is a world leader in the market for the sale of very large
format digital printing systems. We develop, sell, and service digital color
printers for the printing of large images such as billboards, posters, and
banners. We also supply our customers with the inks, solvents and print
substrates for use with our printers.

      On October 6, 1995, we completed an initial public offering and our shares
currently trade on the Nasdaq National Market under the symbol NURTF. There is
no non-United States trading market for our shares.

Our Products
- - - - - - ------------

      Our printers allow customers to print large color images on demand,
generally in substantially less time, with less labor and at a lower cost, than
traditional methods of printing.

      One of our principal products is the Blueboard printer, a second
generation very large format printer that was introduced in early 1997. The
Blueboard can print in variable widths from 0.9 to 5 meters (approximately 3 to
16.4 feet). The Blueboard printer is based on our own continuous ink-jet digital
printing technology and is designed to improve quality and ease of use.

      In April 1998, we introduced a faster version of the Blueboard printer,
the Blueboard 2, in response to demand from our customers for increased
productivity. The Blueboard 2 is now also one of our main products. In September
1998, we acquired rights to a certain piezo drop on demand digital printing 
technology which we plan to incorporate into a new printer.

      Our main product until the end of 1995 was the Outboard printer, which is
capable of printing in widths of up to 1.6 meters. At the end of 1995 we
introduced the Wideboard printer, a first generation very large format printer
capable of printing in variable widths of up to 5 meters.

      The ink we sell to our customers for use in our printers is resistant to 
water and ultraviolet rays and is well suited for indoor and outdoor use. The
substrates we sell to our customers are also suitable for indoor and outdoor use
and are made of vinyl, PVC, paper and mesh.

Our Customers
- - - - - - -------------

      We sell our printers and related products primarily to commercial
printers, design and service firms, screen printers, outdoor media companies,
and trade shops. Our customers use our products to print large images, such as
billboards, posters, banners, and point of purchase displays for advertising, as
well as decorations and backdrops for showrooms, museums, and exhibits.

                                       3
<PAGE>

Our Strategy
- - - - - - ------------

      Our strategy is to:

      o  maintain our position as a world leader in the very large format
         printing market by supplying the most productive and cost-effective 
         very large format digital printers;
 
      o  introduce large format digital ink jet printers to replace current
         large-format screen printers;

      o  be the vendor of choice for our customers for all of their ink and 
         substrate needs;
    
      o  enable our customers to develop new ways to profit from our printing 
         systems; and
    
      o  provide our customers with state of the art service and supplies.


      Where you can obtain additional information:

         Mailing Address                               Executive Office
         ---------------                               ----------------
          P.O. Box 8440                              5 David Navon Street
      Moshav Magshimin 56910                        Moshav Magshimim 56910
              Israel                                        Israel

      Phone: 972-3-908-7676                      Website: http://www.nur.com

      The information on our web site is not a part of this Prospectus.

                                       4
<PAGE>

                                  The Offering

Shares offered assuming exercise of 
  all warrants and options...........  5,897,339 shares

Shares outstanding before offering...  10,880,000

Shares outstanding after offering 
  assuming exercise of all warrants 
  and options........................  12,777,339

Nasdaq National Market
  Trading Symbol.....................  NURTF

Selling Shareholders.................  See "Selling Shareholders" on page 55.

Use of Proceeds......................  The selling shareholders will receive all
                                       of the proceeds from the sale of their
                                       shares to the public. Nur Macroprinters
                                       Ltd. will not receive any proceeds from
                                       the sale of the shares. We will, however,
                                       receive some proceeds when stockholders
                                       exercise their warrants and options.
                                       These proceeds will be used for working
                                       capital and general corporate purposes.
                                       See "Use of Proceeds" on page 18.

Plan of Distribution.................  We are not aware of any specific plan the
                                       selling shareholders may have to sell
                                       their shares. We believe that the selling
                                       shareholders will sell their shares at
                                       prevailing market prices on the Nasdaq
                                       National Market, without payment of any
                                       underwriting commissions or discounts
                                       other than ordinary transaction costs. We
                                       are paying for the preparation of this
                                       Prospectus and the related Registration
                                       Statement.

Risk Factors.........................  Investing in our shares is very risky.
                                       You should be able to bear a complete
                                       loss of your investment. See "Risk
                                       Factors" on page 8.

                                       5
<PAGE>

                   Summary Consolidated Financial Information
               (in thousands, except per share and operating data)

      This summary consolidated financial information is derived from the
consolidated financial statements, which appear later in this prospectus. You
should read this data in conjunction with the consolidated financial statements
and related notes.

<TABLE>
<CAPTION>
                                                                                                              Six Months Ended
                                                                                                              ----------------
                                                          Years Ended December 31,                                 June 30,
                                                          ------------------------                                 --------
                                          1993         1994         1995          1996*         1997*         1997*          1998*
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
<S>                                    <C>          <C>          <C>           <C>           <C>           <C>           <C>       
Revenues
Sales of printers and related products    $6,880      $10,010      $13,824       $13,639       $18,874        $7,909        $14,233
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Sales of printed materials                    --           --           --         2,998         3,085         1,304          1,621
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Cost of revenues                           6,880       10,010       13,824        16,637        21,959         9,213         15,854
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Cost of sales of printers and related
products                                   4,861        6,939        9,374        11,528         9,627         4,213          6,862
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Cost of sales of printed materials            --           --           --         2,008         1,684           711            993
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
                                           4,861        6,939        9,374        13,536        11,311         4,924          7,855
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------

Gross profit                               2,019        3,071        4,450         3,101        10,648         4,289          7,999

Research & development expenses              739          497        1,040         1,530         1,726           756          1,591
Less royalty-bearing grants                  144          161          306           372            43           127            310
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Research & development expenses net          595          336          734         1,158         1,683           629          1,281
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------

Selling and marketing expenses, net          867          715        1,039         4,823         4,620         1,891          2,844

General & administrative expenses            520        1,099        1,187         2,560         3,439         1,662          2,358
Write-off of debts from related parties       --           --           --         3,757            --            99             --
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
                                           1,387        1,814        2,226        11,140         8,059         3,652          5,202
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------

Operating income (loss)                       37          921        1,490        (9,197)          906             8          1,516
Financial expenses, net                      243           65          205           589           320           286            320
Gain (loss) on marketable securities         251          (40)          12            22            --            --             --
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Other income (expenses), net                  --           --          110            76            (8)           --            (91)
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------

Income (loss) before taxes on income          45          816        1,407        (9,688)          578          (278)         1,105
Taxes on income                               60           25          221           400            67            --            112
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------

Income (loss) after taxes on income          (15)         791        1,186       (10,088)          511          (278)           993
Minority interest in earnings 
of subsidiary                                 --           --           --            --           (26)           --            (12)
Equity in loss of 50% owned
joint venture                               (528)        (987)      (1,125)           --            --            --             --
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Net income (loss) for the period           $(543)       $(196)         $61      $(10,088)         $485         $(278)          $981
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Basic and diluted earnings (loss) 
per share                                 $(0.15)      $(0.05)       $0.01        $(1.47)        $0.07        $(0.04)         $0.09
                                       ---------    ---------    ---------     ---------     ---------     ---------     ----------
Weighted average number of shares
outstanding used in computing basic
and diluted earnings (loss)
per share                              3,624,708    4,123,082    4,904,118     6,880,000     7,293,640     6,880,000     10,880,000
                                       =========    =========    =========     =========     =========     =========     ==========
</TABLE>

- - - - - - -------- 
* Represents financial information for NUR Macroprinters Ltd. together with its
subsidiaries, Nur Media Solutions S.A. ("Nur Media Solutions"), Nur America Inc.
("Nur America"), Nur Advanced Technologies (Europe) S.A. ("Nur Europe"), and Nur
Marketing and Communication GmbH ("Nur Germany").

                                       6
<PAGE>

                                                     Balance Sheet Data
                                                      (In U.S. Dollars)
<TABLE>
<CAPTION>
                                                   December 31,                                 June 30,
                                    -----------------------------------------            -----------------------
                                      1995            1996*            1997*             1997*            1998*
                                    -------           -------         -------            ------           ------
<S>                                 <C>               <C>             <C>                <C>              <C>   
Working capital...............      $10,597           $   690         $ 4,674            $1,310           $4,758

Total assets..................       16,759            12,161          13,783            10,908           16,997

Total liabilities.............        4,945            10,325           7,998             9,177           10,388

Total shareholders' equity....      $11,814           $ 1,836         $ 5,785            $1,731           $6,609
</TABLE>

- - - - - - --------
*Represents financial information for Nur Macroprinters, Ltd. together with its
subsidiaries, Nur Media Solutions, Nur America, Nur Europe and Nur Germany.

                                       7
<PAGE>

                                  RISK FACTORS

      Investing in our shares is very risky. You should be able to bear a
complete loss of your investment. To understand the level of risk, you should
carefully consider the following risk factors, as well as the other information
found in this prospectus.

We depend on a few key                We are highly dependent on the sale of    
products in a business subject        our principal products, the Blueboard and 
to rapid technological change.        Blueboard 2 printers and related          
                                      supplies. Rapid changes in technology,    
                                      customer preferences and evolving         
                                      industry standards increasingly           
                                      characterize the market for our printers. 
                                      As a result of these factors, our growth  
                                      and future financial performance will     
                                      depend upon our ability to develop and    
                                      market new products and keep pace with    
                                      the latest technological advances in the  
Our success depends on the            industry. We must also improve our        
research and development of           existing products to accommodate          
new products.                         technological advances and customer       
                                      preferences. During 1997 and through the  
                                      first half of 1998, we invested           
                                      approximately $3.3 million in research    
                                      and development projects. Our business    
                                      could seriously suffer if we fail to      
                                      anticipate or respond adequately to       
                                      changes in technology and customer        
                                      preferences, or if our products are       
                                      delayed in their development or           
                                      introduction. Other events beyond our     
                                      control could also hurt our business. For 
                                      example, one of our competitors could     
                                      develop and market a printer that         
                                      customers prefer over our printers. We    
                                      can not assure you that we will           
                                      successfully develop any new products.    
                                      Finally, we cannot predict how the        
                                      introduction of new products by our       
                                      competitors will affect sales of our      
                                      existing products.                        

In the near future we will take a     In September 1998 we acquired all rights 
significant one time write-off.       to a certain drop on demand inkjet 
                                      technology suitable for large format
                                      digital printers. This acquisition will
                                      result in a one-time write-off of $1.5 to
                                      $1.6 million in the third quarter of 1998
                                      assigned to in-process research and
                                      development. In addition, over the next
                                      three years we will pay royalty payments
                                      to the competitor not exceeding $1.3
                                      million. See "Management's Discussion and
                                      Analysis of Financial Condition and
                                      Results of Operations - General."

Our success depends on our            At the current time we purchase all of    
suppliers and subcontractors.         the ink and ink-jets used in our printers 
                                      from one supplier, Imaje, a French        
                                      manufacturer of ink-related products. We  
                                      have been able to obtain adequate         
                                      supplies of ink and ink-jets in the past, 
                                      although Imaje has occasionally delivered 
                                      the supplies late. If this sole supplier  
                                      experiences any problem resulting in      
Imaje is our only supplier of         production delays, our sales to new       
ink and ink-jets.                     customers and existing customers who rely 
                                      on our ink to operate their printers      
                                      could be hurt. Because the success of our 
                                      business depends on the sale of our       
                                      printers, a supply problem could have a   
                                      severe effect on our financial results.   
                                      Also, if Imaje reduces or changes the     
                                      credit or payment terms it extends to us, 
                                      our business could be hurt.               

                                       8
<PAGE>

We rely on a limited number of        We employ a limited number of unaffiliated
subcontractors.                       subcontractors to manufacture components  
                                      for our printers. We currently employ one
                                      independent sub-contractor to assemble our
                                      Blueboard printers. Our subcontractors
                                      have, in the past, been late in delivering
                                      components. We have, however, been able to
                                      obtain adequate supplies of the components
                                      and raw materials necessary to produce our
                                      printers and we have not had any serious
                                      problems with our subcontractors. Because
                                      we rely on subcontractors, we cannot
                                      assure you that we will be able to
                                      maintain an adequate supply of components.
                                      Moreover, we cannot assure that any of the
                                      components we purchase will satisfy our
                                      quality standards and be delivered on
                                      time. Our business could suffer if we fail
                                      to maintain our relationships with our
                                      subcontractors or fail to develop
                                      alternative sources for our printer
                                      components. Also, as our business grows,
                                      we will need to purchase greater
                                      quantities of components on a timely
                                      basis, and any delay in supply could hurt
                                      our sales. We cannot guarantee that we
                                      will develop alternative sources of
                                      production for our products or that we
                                      would be able to replace the
                                      sub-contractor that assembles our
                                      Blueboard Printers, if required.

Lawsuits                              We are currently involved in several
                                      lawsuits. Our financial results and
                                      business may suffer if we lose any of
                                      these lawsuits. See "Business--Legal
                                      Proceedings."

Our business is extremely             The printing equipment industry is     
competitive.                          extremely competitive and many of our  
                                      competitors possess greater management,
                                      financial, technical, manufacturing,
                                      marketing, sales, distribution, and other
                                      resources than we do. Our ability to
                                      compete depends on factors both within and
                                      outside of our control, including the
                                      performance and acceptance of our current
                                      printers and any products we develop in
                                      the future. We compete against several
                                      companies that market digital printing
We have numerous competitors          systems based on electrostatic,   
in the market for our printers.       drop-on-demand, airbrush and other    
                                      technologies. We also face competition
                                      from existing conventional large format
                                      printing methods, including hand painting,
                                      silk screening, and offset printing. Our
                                      competitors could develop new products,
                                      with existing or new technology, that
                                      could be competitive in price and
                                      performance with our printers. We can
                                      offer no assurance that we can compete
                                      effectively with any such products.

                                       9
<PAGE>

We also face competition in the       We also compete with independent       
market for printing supplies.         manufacturers in the market for printer
                                      supplies, in particular, the inks we
                                      supply. In 1997, ink sales accounted for
                                      21% of our total sales. We cannot
                                      guarantee that we will be able to remain
                                      the exclusive or even principal ink
                                      manufacturer for our printers. We recently
                                      entered the substrate business, which is
                                      also highly competitive and characterized
                                      by a large number of suppliers worldwide.
                                      We are developing substrates through
                                      subcontractors that have a high
                                      added-value when used with our printers.
                                      We believe we are well positioned, both in
                                      our technical knowledge and in the minds
                                      of our customers, to succeed in selling
                                      high value-added substrates to our
                                      customers. We can not assure you that we
                                      will be able to compete effectively or
                                      achieve significant revenues in the
                                      substrate business.

We depend on our key                  Our success depends to a significant  
employees.                            extent upon the contributions of key  
                                      personnel and our senior executives. Our
                                      business could seriously suffer if one or
                                      more or our key personnel or senior
                                      executives were to leave our company. In
                                      addition, we do not have, and do not
                                      contemplate getting, "key-man" life
                                      insurance for any of our key employees.
                                      Our future success will also depend in
                                      part on our continuing ability to retain
                                      our key personnel and senior executives
                                      and to attract other highly qualified
                                      employees. We cannot assure our continued
                                      success in attracting or retaining highly
                                      qualified personnel.

We rely on trade secrets,             We rely on a combination of trade secrets,
patents and proprietary rights.       licenses, patents, and non-disclosure and 
                                      confidentiality agreements to establish
                                      and protect our proprietary rights in our
                                      products. We cannot guarantee that our
                                      existing patents or any future patents
                                      will not be challenged, invalidated, or
                                      circumvented, or that our competitors will
                                      not independently develop or patent
                                      technologies that are substantially
                                      equivalent or superior to our technology.
                                      We cannot be sure that we will receive
                                      further patent protection in Israel, the
                                      United States, or elsewhere, for existing
                                      or new products or applications. Even if
                                      we do secure further patent protection, we
                                      cannot guarantee it will be effective. In
                                      some countries, meaningful patent
                                      protection is not available. We are not
                                      aware of any infringement claims against
                                      us involving our proprietary rights. Third
                                      parties may assert infringement claims
                                      against us in the future, and the cost of
                                      responding to such assertions, regardless
                                      of their validity, could be significant.
                                      In addition, such claims could be found to
                                      be valid and result in large judgments
                                      against us. Even if such claims are not
                                      valid, the cost could be substantial to
                                      protect our patent rights. See "Business -
                                      Legal Proceedings."

                                       10
<PAGE>

It is difficult to protect our        We believe that our success is less 
proprietary rights.                   dependent upon the legal protection 
                                      afforded by patent and other proprietary
                                      rights than on the knowledge, ability,
                                      experience, and technological expertise of
                                      our employees and our key suppliers. Our
                                      policy is to have employees sign
                                      confidentiality agreements, to have
                                      selected parties, including key suppliers,
                                      sub-contractors, and distributors, sign
                                      non-competition agreements, and to have
                                      third parties that we deal with sign
                                      non-disclosure agreements. Although we
                                      take precautionary measures to protect our
                                      trade secrets, we cannot guarantee that
                                      others will not acquire equivalent trade
                                      secrets or steal our exclusive technology.
                                      Moreover, we may not be able to
                                      meaningfully protect our rights that are
                                      not protected by patents.

We rely on international sales.       Our printers and supplies are sold
                                      worldwide, with revenues generated in
                                      various currencies. There are a number of
                                      risks inherent in international business
                                      activities, including unexpected changes
                                      in regulatory requirements, political
                                      instability, tariffs and other trade
                                      barriers, as well as the burdens of
                                      complying with different foreign laws. To
                                      date, fortunately, these risks have not
                                      materially affected our business or
                                      financial situation. We cannot predict,
                                      however, when exchange or price controls
                                      or other restrictions on the conversion of
                                      foreign currencies could impact our
                                      business.

Currency fluctuations are a risk      Because we have revenues and expenses in  
we face on a daily basis.             various currencies, including the U.S.    
                                      dollar, the NIS, and certain European
                                      currencies, our financial results are
                                      subject to the effects of fluctuations of
                                      foreign currency exchange rates. In the
                                      future, currency fluctuations could hurt
                                      our profitability. We do not hedge against
                                      fluctuations in currency exchange rates,
                                      but we may do so in the future.

We depend on a few major              In the fiscal year ended December 31,    
distributors.                         1997, and the six months ended June 30,  
                                      1998, our sales to Scitex Corporation and
                                      its subsidiaries accounted for about 10%
                                      and 8.6% of our total sales. Scitex
                                      Corporation and its subsidiaries made
                                      these sales in the Far East and the Middle
                                      East and are the most significant outside
                                      distributors of our products. If Scitex
                                      should suddenly stop distributing or
                                      marketing our printers, we may be forced
                                      to undertake the marketing ourselves or
                                      find another distributor in the Far East
                                      and the Middle East. Our business could
                                      suffer if our efforts prove unsuccessful.

Environmental concerns.               We mix the ink used in our printers with a
                                      MEK solvent. MEK is a hazardous substance
                                      and is subject to various government
                                      regulations relating to its transfer,
                                      handling, packaging, use, and disposal. We
                                      store the ink at warehouses in Europe, the
                                      U.S. and in Israel, and a shipping company

                                       11
<PAGE>

                                      ships it at our direction. We face
                                      potential responsibility for problems that
                                      may arise when we ship the ink to
                                      customers. We believe that we are in
                                      material compliance with all applicable
                                      environmental laws and regulations. If we
                                      fail to comply with these laws or an
                                      accident involving our ink waste or MEK
                                      occurs then our business and financial
                                      results could be adversely affected.

We rely on government                 We receive grants and tax benefits from   
grants, tax benefits, and other       the Israeli government, which also        
funding from third parties.           sponsors programs in which we participate.
                                      The Government of Israel, through the
                                      Office of the Chief Scientist ("OCS"),
                                      encourages research and development
                                      projects oriented toward products for
                                      export. Since our inception we have used
                                      grants from the OCS to develop our
                                      products. Under our agreement with the
                                      OCS, we pay royalties to OCS generally at
                                      a rate of 2% to 3% on sales of products
                                      developed with the help of OCS funds. The
                                      royalties end when 100% to 150% of the
                                      dollar value of the grant is repaid.
                                      During the years ended December 31, 1995,
                                      1996 and 1997 and the six months ended
                                      June 30, 1998, OCS provided us with grants
                                      for research and development expenses in
                                      the amounts of $0.31 million, $0.37
                                      million, $0.04 million, and $0.0 million,
                                      respectively. These grants amounted to
                                      approximately 29%, 24%, 2.5%, and 0%,
                                      respectively, of our total research and
                                      development expenses. During 1995, we paid
                                      approximately $0.10 million in royalties
                                      to the OCS. We did not pay royalties in
                                      the years ended December 31, 1996 and 1997
                                      and during the six months ended June 30,
                                      1998. As of June 30, 1998, we had a
                                      contingent liability to pay OCS $0.99
                                      million in future royalty payments.

The Israeli government has            The Israeli Government, through the Fund  
subsidized our international          for the Encouragement of Marketing        
marketing expenses.                   Activities of the Ministry of Industry and
                                      Commerce (the "Marketing Fund"), awards
                                      participation grants for marketing
                                      expenses incurred overseas. We received
                                      grants from the Marketing Fund totaling
                                      approximately $0.253 million in 1995 for
                                      the promotion of our printers and another
                                      product that has since been discontinued.
                                      We did not receive any grants in 1996, but
                                      we did receive $0.20 million in 1997 and
                                      $0.13 million during the six months ended
                                      June 30, 1998. Our business did not suffer
                                      because we did not receive a grant in
                                      1996. We may not be eligible for
                                      additional grants from the Marketing Fund
                                      in the future due to our reaching the
                                      maximum allowed export revenues. We are
                                      obligated to pay a royalty of 3% of the
                                      export added value of our products to the
                                      Marketing Fund until 100% of the grants
                                      have been repaid. The principal 

                                       12
<PAGE>

                                      amount of the grants are linked to the
                                      U.S. dollar. As of June 30, 1998, we had
                                      made royalty payments to the Marketing
                                      Fund totaling $0.08 million.

We receive tax benefits from the      Pursuant to the Law of Encouragement of
Israeli government.                   Capital Investments, the Israeli       
                                      government has granted "Approved
                                      Enterprise" status to some of our
                                      production facilities. Consequently, these
                                      facilities are eligible for certain tax
                                      benefits for the first several years in
                                      which they generate taxable income. If we
                                      fail to obtain additional grants, or if
                                      our tax benefits are significantly
                                      reduced, our financial condition could
                                      suffer.

We must comply with conditions        In order to receive grants and tax       
to receive grants and tax             benefits, we must comply with a number of
benefits.                             conditions. If we fail to comply with    
                                      these conditions and criteria, the grants
                                      and tax benefits that we receive could be
                                      partially or fully canceled and we would
                                      be forced to refund the amount of the
                                      canceled benefits received, adjusted for
                                      inflation and interest. We believe that we
                                      have operated and will continue to operate
                                      in compliance with the required
                                      conditions, although we cannot be sure. We
                                      further believe that the likelihood is
                                      remote that we will be required to refund
                                      grants or tax benefits that we receive
                                      from the OCS, the Marketing Fund, and
                                      under our "Approved Enterprise" status.

We also receive grants from the       Nur Europe has secured two non-related   
Government of Belgium                 grants from local authorities in Belgium.
                                      The first grant will provide up to
                                      approximately $0.5 million, provided Nur
                                      Europe completes an approximately $3.0
                                      million investment program and employs at
                                      least 21 full time employees in Belgium by
                                      December 31, 1999. The second grant
                                      provides reimbursement of up to 70% of our
                                      research and development investment in
                                      Belgium. The maximum amount of this grant
                                      is approximately $1.0 million. If we do
                                      not derive revenue or develop products as
                                      a result of our investment in Belgium,
                                      then we do not have to repay the grant;
                                      otherwise, we will repay the grant over 5
                                      years. See "Business--Research and
                                      Development."

                                       13
<PAGE>

We may need additional                We believe that the capital resources and 
financing and we have                 credit facilities we now have will be     
experienced financial                 enough to fund our current activities at  
difficulties in the past.             their present and planned rate through    
                                      mid-1999. We may, however, require
                                      additional funds, to be raised through
                                      public or private financing of debt or
                                      equity, to ensure our ability to maintain
                                      our current and planned operations, after
                                      mid-1999. If we are unable to raise such
In the future we may need to          funds, we may have to reduce or eliminate 
raise more money to                   expenditures for research and development,
successfully run our business.        production, or marketing of our products, 
                                      any one of which could have a negative
                                      impact on our financial results. Even if
                                      we do obtain additional financing,
                                      expansion of our business requires, and
                                      will continue to require, significant
                                      capital. In this regard, how much money we
                                      will need depends on numerous factors,
                                      including the success of our marketing and
                                      customer service efforts, our research and
                                      development activities, and the demand for
                                      our products and services. We cannot
                                      guarantee that additional financing will
                                      be available or that, if available, it
                                      will be obtained on terms we find
                                      favorable.

We have experienced financial         In the past we experienced financial     
difficulties in the past.             difficulties. As of December 31, 1996, we
                                      have written off $3.7 million due to
                                      outstanding debts owed to us by Moshe Nur,
                                      our previous Chairman of the Board and
                                      major shareholder, and companies
                                      controlled by Mr. Nur. These companies are
                                      now in various insolvency proceedings. 
                                      The written off debts resulted, in part, 
                                      from ineffective controls, which failed to
                                      prevent unauthorized transactions and the
                                      misappropriation of funds. These
                                      difficulties resulted in losses of $10.1
                                      million in the year ended December 31,
                                      1996, and reduced our shareholders' equity
                                      to approximately $1.8 million. In April
                                      1997, Moshe Nur transferred control of the
                                      Company and subsequently resigned from the
                                      Board of Directors. We have reached a
                                      settlement agreement resolving all
                                      outstanding material claims related to the
                                      insolvency proceedings of Moshe Nur and
                                      his companies. Despite this settlement, in
                                      the future we may be exposed to claims
                                      arising from Moshe Nur's actions.
                                      Liabilities arising from any such claims
                                      and the cost to defend our company may be
                                      substantial.


We have recently changed our          In April 1997, when Moshe Nur transferred 
leadership and have limited           control of Nur Macroprinters Ltd., we     
management resources to manage        replaced most of the members of our Board 
future growth.                        of Directors. We also made several        
                                      management changes. Our recent growth has
                                      placed, and will continue to place, a
                                      significant strain on our management team,
                                      facilities, and other resources. In order
                                      to support our growth, our new leadership
                                      adopted financial controls and reporting
                                      systems 

                                       14
<PAGE>

                                      and expanded our management, facilities,
                                      financial, and other resources. To avoid
                                      any negative effects on our business, we
                                      must successfully implement financial
                                      controls, expand our manufacturing, sales,
                                      marketing, and service organizations, and
                                      update our accounting, operational, and
                                      management information systems. Failure to
                                      do so effectively could have a material
                                      adverse effect on our business and
                                      financial results.

Our operating results tend to         Our revenues may vary significantly from 
fluctuate.                            quarter to quarter as a result of, among 
                                      other factors, the timing of new product
                                      announcements and releases by our
                                      competitors and us. We do not typically
                                      have a material backlog of orders at the
                                      beginning of each quarter. We generally
                                      ship and record a significant portion of
                                      our revenues for orders placed within the
                                      same quarter, primarily in the last month
                                      of the quarter. We may not learn of
                                      shortfalls in sales until late in, or
                                      shortly after the end of, the fiscal
                                      period. As a result, our quarterly
                                      earnings may be subject to significant
                                      variations.

We have an uneven history of          We have an uneven history of financial 
financial results.                    results. We incurred an operating loss of
                                      approximately $0.32 million in 1991 and
                                      $0.22 million in 1992. In 1993 we made an
                                      operating profit for the first time,
                                      earning approximately $0.04 million, which
                                      increased to approximately $0.92 million
                                      in 1994, and to $1.49 million in 1995. In
                                      1996 we incurred an operating loss of $9.2
                                      million. In 1997 we achieved an operating
                                      income of $0.91 million and in the six
                                      months ended June 30, 1998 had operating
                                      income of $1.52 million. We cannot assure
                                      profitability in the future.

Important facilities and              Our most important facilities and        
operations are located                operations and many of our subcontractors
in Israel.                            are located entirely in the State of     
                                      Israel. Political and military conditions
                                      in Israel directly affect operations.
                                      Since Israel was established in 1948, a
                                      state of hostility has existed, varying in
                                      degree and intensity, between Israel and
                                      certain Arab countries. Although Israel
                                      has entered into agreements with some of
                                      these countries, the Palestine Liberation
                                      Organization and the Palestinian
                                      Authority, and the feuding parties have
                                      signed various declarations in hopes of
                                      resolving some of the hostilities, we
                                      cannot predict the future of the volatile
                                      Middle East and of Israel in particular.
                                      To date, Israel has not entered into a
                                      peace treaty with Lebanon or Syria, with
                                      whom Israel shares its northern borders,
                                      or with certain other Arab countries with
                                      whom a state of hostility exists. Any
                                      major hostilities involving Israel, the
                                      Palestinian Authority, or Arab countries
                                      in the Middle East could have a serious
                                      negative impact on our business
                                      operations. 

                                       15
<PAGE>

Some of our officers and              Furthermore, all nonexempt male adult    
employees are on military             citizens of Israel, including some of our
reserve.                              officers and employees, are obligated to 
                                      perform military reserve duty and are
                                      subject to being called for active duty
                                      under emergency circumstances. While we
                                      have operated effectively under these
                                      conditions in the past, we cannot predict
                                      the full impact of such conditions on us
                                      in the future, particularly if emergency
                                      circumstances occur.

We are sensitive to economic          Inflation in Israel and devaluation of the
conditions in Israel.                 NIS have an impact on our financial       
                                      results. Although Israel has substantially
                                      reduced the rates of inflation and
                                      devaluation in recent years, they are
                                      still relatively high and we could
                                      experience losses due to inflation or
                                      devaluation. If inflation rates in Israel
                                      increase again and hurt Israel's economy
                                      as a whole, our operations and financial
                                      condition could be negatively impacted.

We do not know the impact of          Israeli law limits foreign currency   
recent policy changes on              transactions and transactions between 
foreign currency transactions.        Israeli and non-Israeli residents. The
                                      Controller of Foreign Exchange at the Bank
                                      of Israel, through "general" and "special"
                                      permits, may regulate or waive these
                                      limitations. Until recently, transactions
                                      in foreign currency were strictly
                                      regulated. In May 1998, the Bank of Israel
                                      liberalized its foreign currency
                                      regulations by issuing a new "general
                                      permit" pursuant to which foreign currency
                                      transactions are generally permitted,
                                      although certain restrictions still apply.
                                      Restricted transactions include foreign
                                      currency transactions by institutional
                                      investors, including futures contracts by
                                      foreign residents for periods of more than
                                      one month, and investments outside of
                                      Israel by pension funds and insurers.
                                      Under the new general permit, all foreign
                                      currency transactions must be reported to
                                      the Bank of Israel. We cannot currently
                                      assess what impact, if any, this
                                      liberalization will have on us. We also
                                      cannot predict its impact on the value of
                                      the NIS compared to the dollar and the
                                      corresponding effect on our financial
                                      statements.

Service of process and                We are organized under the laws of Israel
enforcement of judgments.             and our headquaters are in Israel. Certain
                                      of our officers, directors, selling
                                      shareholders and named experts in this
                                      Prospectus reside outside of the United
                                      States. Therefore, you may not be able to
                                      enforce any judgment obtained in the U.S.
                                      against us or any of such persons. You may
                                      not be able to enforce civil actions under
                                      U.S. securities laws if you file a lawsuit
                                      in Israel. However, we have been advised
                                      by our Israeli counsel that subject to
                                      certain limitations, Israeli courts may
                                      enforce a final judgment of a
We have appointed an agent to         U.S. court for liquidated amounts in civil
accept service of process in          matters after a hearing in Israel. We have
New York.                             appointed CT Corporation System as our    
                                      agent to receive service of process in any
                                      action against us in any Federal or State
                                      Court in New York City arising out 


                                       16
<PAGE>

                                      of this offering. We have not given our
                                      consent for our agent to accept service of
                                      process in connection with any other
                                      claim. If a foreign judgment is enforced
                                      by an Israeli court, it will be payable in
                                      Israeli currency.

We are preparing for the              Many computer systems and software        
Year 2000.                            products will not function properly as the
                                      year 2000 approaches due to a once-common
                                      programming standard that represents years
                                      using only two-digits. This is known as
                                      the Year 2000 problem. We are in the
                                      process of upgrading our computers to
                                      avoid the Year 2000 problem. As part of
                                      this program, we will identify those
                                      systems and applications that require
                                      modification, redevelopment or
                                      replacement. We expect to be Year 2000
                                      compliant by December 31, 1998 with
                                      respect to our internal systems. We do not
                                      believe that the failure of our vendors or
                                      other third-party providers' systems to be
                                      Year 2000 compliant will negatively impact
                                      our business.

Forward-looking statements.           In this prospectus we make forward-looking
                                      statements that involve risks and
                                      uncertainties. Our actual results could
                                      differ considerably due to a variety of
                                      factors, including competitive
                                      developments, the risk factors listed
                                      above, and the risk factors listed from
                                      time to time in the reports we file with
                                      the U.S. Securities and Exchange
                                      Commission.

                                       17
<PAGE>

                                 USE OF PROCEEDS

      The Company will not receive any proceeds from the sale of the Shares
offered by the Selling Shareholders. Management estimates that the aggregate
expense of this offering will be approximately $254,000, all of which will be
borne by the Company.

      The gross proceeds from the exercise of all of the outstanding Warrants
and Options would be $1.51 million and from the exercise of all outstanding
Warrants and Options Options would be $1.72 million, assuming no exercise of
Warrants pursuant to cashless exercise provisions thereof. The Company intends
to use the proceeds from the exercise of the Warrants and Options, if any, for
working capital and general corporate purposes.

                            MARKET FOR COMMON EQUITY

      The Company's Ordinary Shares have traded in the over-the-counter market
in the United States since the initial public offering on October 6, 1995, and
are quoted on the Nasdaq National Market under the symbol NURTF. There is no
non-United States trading market for the shares.

      As of October 9, 1998, there were 137 record holders of Ordinary Shares,
of which 114 represented United States record holders holding approximately
78.85% the outstanding Ordinary Shares of the Company.

      The prices set forth below are high and low closing bid prices for the
Ordinary Shares of the Company as reported by Nasdaq National Market. Such
quotations reflect inter-dealer prices, without retail markup, markdown, or
commission and may not necessarily represent actual transactions.

<TABLE>
<CAPTION>
            Quarter                         High             Low
            -------                         ----             ---
            <S>                             <C>              <C>      
            1st Quarter 1996                5 1/8            2 3/4
            2nd Quarter 1996                4 1/2            2 3/8
            3rd Quarter 1996                3 1/4            1 3/4
            4th Quarter 1996                2 3/4            1 1/2
            1st Quarter 1997                2 1/4            1 1/4
            2nd Quarter 1997                1 3/4            1
            3rd Quarter 1997                2 1/8            1 1/16
            4th Quarter 1997                2 1/8            1 1/4
            1st Quarter 1998                3 1/8            1 11/16
            2nd Quarter 1998                4 1/2            2 1/4
            3rd Quarter 1998                3 1/8            1 15/16
            4th Quarter 1998*               3                1 3/4
</TABLE>

- - - - - - ----------
* Represents the period from October 1, 1998 through October 19, 1998.

                                       18
<PAGE>

                                 DIVIDEND POLICY

      The Company has never paid a cash dividend on its Ordinary Shares and does
not anticipate that it will pay any cash dividend on its Ordinary Shares in the
foreseeable future.

                                 CAPITALIZATION

      The following table sets forth the actual capitalization of the Company as
of June 30, 1998, and pro forma as adjusted to give effect to (i) the issuance
of 400,000 additional Ordinary Shares upon exercise of the Warrants; (ii) the
Recapitalization; and (iii) the issuance of 1,342,339 additional Ordinary Shares
upon the exercise of options granted under the Company's 1995 and 1997 Stock
Option plans (the "Stock Option Plans"). See "Description of Securities" and
"Management--Stock Option Plans."

This table should be read in conjunction with the Company's Financial Statements
and the Notes thereto included elsewhere in this Prospectus.

<TABLE>
<CAPTION>
                                                             June 30, 1998
                                                             -------------
                                                                    Pro Forma as
                                                         Actual       Adjusted
                                                        --------    ------------
                                                            (In Thousands)
                                                        --------      --------
<S>                                                     <C>           <C>     
Cash and cash equivalents ............................  $  2,082      $  4,206

Ordinary Shares of NIS 1 per nominal value:
20,000,000 shares authorized; 10,880,000 shares
issued and outstanding; 1,742,339 shares issued
and outstanding pro forma as adjusted ................     2,729         3,188

Additional paid-in capital ...........................    14,350        16,016

Cumulative translation adjustments ...................       (30)          (30)

Accumulated deficit ..................................   (11,297)      (11,297)
                                                        --------      --------
Total shareholders' equity ...........................     5,752         7,877
                                                        --------      --------
Total capitalization .................................  $  5,752      $  7,877
                                                        --------      --------
</TABLE>

                                       19
<PAGE>

                                            SELECTED CONSOLIDATED FINANCIAL DATA
                                                  STATEMENTS OF OPERATIONS
                                                      (In U.S. Dollars)
<TABLE>
<CAPTION>
                                                                                                               Six Months Ended
                                                          Years Ended December 31,                                 June 30,
                                     ------------------------------------------------------------------    ------------------------
                                        1993          1994          1995          1996*         1997*         1997*         1998*
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
                                                              (in thousands except share data)
<S>                                  <C>           <C>           <C>           <C>           <C>           <C>           <C>       
Revenues
Sales of printers and related        $    6,880    $   10,010    $   13,824    $   13,639    $   18,874    $    7,909    $   14,233
products
Sales of printed materials                   --            --            --         2,998         3,085         1,304         1,621
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
                                          6,880        10,010        13,824        16,637        21,959         9,213        15,854
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
Cost of revenues
Cost of sales of printers and
related products                          4,861         6,939         9,374        11,528         9,627         4,213         6,862
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
Cost of sales of printed
materials                                    --            --            --         2,008         1,684           711           993
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
                                          4,861         6,939         9,374        13,536        11,311         4,924         7,855
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------

Gross profit                              2,019         3,071         4,450         3,101        10,648         4,289         7,999

Research & development expenses             739           497         1,040         1,530         1,726           756         1,591
Less royalty-bearing grants                 144           161           306           372            43           127           310
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
Research & development
expenses, net                               595           336           734         1,158         1,683           629         1,281
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------

Selling and marketing
expenses, net                               867           715         1,039         4,823         4,620         1,891         2,844

General & administrative
expenses                                    520         1,099         1,187         2,560         3,439         1,662         2,358
Write-off of debts from
related parties                              --            --            --         3,757            --            99            --
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
                                          1,387         1,814         2,226        11,140         8,059         3,652         5,202
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------

Operating income (loss)                      37           921         1,490        (9,197)          906             8         1,516
Financial expenses, net                     243            65           205           589           320           286           320
Gain (loss) on marketable
securities                                  251           (40)           12            22            --            --            --
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
Other income (expenses), net                 --            --           110            76            (8)           --           (91)
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------

Income (loss) before taxes
on income                                    45           816         1,407        (9,688)          578          (278)        1,105
                                     ----------    ----------    ----------    ----------    ----------    
Taxes on income                              60            25           221           400            67            --           112
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------

Income (loss) after taxes
on income                                   (15)          791         1,186       (10,088)          511          (278)          993

Minority interest in earnings
of subsidiary                                --            --            --            --           (26)           --           (12)
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
Equity in loss of 50% owned
joint venture                              (528)         (987)       (1,125)           --            --            --            --
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
Net income (loss) for the year       $     (543)   $     (196)   $       61    $  (10,088)   $      485    $     (278)   $      981
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------
Basic and diluted earnings
(loss) per share                     $    (0.15)   $    (0.05)   $     0.01    $    (1.47)   $     0.07    $    (0.04)   $     0.09
                                     ----------    ----------    ----------    ----------    ----------    ----------    ----------

Weighted average number of
shares outstanding used in
computing basic and diluted
earnings (loss) per share             3,624,708     4,123,082     4,904,118     6,880,000     7,293,640     6,880,000    10,880,000
                                     ==========    ==========    ==========    ==========    ==========    ==========    ==========
</TABLE>
- - - - - - ----------

* Represents the Company on a consolidated basis with its subsidiaries, Nur
Media Solutions, Nur America, Nur Europe and Nur Germany.

                                       20
<PAGE>

<TABLE>
<CAPTION>
                                                     Balance Sheet Data
                                                      (In U.S. Dollars)

                                                December 31,                                June 30,
                                 ------------------------------------------          ----------------------
                                   1995             1996*             1997*           1997*           1998*
                                 -------           ------           -------          ------          ------
                                                              (in thousands)
                                 --------------------------------------------------------------------------
<S>                              <C>                 <C>            <C>              <C>             <C>   
Working Capital..............    $10,597             $690           $ 4,674          $1,310          $4,758
Total assets.................     16,759           12,161            13,783          10,908          16,997
Total liabilities............      4,945           10,325             7,998           9,177          10,388
Total shareholders' equity...    $11,814           $1,836           $ 5,785          $1,731          $6,609
</TABLE>

*Represents the Company on a consolidated basis with its subsidiaries, Nur Media
Solutions, Nur America, Nur Europe and Nur Germany.

                                       21
<PAGE>

         MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
                             RESULTS OF OPERATIONS

General

      NUR Macroprinters Ltd. (the "Company") is a world leader in the market 
for the sale of very large format digital printing systems. The Company
develops, manufactures, sells, and services digital, ink-jet color printing
systems for on demand, short-run, large format ("LF") and very large format
("VLF") printing. The Company also supplies ink and its solvent, which are
consumable products essential to the operation of the Company's printers. In
June 1998, the Company began supplying substrates for use with the Company's
printers. The Company's total revenues grew from approximately $13.8 million for
the year ended December 31, 1995 to approximately $22 million for the year ended
December 31, 1997.

      The Company carries out its main research, development and assembly
operations at its facilities in Moshav Magshimim and Rosh Ha'ain, Israel. The
Company's main sales and service activities are carried out through its wholly
owned subsidiaries, Nur Europe, located in Brussels, Belgium, and Nur America,
located in Newton, Massachusetts, in the United States. The Company wholly owns
Nur Media Solutions (formerly Nur International), which is located in Brussels,
Belgium and which engages in developing and marketing advanced consumables for
the Company's rinters. The Company also owns 84% of Nur Germany, a digital
printing and outdoor advertising company located in Kassel, Germany.

      The Company has been traded on the Nasdaq National Market under the symbol
of NURTF since October 1995.

      Revenues from the Company's printers and related materials are derived
from the sale of the Company's printers, inks, substrates, spare parts and
related services. Revenues from printed materials are derived from Nur Germany's
printing and advertising display services.

      Cost of sales of printers and related materials includes costs related to
product shipments including materials, labor, overhead, and other direct or
allocated costs involved in the manufacture, warehousing, delivery, support and
maintenance of products. Cost of sales of printed materials includes costs
related to product materials involved in the printing and delivery of printed
materials.

      Research and development expenses include mainly labor, materials consumed
and investments in research and development expenses by sub-contractors,
consultants and others. Research and development expenses are carried to the
statement of operations as incurred. Grants are netted from research and
development costs on an accrual basis as the related expenses are incurred.

      The sales and marketing expenses include the costs associated with the
staff of the sales and marketing force of the Company and its subsidiaries,
advertising and promotion of existing and new products, trade shows,
commissions, and other marketing activities.

      During 1997, the Company expended significant financial and management
resources to expand its business and product offerings. The Company has invested
in strengthening the service and sales organizations in Nur Europe and Nur
America, by hiring additional sales and service staff in both territories. The
Company has also invested in the creation and set-up of Nur 

                                       22
<PAGE>

Media Solutions, a subsidiary dedicated to the development and marketing of
substrates for the use with the Company's products. The Company will be
expending more resources to this operation during 1998. During 1997 and 1998,
the Company invested in a new line of printer products aimed at the screen
printing market. Revenues from such printers are expected in the first half of
1999.

      In the first quarter of 1997, the Company introduced the Blueboard, a 16.4
ft. wide format printer designed and developed by the Company, which became the
Company's principal product. The Blueboard printer was the first product of the
Company developed fully in-house, and as a result contributed significantly to
the increase in the gross margins on equipment, and enhanced the ability of the
Company to introduce upgrades and enhancements to the product.

      In April 1998, the Company introduced a faster version of the Blueboard,
the Blueboard 2, in response to increased demand in the VLF printing industry
for increased productivity.

      In September 1998, the Company acquired from Meital Electronic Technology
Ltd. ("Meital") all rights (including all related assets) to Meital's piezo drop
on demand inkjet technologies for application in large format digital printers
for approximately $3.0 million, consisting of an up-front payment of $0.75
million, the assumption of certain liabilities, and future sales based 
royalties. The Meital acquisition is expected to result in the recognition by
NUR of a one-time charge involving a write-off assigned to in-process research
and development in the range of $1.5 million to $1.6 million. This charge will
be taken in the third quarter of 1998. In addition, the Company has future
royalty obligations, during the next three years, which will not exceed $1.3
million.

Certain Royalty Obligations

      As of June 30, 1998, the Company had a contingent liability to pay OCS
$0.99 million in future royalty payments. During the six months ended and as of
June 30, 1998, the Company had made royalty payments of approximately $.08
million to the Marketing Fund. The Company is obligated to pay such royalty
until 100% of the grants have been repaid. The Company is also obligated to pay
the OCS and the Marketing Fund royalties in the amount of 2% to 3% of sales and
3% of the export added value of the Company's sale of printers and related
products, respectively, in connection with certain research and development and
marketing grants. During 1995, the Company paid royalties of approximately $0.10
million to OCS. No royalty payments were made in 1996 or in 1997. The Company
may not be eligible for additional grants from the Marketing Fund in the future
due to the Company reaching the maximum allowed export revenues.

      In the past, there were agreements with Rami Dochovna, an individual and a
group of companies affiliated with him, who were involved in the development and
manufacturing of the Company's first generation Outboard and Wideboard printers
(collectively: the "Dochovna Group"). Pursuant to these agreements, the Company
paid royalties in the amount of 4% of the sales of the Outboard printer and the
Wideboard printer. The Dochovna Group and the Company are currently in
litigation concerning, among other matters, the Dochovna Group's claim for
royalties on the sales of the Blueboard printer and the Ink. See
"Business--Legal Proceedings."

                                       23
<PAGE>

Certain Accounting Policies

      The main sources of revenues for the Company are sales of the Company's
printers and related consumable products. Sales are recognized upon shipment of
the product to customers, when no significant vendor obligation remains and
collection is deemed probable.

      The Company prepares its financial statements in U.S. dollars. The U.S.
dollar is the currency of the primary economic environment in which the
operations of the Company are conducted. The majority of the Company's sales are
made outside of Israel in U.S. dollars and the majority of purchases of
materials and components are invoiced and paid in U.S. dollars. In addition,
substantial amounts of other expenses are incurred outside Israel in U.S.
dollars or paid in U.S. dollars or in NIS linked to the exchange rate of the
U.S. dollar. See note 2 to the Company's Financial Statements for a discussion
of the Company's accounting policy for determining rate of exchange and linkage
based amounts.

      Transactions and balances originally denominated in U.S. dollars are
presented at their original amounts. Transactions and balances in other
currencies are re-measured into U.S. dollars in accordance with the principles
set forth in Statement No. 52 of the Financial Accounting Standards Board 
("FASB").

Current and Future Trends

      The Company has estimated based on its own market research that the VLF
industry has grown at a rate of 15-20% annually for the last 3 years. The
Company's growth during 1997 and the first six months of 1998 has exceeded this
growth rate, mainly as a result of increasing market share of the Company in the
VLF market and the introduction of new products. Although there can be no
assurance, the Company believes it will maintain during the last six months of
1998 and during 1999 a growth rate similar to the general industry's growth rate
in the VLF segment of its business. The Company is also planning to introduce
products to the LF professional print market during 1999. The gross margins of
the Company are expected to remain at the 1997 levels throughout 1998. Although
there is a downward price pressure on the Company's existing products, there
have been certain reductions in the manufacturing cost of these products. The
Company's new products are anticipated to be launched at gross margins similar
to its existing products.

      The VLF industry has undergone significant changes in the past few years,
and additional change is anticipated in the future. The most noticeable change
in the industry during 1997 has been the adoption of inkjet technologies by all
major competitors in the industry. Until 1997, the Company had the only
continuous inkjet VLF printer in the market. During 1997, the Company's major
competitors have each introduced an inkjet-based printer to replace their
existing airbrush printers. The new printers, introduced during 1997, are based
on the DOD technology, as opposed to the Continuous InkJet (CIJ) technology
currently used by the Company's printers. To date, the Company has been
successful in maintaining and increasing its growth in revenues from the
Company's printers.

      With the cost of digital printing expected to decrease and the ability of
digital technology expected to produce shorter runs more economically, the
Company believes that the use of LF and VLF printing, such as that produced by
the Company's printers, should grow, and that the 

                                       24
<PAGE>

portion of the market serviced by digital printing should increase. The ability
to produce VLF images digitally has also opened new media opportunities for
advertisers, such as mural printing, carpet printing, new forms of fleet
graphics printing. The growth in demand for VLF digital printers is fueled by
both the replacement of conventional print methods and the development of new
printing applications.

      The Company's future results may be affected by a number of factors,
including its ability to continuously develop, introduce, and deliver products
and technologies that offer its customers enhanced performance at competitive
prices; to strengthen its distribution channels in its primary markets; and to
expand its digital printing product offerings. Future operating results may also
be affected by the Company's ability to introduce new products on a timely
basis; to offer customers competitive technologies; to develop customer interest
in its new products and product enhancements; to anticipate accurately customer
demand patterns; and to manage future inventory levels in line with anticipated
demand. The Company's operating results may also be affected by delays in
customer purchasing decisions as a result of the introduction of new products
and product enhancements. These results may also be affected by currency
exchange rate fluctuations and economic conditions in the different territories
in which the Company operates.

      Certain of the statements made in this report are forward-looking
statements that involve risks and uncertainties. Actual results could differ
materially as a result of a variety of factors. See "Risk Factors."

                                       25
<PAGE>

Results of Operations

      The following table sets forth for the periods indicated certain line
items from the Company's statement of operations as a percentage of the
Company's sales:

<TABLE>
<CAPTION>
                                                                                                                   Six Months Ended
                                                                                Years ended December 31,                June 30,
                                                                       -----------------------------------------    ---------------
                                                                       1993     1994     1995     1996*    1997*    1997*     1998*
                                                                       ----     ----     ----     -----    -----    -----     -----
                                                                                                (in percents)
                                                                       ------------------------------------------------------------
<S>                                                                    <C>      <C>      <C>      <C>       <C>      <C>       <C> 
Revenues ..........................................................    100%     100%     100%     100%      100%     100%      100%
   Cost of sales of printers and
   related products ...............................................     71       69       68       69      43.9     45.7      43.3
   Cost of sales of printed materials .............................     --       --       --       12       7.6      7.7       6.3
   Gross profit ...................................................     29       31       32       19      48.5     46.6      50.4
   Research & development expenses ................................     11        5        8        9       7.8      8.2        10
   Research & development expenses net ............................      9        3        5        7       7.7      6.8       8.1
   Selling expenses, net ..........................................     12        7        7       29        21     20.6      17.9
   General & administrative expenses ..............................      7       11        9       15      15.7       18      14.9
   Write-off debts of related parties .............................     (4)      --       --       23        --      1.1        --
   Operating income (loss) ........................................      1        9       11      (55)      4.1      0.1       9.5
   Financial expenses, net ........................................      4        1        2        4       1.5      3.1         2
   Gain (loss) on marketable securities ...........................      4       --       --       --        --       --        --
   Other income (expense) .........................................     --       --        1       --        --       --      (0.6)
   Taxes on income (tax benefit) ..................................      1       --        2        2       0.3       --       0.7
   Minority interest in earnings of subsidiary ....................     --       --       --       --       0.1       --        --
   Equity in loss of a 50% owned subsidiary .......................     (8)     (10)      (8)      --        --       --        --
   Net income (loss) for the year .................................     (8)      (2)      --      (61)      2.2       (3)      6.2
</TABLE>

- - - - - - ----------
*Represents the Company on a consolidated basis with its subsidiaries, Nur Media
Solutions, Nur America, Nur Europe and Nur Germany.

   Six Months Ended June 30, 1998 Compared with Six Months Ended June 30,1997

      Total revenues increased by 72%, to approximately $15.85 million for the
six months ended June 30, 1998 from approximately $9.2 million for the six
months ended June 30, 1997. This was mainly as a result of a growth in unit
sales of the Blueboard printer and growth of ink sales due to a larger installed
base of the Company's printers.

      Sales of the Company's printers and related products increased by 80% to
approximately $14.2 million for the six months ended June 30, 1998 from
approximately $7.9 million for the six months ended June 30, 1997. The increase
is due to the sale of a larger quantity of printers and growth of ink revenues
from the Company's growing installed base.

      Gross profit was approximately $8 million for the six months ended June
30, 1998, an increase of $3.7 million from $4.3 million for the six months ended
June 30, 1997. Gross profit as percentage of sales increased to 50.4% for the
six months ended June 30, 1998 from 46.6% for the six months ended June 30,
1997. The increase in the gross profit as a percent in sales is attributable
mainly to a reduction in manufacturing and procurement costs.

      Research and development costs, net of OCS grants, were approximately
$1.28 million for the six months ended June 30, 1998, rising by 100.3% from
$0.63 million for the six months 

                                       26
<PAGE>

ended June 30, 1997, as a result of increased efforts in developing new
products. The Company expects to continue to invest significant resources in its
research and development programs for new products and enhancements of existing
products. The Company expects that research and development expenses will
continue to increase in absolute dollar terms as compared to previous years.

      Selling and marketing expenses were approximately $2.8 million for the six
months ended June 30, 1998 compared to approximately $1.9 million for the six
months ended June 30, 1997. The Company received $0.3 million for the six months
ended June 30, 1998 from the Marketing Fund for selling and marketing expenses
as compared to $0.13 million for the six months ended June 30, 1997. The
distribution subsidiaries, Nur Europe and Nur America incur the majority of
sales and marketing expenses. The Company will not be eligible for support from
the Marketing Fund commencing in 1999 due to the Company reaching the maximum
allowed export revenues.

      General and administrative expenses were approximately $2.36 million for
the six months ended June 30, 1998, compared to approximately $1.66 million for
the six months ended June 30, 1997, representing a 41.9% increase. This was due
primarily to ongoing re-building of the administrative infrastructure of the
company legal and audit costs.

      Taxes on income were $0.112 million in the six months ended June 30, 1998
as compared to no taxes in the six months ended June 30, 1997, due to taxable
income in the Company's subsidiaries.

      Financial expenses, net increased to $0.32 million in the six months ended
June 30, 1998 from $0.29 million in the six months ended June 30, 1997.
Approximately half of the financial expenses are due to bank and interest rate
charges and half to exchange rate differences.

   Year Ended December 31, 1997 Compared with Year Ended December 31, 1996

      Total revenues increased by 32.3%, to approximately $21.96 million for the
year ended December 31, 1997 from approximately $16.6 million for the year ended
December 31, 1996, mainly as a result the introduction and market acceptance of
the Blueboard and as a result of the move to direct distribution by the Company
of the Company's products in Europe and the United States, the Company's two
major markets. Growth was also fueled by the growth of sales of the ink as a
result of the growth of the installed base of the Company's printers.

      Sales of the Company's printers and related products increased by 38.4% to
approximately $18.8 million for the year ended December 31, 1997 from
approximately $13.6 million for the year ended December 31, 1996. This increase
is attributable primarily to the introduction and market acceptance of the
Blueboard and to increased revenues due to the move from sales through
distributors to direct sales to end users through the Company's subsidiaries in
Europe and the United States.

      Gross profit was approximately $10.6 million in the year ended December
31, 1997, an increase of $7.5 million from $3.1 million in the year ended
December 31, 1996. Gross profit as percentage of sales increased to 48.5% in the
year ended December 31, 1997 from 19% in the 

                                       27
<PAGE>

year ended December 31, 1996. The increase in gross profit is attributable
mainly to the change in distribution strategy discussed above and reduced
manufacturing costs.

      A portion of the Company's research and development expenses is funded by
the OCS pursuant to programs entitling the OCS to receive royalties on sales of
products developed with the use of OCS funds. Research and development costs,
net of OCS grants, were approximately $1.68 million in the year ended December
31, 1997, rising by 45% from $1.16 million in the year ended December 31, 1996,
as a result of increased efforts in developing new products. The Company expects
to continue to invest significant resources in its research and development
programs for new products and enhancements of existing products. The Company
expects that research and development expenses will continue to increase in
absolute dollar terms as compared to previous years.

      Selling and marketing expenses were approximately $4.6 million in the year
ended December 31, 1997 compared to approximately $4.8 million in the year ended
December 31, 1996. The Company received $0.2 million in the year ended December
31, 1997 from the Marketing Fund for selling and marketing expenses as compared
to no receipt of such funds in the year ended December 31, 1996. The Company
will not be eligible for support from the Marketing Fund commencing in 1999 due
to the Company reaching the maximum allowed export revenues. The majority of
sales and marketing expenses are incurred by the distribution subsidiaries, Nur
Europe and Nur America.

      In early 1997, Moshe Nur, the previous Chairman of the Company and its
former major shareholder, and companies controlled by Moshe Nur, experienced
financial difficulties. These affiliated companies and Moshe Nur had outstanding
debts to the Company stemming from a combination of purchases of printers, spare
parts, ink, and cash transfers. As a result, management of the Company decided
to write-off these debts in the year ended December 31, 1996, totaling $3.7
million. The Company was in litigation with Moshe Nur and his court appointed
receiver for the return of funds misappropriated from the Company until
September 1998 when a settlement was reached. See "Business--Legal Proceedings."

      In April 1997, following Moshe Nur's financial difficulties, a group of
investors led by Dan Purjes, the Chairman and CEO of Josephthal & Co. Inc.
("Josephthal") assumed control of the Company and consequently replaced all but
one of the previous directors. The Chairman, Chief Executive Officer and Chief
Financial Officer of the Company were also consequently replaced. See "Certain
Transactions."

      In the year ended December 31, 1997, sales to related parties were 0.8%,
as opposed to 3.6% for the year ended December 31, 1996 as a result of the
change in control of the Company.

      General and administrative expenses were approximately $3.4 million for
the year ended December 31, 1997, compared to approximately $2.56 million for
the year ended December 31, 1996, representing a 34.3% increase. This increase
was due primarily to legal and extra-ordinary audit costs resulting from the
change in control and management of the Company, and to the re-building of the
financial and administrative infrastructures of the Company.

      Taxes on income decreased by 83.25% to $0.067 million in the year ended
December 31, 1997 as compared to $0.4 million in the year ended December 31,
1996, due to available carry-forward losses (including capital losses) and
deductions aggregating approximately $7.5 million.

                                       28
<PAGE>

      Financial expenses, net decreased to $0.32 million in the year ended
December 31, 1997 from $0.59 million in the year ended December 31, 1996.

   Year Ended December 31, 1996 Compared with Year Ended December 31, 1995

      Following the review of its annual results, the Company found it necessary
to recast the breakdown of its quarterly results for the year ended December 31,
1996. The need for recasting of the quarterly reports arose from the discovery
of non-authorized transactions and misappropriation of funds by former company
officials.

      Total revenues increased by 20%, to approximately $16.6 million for the
year ended December 31, 1996 from approximately $13.8 million for the year ended
December 31, 1995.

      Sales of the Company's printers and related products increased by 6.4% to
approximately $13.6 million for the year ended December 31, 1996 from
approximately $12.6 million for the year ended December 31, 1995.

      Gross profit was approximately $3.1 million in the year ended December 31,
1996, a decrease of 30% from $4.45 million in the year ended December 31, 1995.
Gross profit as percentage of sales decreased to 19% in the year ended December
31, 1996 from 32% in the year ended December 31, 1995, mainly as a result of the
lower gross margins of the Wideboard as compared to the Outboard printer.

      Research and development costs, net of OCS grants, were approximately
$1.16 million in the year ended December 31, 1996, rising by 58% from $0.73
million for the year ended December 31, 1995, as a result of increased efforts
in developing new products.

      Selling and marketing expenses were approximately $4.8 million in the year
ended December 31, 1996 compared to approximately $1.04 million in the year
ended December 31, 1995. Selling expenses increased significantly due to the
Company and its subsidiaries undertaking direct sales and marketing in Europe
and the United States, which activities were previously handled by Scitex. There
was no participation by the Company in the Israeli government-sponsored
Marketing Fund with respect to the selling and marketing expenses in the year
ended December 31, 1996 as compared to a participation of $0.25 million in the
year ended December 31, 1995.

      For the year ended December 31, 1996, sales to related parties amounted to
3.6% of total sales, as opposed to 18% for the year ended December 31, 1995.

      General and administrative expenses were approximately $2.56 million for
the year ended December 31, 1996, compared to approximately $1.19 million for
the year ended December 31, 1995, representing a 115% increase, mainly due to
the consolidation of the subsidiaries, and increased administrative and
financial staffing expenses relating to the move to a publicly traded company.

                                       29
<PAGE>

      Taxes on income increased by 81% to $0.4 in the year ended December 31,
1996 as compared to $0.22 million in the year ended December 31, 1995 due to
increased profitability of Nur Germany.

      Financial expenses, net increased to $0.59 million in the year ended
December 31, 1996 from $0.21 million in the year ended December 31, 1995.

Liquidity and Capital Resources

      Since the commencement of the Company's activities in the second half of
1991 through mid-1993, the Company financed its operations primarily through
loans and injection of equity by shareholders. In October 1993, the Company
raised, through a private placement, approximately $6 million (approximately $3
million in equity and $3 million in convertible debentures).

      Following the 1993 private placement, the Company financed its operations
primarily through cash generated from operations. For the year ended December
31, 1995, the Company's major source of cash was the $6.86 million of net
proceeds from the Company's initial public offering in October 1995.

      The Company incurred a loss of approximately $10.1 million in the year
ended December 31, 1996. This loss is comprised of approximately $4.8 million in
losses due to increased expenses associated with the setup of direct sales and
marketing efforts by the Company in Europe and in the United States, and to the
assumption of international support and service; approximately $1.2 million in
research and development expenses; approximately $0.6 million in financing
expenses; approximately $0.4 million in elimination of deferred taxes; and
approximately $3.7 million in losses due to the write-off of debts to the
Company associated with Moshe Nur and companies controlled by him. These debts
resulted, in part, from ineffective controls that failed to prevent unauthorized
transactions and failed to detect the misappropriation of funds. As a result,
the Company's shareholders' equity was reduced to approximately $1.8 million.

      In the year ended December 31, 1997, the Company's net income was $0.485
million. In the fourth quarter of 1997, the Company completed a private
placement of $4 million of Ordinary Shares, from which the Company received net
proceeds of approximately $3.51 million (the "Private Placement"). Additional
capital was needed in order to fund accrued debts to suppliers during the year
ended December 31, 1996 and the beginning of 1997, and to increase the Company's
working capital and equity base.

      For the year ended December 31, 1997, the Company's major source of cash
was the $3.51 million of net proceeds from the Private Placement of equity.

Operating activities

      In the year ended December 31, 1997, the Company had net income of $0.485
million. Net cash used by operating activities was approximately $2.2 million.
The main changes in the Company's working capital were (i) an increase of
approximately $1.8 million in trade accounts receivable, (ii) a decrease of
approximately $1.24 million in trade payables, and (iii) a decrease of
approximately $1.3 million in customer advances

                                       30
<PAGE>

      In the six months ended June 30, 1998, the Company had net income of
$0.981 million. Net cash provided by operating activities was approximately
$2.27 million. The main changes in the Company's working capital were (i) an
increase of approximately $0.85 million in trade accounts receivable, (ii) an
increase of approximately $0.8 million in trade inventories, and (iii) an
increase of approximately $1.9 million in trade payables.

Investing activities

      The Company's investing activities used approximately $1.59 million in the
year ended December 31, 1995, approximately $0.53 million in the year ended
December 31, 1996, and approximately $1.38 million in the year ended December
31, 1997. The Company invested in the year ended December 31, 1997 approximately
$1.48 million in the purchase of property and equipment.

      The Company's investing activities used approximately $1.2 million in the
six months ended June 30, 1998, mainly due to the purchase of equipment,
computers and other properties.

Financing activities

      Net cash provided by financing activities in the six months ended June 30,
1998 was approximately $0.23 million.

      The Company maintains long and short-term credit facilities in an
aggregate amount of approximately $2.1 million. At June 30, 1998, the Company
had approximately $1.28 million in long-term loans from banks and others, $0.46
million of which is payable within 12 months.

      As of June 30, 1998, total current assets of the Company amounted to
approximately $13.6 million, out of which $2.14 million was in cash, cash
equivalents and marketable securities, compared with total current liabilities
of approximately $8.8 million. The increase in current assets is attributable
primarily to growth in trade receivables resulting from the growth in the
Company's revenues. The increase of the current liabilities is attributable
primarily to the increase of trade payables.

      Net cash provided by financing activities in the year ended December 31,
1995 was approximately $7.04 million. Substantially all of the cash provided in
the year ended December 31, 1995 constituted the net proceeds of the Company's
public offering. Net cash provided by financing activities in the year ended
December 31, 1996 was approximately $1.07 million. Net cash provided by
financing activity for the year ended December 31, 1997 was approximately $3.08
million.

      The Company maintains long and short-term credit facilities in an
aggregate amount of approximately $2.0 million. At December 31, 1997, the
Company had approximately $1.6 million in long-term loans from banks and others,
$0.53 million of which is payable within 12 months. Most of the Company's long
term loans are linked to the U.S. dollar bearing interest at a rate ranging
between 6.2% and LIBOR plus 3.12%.

      As of December 31, 1997, total current assets of the Company amounted to
approximately $11.2 million, out of which $1.23 million was in cash, cash
equivalents and marketable securities, compared with total current liabilities
of approximately $6.54 million. The 

                                       31
<PAGE>

increase in current assets is attributable primarily to growth in trade
receivables resulting from the growth in the Company's revenues. The decrease of
the current liabilities is attributable primarily to the decrease of trade
payables and customer advances.

Impact of Inflation and Exchange Rates

      Most of the Company's sales are in U.S. dollars. However, a large
proportion of the Company's costs relate to its operations in Israel linked to
the U.S. dollar. Approximately 50% of these costs are denominated in U.S.
dollars. Costs not effectively denominated in U.S. dollars are translated to
U.S. dollars, when recorded, at prevailing exchange rates for the purposes of
the Company's financial statements, and will increase if the rate of inflation
in Israel exceeds the devaluation of the Israeli currency against the U.S.
dollar or if the timing of such devaluations were to lag considerably behind
inflation. Consequently, the Company is and will be affected by changes in the
prevailing NIS/ U.S. dollar exchange rate.

      The Company might also be effected by the U.S. dollar exchange rate to the
major European currencies - mainly the German Mark and the Belgian Franc.

      During 1992 and 1993, the value of the U.S. dollar increased relative to
major currencies and the rate of inflation in Israel exceeded the rate in the
United States. In 1995 and 1996, the value of the U.S. dollar decreased relative
to major currencies, and the rate of inflation in Israel exceeded the rate in
the United States. The annual rate of inflation in Israel in 1995 was 8.1%,
which increased to 10.6% in 1996 and decreased to 7.0% in 1997 and to 2.2% in
the first six months of 1998. The NIS was devalued against the U.S. dollar by
approximately 8%, 1%, 3.9%, 3.7%, 8.8% and 3.7% in 1993, 1994, 1995, 1996, 1997
and the first six months of 1998 respectively. The Company cannot predict
whether the rate of devaluation of the NIS against the U.S. dollar will continue
to exceed the rate of inflation in the future and whether these conditions will
have a material adverse effect on the Company.

      The representative dollar exchange rate for converting the NIS to dollars,
as reported by the Bank of Israel, was NIS 3.667 for one dollar US on June 30,
1998. (NIS 3.536 on December 31, 1997, NIS 3.251 on December 31, 1996 and NIS
3.135 on December 31, 1995).

Current and Future Capital Needs

      The Company believes that existing capital resources and credit facilities
will be sufficient to fund the Company's current activities at their present and
planned rate through mid 1999. The Company may require additional funds, to be
raised through public or private financing of debt or equity, in order to ensure
its ability to maintain its current and planned operations after such time. If
such funds are not raised, the Company may have to reduce or eliminate
expenditures for research and development, production, or marketing of its
products, any one of which could have an adverse effect on the Company's
business.

      Even if additional financing is obtained, expansion of the Company's
business requires, and will continue to require, significant capital. In this
regard, the Company's capital requirements and level of expenses depend upon
numerous factors, including the scope and success of the Company's marketing and
customer service efforts, and of its research and development activities, as
well as the demand for the Company's products and services. 

                                       32
<PAGE>

Furthermore, there can be no assurance that such additional financing will be
available or that, if available, it will be obtained on terms favorable to the
Company. Moreover, in the course of the bankruptcy proceedings of Moshe Nur and
the companies controlled by him, the Company in the future may be exposed to
claims arising from the actions of Moshe Nur despite the recent settlement of
all material claims related to such persons and entities. Liabilities arising
from any such claims may be material. See "Business--Legal Proceedings."

Year 2000

       Many computer systems and software products will not function properly
as the year 2000 approaches due to a once-common programming standard that
represents years using only two-digits. This is known as the Year 2000 problem.
We are in the process of upgrading our computers to avoid the Year 2000 problem.
As part of this program, we will identify those systems and applications that
require modification, redevelopment or replacement. We expect to be Year 2000
compliant by December 31, 1998 with respect to our internal systems. We do not
believe that the failure of our vendors or other third-party providers' systems
to be Year 2000 compliant will negatively impact our business.

                                       33
<PAGE>

                                    BUSINESS

General

      Nur Macroprinters Ltd. (the "Company")(formerly Nur Advanced Technologies
Ltd.) is a world leader in the market for the sale of very large format
subcontractors, sells, and services digital ink-jet color printing systems for
on demand, short-run, large format printing in widths up to 1.80 meters
(approximately 6 feet) ("LF") and very large format printing of 1.80 meters
through to 5.0 meters (approximately 16.4 feet) ("VLF"). The Company also
supplies inks and solvents, which are essential to the operation of the
Company's printers, and print substrates for use with the Company's Printers.

      In early 1997, the Company introduced the Blueboard printer, a second
generation VLF printer, which prints on substrates of variable widths of up to 5
meters. The Blueboard printer is based on the Company's proprietary
continuous ink-jet technology, but otherwise is a completely new printer
designed for high throughput, high print quality, and ease of use. In April
1998, the Company introduced a faster version of the Blueboard printer, the Nur
Blueboard 2, in response to demand in the VLF printing industry for increased
productivity. The Blueboard printer, the Blueboard 2 printer and their upgrades
are referred to collectively as the "Blueboard Printers." The Blueboard Printers
are the Company's main hardware products.

      In September 1998, the Company acquired from Meital all rights (including
all related assets) to Meital's piezo drop on demand inkjet technologies for
application in large format digital printers for approximately $3.0 million,
consisting of an up-front payment of $0.75 million, the assumption of certain
liabilities and future sales based royalties. The Meital acquisition is expected
to result in the recognition by the Company of a one-time charge involving a
write-off assigned to in-process research and development in the range of $1.5
million to $1.6 million. In addition, the Company has future royalty
obligations, during the next three years, which will not exceed $1.3 million.
This charge will be taken in the third quarter of 1998.

      Until the end of 1995, the Outboard Printer, which is capable of printing
in widths of up to 1.6 meters (approximately 5 feet), was the Company's
principal product. In the fourth quarter of 1995, the Company introduced its
first generation VLF, the Wideboard Printer, which is capable of printing on
substrates of variable widths of up to 5 meters. The Outboard Printer, Wideboard
Printer, Blueboard Printer and the Blueboard 2 are referred to collectively as
the "Company's Printers."

      The Company's Printers are targeted principally to commercial printers,
design and service firms, screen printers, outdoor media companies and trade
shops for a variety of LF and VLF format printing applications, such as
billboards, posters, banners, and point of purchase displays for advertising, as
well as decorations and backdrops for showrooms, fleet graphics, trade shows,
museums, and exhibits. The Company's Printers allow customers to print LF and
VLF color prints on demand, generally in substantially less time, with less
labor and at a lower cost, than traditional methods of LF printing.

Industry Background

      The market for printed applications requiring VLF and LF printing has 
expanded over the last few years. VLF and LF printing applications include
billboards, posters and banners; special event and trade

                                       34
<PAGE>

show displays; point of purchase displays; fleet graphics; and decorations and
backdrops. For example, the retail, automotive, cigarette and tobacco,
restaurant, travel, and gasoline industries use outdoor advertising to promote
their products in locations which include roadside billboards and posters
displayed on streets and buildings, as well as the outside of buses, vans,
trucks, and trains, so-called fleet graphics. VLF and LF prints can also be
found in theaters as stage decorations, in museums and exhibitions as backdrops
or displays, and on construction sites as building site coverings. Prior to the
introduction of digital printing systems, VLF and LF short-run prints were
produced either by hand painting, which is slow, expensive, and produces lesser
quality images, or by silk screen or offset printing, both of which are
relatively expensive and time consuming processes.

      With the cost of digital printing expected to decrease and the ability of
digital technology expected to produce shorter runs more economically, the
Company believes that the use of LF and VLF printing, such as that produced by
the Company's Printers, should grow, and that the portion of the market serviced
by digital printing should increase. The ability to produce VLF images digitally
has also opened new media opportunities for advertisers, such as mural printing,
carpet printing, new forms of fleet graphics printing. The growth in demand for
VLF digital printers, is fueled by both the replacement of conventional print
methods and the development of new printing applications.

   Traditional VLF and LF Printing Methods

      Conventional methods of VLF and LF printing have included hand painting,
silk screen printing, and offset printing. Generally, producing VLF and LF color
prints by traditional methods in short-runs of 100 or less, depending on the
application, has either been relatively slow and expensive or of limited
quality. Because of the inherent limitations of the traditional VLF and LF
printing methods, quality VLF and LF prints produced by these methods are
generally limited to long runs of identical prints, designed and prepared well
in advance or, in the case of hand painting, to single print applications. As a
result, traditional methods of producing VLF and LF printing have not provided
timely and economic solutions for the needs of the short run printing market.

      Hand Painting. Hand painting involves either the projection of an image
onto a substrate, which is then drawn onto the substrate and subsequently
painted by hand, or the spraying of paint onto material covered by a template
that has been cut to the desired shape. The process of hand painting is an
alternative mainly in developing countries where labor costs are significantly
lower.

      Silk Screen-Printing. The silk screening process is distinguished by its
ability to print finely detailed images on practically any surface, including
paper, plastics, metals, and three-dimensional surfaces. Due to the expense of
creating the silk screen templates, the process is not considered economical for
quantities of fewer than 50 prints. In addition, due to the time and effort
required to create the template, customers are effectively prohibited from
altering a template, whether to correct a mistake, update information, or
customize a print, unless a new template is created. As a result, screen
printing is best suited for print runs requiring an identical image on every
print.

      Offset Printing. Offset color printing generally produces very high
quality images compared to hand painting or silk screen printing. Because of the
complex steps involved in 

                                       35
<PAGE>

offset color printing, each printing job, whether small or large, involves
substantial setup time and costs. In addition, much like hand painting and silk
screen printing, alterations and customizations are not economically feasible
unless the entire offset color printing process is repeated. Therefore, offset
color printing is generally best suited for long print runs.

   VLF and LF Digital Printing

      The introduction of digital printing is aiding in the transformation of
the VLF and LF printing industry by lowering setup costs, shortening turnaround
time, and reducing labor requirements. To the best belief of the Company, VLF
and LF digital printing should lead to an increase in limited runs for
customized and localized advertising campaigns. In addition, the Company
believes that single use applications, such as the use of banners, displays, and
backdrops for trade shows, theme parks, entertainment, and special events,
should become more popular. The Company believes that the market for VLF and LF
printing should increase as current applications gain market acceptance and as
new applications are developed.

      Digital printing involves the production of hard-copy images and text from
digital data that is either generated on a computer at the printing site or
originated by a customer on the customer's computer system. The digital data is
then transferred directly from an electronic pre-press or desktop publishing
system to the digital printer. There are currently several digital printing
technologies available, including electrostatic, airbrush, drop-on-demand,
thermal transfer, and continuous ink-jet printing.

      Electrostatic Printing. Electrostatic printing is a non-impact printing
technique which employs an array of metal styli, selectively pulsed to a high
potential to generate a charged latent image on dielectric-coated paper, which
is then toned to develop the latent image into a visible image. The achievable
printing resolution is up to 400 dots per square inch ("DPI"). The main drawback
of the technology is the need for special and expensive substrates. Moreover,
the electrostatic printing process is highly sensitive to both temperature and
humidity and must operate under controlled conditions.

      Airbrush Printing. Airbrush printing is accomplished by forcing a low
viscosity colored fluid through small aperture nozzles, thus creating a spray
jet. Computer driven modulation of the spray jets deposits an image-wise colored
layer deposited onto the substrate. The strongest feature of airbrush technology
is the printer's ability to cover large areas with uniform color. One
manufacturer of airbrush printers produces a printer that can also print on both
sides of a poster at the same time. This feature is important for signs that are
backlit.

      Drop-on-Demand Ink-Jet Printing ("DOD"). DOD technology involves the
firing of ink drops when needed on the substrate while the printing head travels
across the substrate. Until recently, this technology was limited to dye-based
inks that are not suitable for outdoor use. However, several new DOD printers
that use pigment inks, which are suitable for outdoor use, are now available.

      In the VLF market, there are several new DOD based printers. These
printers use a large number of nozzles to achieve print speeds similar to that
of the Company's Printers. As a result of the large number of nozzles the
Company believes that such printers may not be as reliable and productive as the
Company's Printers. Other advantages of the Company's Printers over 

                                       36
<PAGE>

DOD based printers are higher color repeatability and handling of larger variety
of substrates on which to print.

      Thermal Transfer Printing. Thermal transfer printing is a contact printing
technology that employs arrays of heated needles and pressure to melt and
transfer wax based inks from a carrier roll onto a restricted variety of
substrates.

      Continuous Ink-Jet Printing. Continuous ink-jet technology involves the
continuous flow of electrically conductive ink within a closed loop that is
deflected to a specific location on a sheet of paper or other medium. The ink is
separated into uniform micro-drops and the micro-drops are electronically
directed to be printed onto a selected area of the medium. Continuous ink-jet
technology allows for high speed printing and produces images with good
resolutions sufficient for viewing from distances of beyond five feet.
Continuous ink-jet printers also produce multiple copies with consistent color
quality, unlike airbrush printers. The cost of equipment using continuous
ink-jet technology is relatively high in comparison to printers using
electrostatic technology. However, the cost of the output produced with
continuous ink-jet printers is lower than that of electrostatic printers.
Although the printer and printing costs of continuous ink-jet and airbrush
technology are comparable, continuous ink-jet printers produce higher quality
prints, at higher speeds.

      The Company believes that its printers are currently the only commercially
available VLF or LF digital printers using multiple continuous ink-jet
deflection technology. The Company believes that the Company's Printers are well
suited to fit the overall needs of the VLF and LF printing market.

      The Company's strategy is to:

      o  maintain its position as a world leader in the VLF printing market by
         supplying the most productive and cost-effective digital VLF printers;

      o  introduce LF digital ink jet printers to replace current LF screen
         printing technology;

      o  be the vendor of choice for all its customers' ink and substrate needs;

      o  enable its customers to develop new ways to profit from the Company's
         printing systems; and

      o  provide its customers with state of the art service and supplies.

Products

   The Company's Printers

      The Outboard Printer, which was introduced in 1992, was the Company's
first product, and, until the end of 1995, its principal product. The Outboard
Printer is capable of producing LF prints of up to 63 inches in width. In the
fourth quarter of 1995, the Company introduced the Wideboard Printer, which was
the Company's first generation VLF printer and its principal product in 1996.
The Wideboard Printer is capable of producing prints of

                                       37
<PAGE>

widths of 16.4 feet. The Company has discontinued the manufacture of the
Outboard Printer and of the Wideboard Printer. The Company plans, however, to
provide further enhancements and upgrades to its Outboard and Wideboard
installed base.

      Since the beginning of 1997, the Company has been marketing and selling
the Blueboard Printer, a second-generation VLF printer that is also capable of
producing prints of up to 16.4 feet in width with practically no limit on the
legnth of the print. The Blueboard is designed for high throughput, high print
quality, and ease of use. When wider widths of prints are required, the
Blueboard Printer, as is the case with the other Company's Printers, creates a
print layout in sections that, when sealed and placed together, create a
continuous image due to the Blueboard Printer's high level of color consistency
and accuracy.

      In April 1998, the Company introduced a faster version of the Blueboard
Printer, the Blueboard 2 printer, in response to demand in the VLF printing
industry for increased productivity. In addition, the Company announced that all
Blueboard Printers are upgradable to the new double speed version for an
additional fee. The Blueboard Printers are now the Company's main hardware
products.

      The Blueboard Printers accept a wide variety of substrates, differing in
types and sizes, with a new design feeding mechanism which allows for ease of
loading and unloading of substrate rolls weighing 150 Kg or more. The Blueboard
Printers are unique in that they are able to print at their respective top
speeds (up to 300 sq. ft./hr. for the Blueboard and up to 600 sq. ft./hr for the
Blueboard 2) while printing at their respective highest resolutions (70 DPI for
each of the Blueboard Printers). The Blueboard Printers' software accepts many
popular types of image formats (such as TIFF, CT, JPEG, BMP, and PostScript) and
images with various resolutions, and converts them automatically for printing.
In addition, the Blueboard Printers' software can be connected to any
communication configuration supported by the operating system, which enables
smooth integration of the printers in the pre-press environment for higher
productivity. The Blueboard Printers' operating software is based on the
Windows-NT multitasking operating system that enables printing while preparing
the next job for print. The software has sophisticated color correction tables
that enable the printers to match color output according to substrate
characteristics.

      The Company's Printers are marketed primarily to commercial printers,
design and service firms, screen printers, outdoor media companies and trade
shops for short-run, LF and VLF printing. The Company's Printers reproduce
images with resolutions of 70 DPI, which allows for superior viewing from
distances of at least 10 feet, depending on the image file resolution. The
Company's Printers are capable of producing millions of distinctive colors. Due
to the constant ink monitoring of its continuous ink-jet printing technology,
the Company's Printers achieve a high level of color consistency for copies
printed from the same batch or from different batches produced from the same
file. Generally, depending upon the required print resolution, the Outboard
Printer operates at speeds of between 200 to 600 sq. ft./hr; the Wideboard
Printer operates at speeds of between 100 to 300 sq. ft./hr; the Blueboard
Printer operates at speeds of up to 300 sq. ft./hr; and the Blueboard 2 operates
at up to 600 sq. ft./hr.

      The Company's Printers are digital sheet or roll-fed presses that accept a
wide range of substrates. They print directly from digital data, using no
printing plates. The Company's Printers 

                                       38
<PAGE>

can be operated in a standalone mode or in conjunction with pre-press and
desktop publishing systems. When configured with a pre-press system, the
pre-press workstation prepares the digital file containing the specifications
for the output to be produced.

      The Company's Printers require little operator supervision, enabling one
operator to run several of the Company's Printers at once. While an operator
must be specifically trained in the operation of the printer, unlike
conventional methods such as offset printing, no special color mixing skills are
required.

      The Company's Printers significantly reduce the setup costs associated
with each print job, the skill level of the personnel required, and the number
of skilled personnel required as compared to traditional methods of LF printing.
These advantages make LF short-run color printing significantly more economical
than conventional printing methods. Additionally, the relatively quick
turnaround for the printed product enables the Company's Printers to produce
more output in a given period, thereby lowering the costs of labor per print.

      Unlike hand painting, silk screen, or offset printing, the layout can be
viewed through the pre-press workstation prior to printing, permitting last
minute fine-tuning. By running a single copy of the print, corrections of text,
enhancements of images, and additions of color can all be accomplished with
minimal time, effort, and cost. Additionally, since the format can readily be
changed, the Company's Printers allow the end-user to make each print in the run
different, with little time, effort, or additional cost. For example, if so
desired, different languages, graphics, and text can be added to each print in a
run.

      During the years ended December 31, 1995, 1996 and 1997 and the six months
ended June 30, 1998, sales of the Company's Printers accounted for approximately
73%, 56%, 55%, and 55%, respectively, of the Company's total sales. Sales of
spare parts used in the Company's Printers accounted for approximately 5%, 9%,
6% and 5%, of total sales for the years ended December 31, 1995, 1996 and 1997,
respectively. Currently, the retail price of the Company's Printers ranges
generally from $400,000 to $500,000 per printer.

   Ink

      The Company's Printers use a specialized pigment-based ink mixed with a
methyl-ethyl-keton ("MEK") solvent. The ink is resistant to water and
ultraviolet rays, making it fairly durable and thus well-suited for outdoor
conditions. The Company's Printers, through the utilization of the ink, can
print on almost an unlimited variety of substrates, including numerous types of
paper, vinyl, cloth, textiles, mesh, and metals. The ink enables the output of
the Company's Printers to be used both for indoor and outdoor advertising.
During the years ended December 31, 1995, 1996 and 1997 and the six months ended
June 30, 1998, sales of the ink accounted for approximately 11%, 15%, 21% and
24%, respectively, of the Company's total sales.

      The ink was developed jointly with Imaje S.A. ("Imaje"), a French Ink
manufacturer, specifically for use in the Company's Printers. The Company has an
exclusive distribution and manufacturing agreement with Imaje.

                                       39
<PAGE>

   Substrates

      As of June 1998, the Company also began supplying cost-effective
substrates designed to work with the Company's Printers and the ink. The Company
sells substrates under the Nur brand name that are manufactured by several
different suppliers for the Company. The substrates are made of vinyl, PVC,
paper, and mesh and are suited for indoor and outdoor use. The substrates will
be distributed worldwide by the Company's sales and service organizations.

Sales and Marketing

      The Company currently distributes and sells a vast majority of the
Company's Printers and related products in Western Europe and North America
through its wholly-owned subsidiaries, Nur Europe, a subsidiary registered in
Belgium, and Nur America, respectively. The Company engages in the sale and
marketing of printed material produced by the Company's Printers through Nur
Germany.

      In some countries of Eastern Europe and Latin America, distribution is
performed with the assistance of local dealers and distributors; in the Middle
East and the Far East, Scitex Corporation ("Scitex") has been distributing the
Company's Printers. Until the end of 1996, most worldwide sales of the Company's
Printers had been performed by Scitex.

      The marketing activities of the Company include participating in relevant
tradeshows worldwide, advertising in trade publications, direct marketing to a
target base, as well as publishing its own newsletter, participating in services
and industry forums and maintaining an internet site. The Company has also
started to sell its consumable products through a dedicated intranet site.

      In April 1998, the Company renamed its previously established wholly-owned
subsidiary, Nur International, to NUR Media Solutions. Nur Media Solutions'
objective is to develop and market a wide range of advanced consumables for the
Company's LF and VLF printers. Included in such consumables are the Company's
cost-effective substrates, which are designed to work with the Company's
existing range of printers and inks and will be distributed worldwide by the
Company's sales and service organizations.

      The Israeli Government, through the Marketing Fund, awards participation
grants for marketing expenses incurred overseas, including expenses for
maintaining warehouses and branches, advertising, catalogs, exhibitions and
surveys. In the years ended December 31, 1991, 1992, 1993, and 1995, and in the
six months ended June 30, 1998, the Company received grants from the Marketing
Fund totaling approximately $ 0.4 million for the promotion of the Outboard
Printer and the MegaLight. In 1997, the Company received $0.2 million for the
promotion of the Company's exportation of its printers. In the six months ended
June 30, 1998 the Company received $0.13 million for the same purpose. The
Company did not receive any grants in 1994 or in 1996. The Company is obligated
to pay a royalty of 3% of the export added value to the Marketing Fund until
100% of the grants have been repaid. The value of the grants are linked to

                                       40
<PAGE>

the U.S. dollar. As of June 30, 1998, the Company had made royalty payments in
respect of such grants to the Marketing Fund totaling approximately $.08
million.

Production and Sources of Supply

      The Company manufactures and assembles the Blueboard Printers, directly
performing the installation of the Company's proprietary software into the
Blueboard Printers and full system integration and acceptance testing of the
printer. The mechanical assembly of the Blueboard Printers is carried out by an
independent sub-contractor (the "Blueboard Assembler") at a facility located
near the Company's operations in Israel.

      The Company owns all rights to the Blueboard Printers, including the
rights to the production files and all know-how relating to the manufacture of
the printers, and the Company has the right to obtain the Blueboard Assembler's
production files and all special tooling it uses to manufacture the Blueboard
Printers in the event that the Company should have the need to assemble on its
own printers. The Blueboard Assembler currently has the capacity to assemble up
to about six Blueboard Printers per month. The Company believes that it can
expand production to meet any required increase in production, either through
the Blueboard Assembler, by utilizing additional sub-contractors, or by directly
undertaking assembly of the Blueboard Printers. The Company installs its
computer software and performs full system integration and acceptance testing of
the Blueboard Printers at the Blueboard Assembler's facility.

      The Company believes that its relations with the Blueboard Assembler are
satisfactory and that the Blueboard Assembler has complied in all material
respects with the Company's quality standards. If it should become necessary to
replace the Blueboard Assembler with another assembler or if the Company should
undertake the direct production of the Blueboard Printer, the Company believes
that such an event may have a material adverse effect on the Company's
production capabilities due to a possible delay during the transition period.

      The Company obtains the ink-jet heads and the ink used in the Company's
Printers from Imaje, the sole manufacturer and supplier of these components. The
Company has an exclusive distribution agreement for the ink with Imaje dated
June 26, 1995. Imaje has agreed to deposit the formula for the ink with a public
notary. Pursuant to the agreement, the Company has the right to obtain the
formula for the ink from Imaje, for a minimum period of three years from the
date of the agreement, if Imaje ceases to manufacture the ink or to sell the ink
to the Company or, subject to certain conditions, if Imaje fails to deliver the
ink within three months of a confirmed delivery date. In the case of either such
event, if Imaje does not deliver the formula to the Company within three months
following the Company's written request to obtain the formula, the public notary
shall release the formula to the Company. The Company believes that it will be
able to obtain and/or manufacture adequate supplies of the ink in the
foreseeable future.

      The Company has also entered into an agreement with Imaje for the supply
of the ink-jets pursuant to which Imaje has guaranteed to supply a specific
number of ink-jets to the Company until the end of 1998, with an option to
extend the agreement until the end of 1999. The Company has the right to modify
the quantity of ink-jets to be ordered annually upon two months' prior notice.
Under this agreement, Imaje, if required, maintains a limited inventory of eight
ink-jets in order to meet a temporary increase in the demand for ink-jets on
short notice. 

                                       41
<PAGE>

Imaje has also agreed to supply spare parts for the ink-jets for a period of
five years. There can be no assurance that, if necessary, the Company will be
able to obtain or manufacture adequate supplies of ink-jets in the future.

Service and Support

      The Company's warranty to its direct customers and the Company's
distributors in most cases covers defects in the Company's Printers for a period
of six months after installation. In most cases the Company has a parallel
warranty from its suppliers and the Blueboard Assembler with respect to most of
the components covered by the Company's warranty. The Company is also committed
to maintaining sufficient spare parts and materials necessary for the operation
of the Company's Printers for a period of five years after the manufacturing
date of the last Blueboard Printer.

Research and Development

      The development of new products, technologies, and applications and the
enhancement of existing products are believed to be an integral part of the
Company's operations. As of September 30, 1998, approximately 25% of the
Company's work force was engaged in research, development, and engineering.

      The Company is engaged in ongoing research and development projects aimed
at upgrading the capabilities of its printers to include faster operating speeds
and higher resolutions. The Company developed the Blueboard Printer during 1996
and introduced it in early 1997. In the first quarter of 1998, the Company
introduced the Blueboard 2, which is capable of greater printing speed. The
Company started commercial deliveries of the Blueboard 2 in July 1998. The
Blueboard 2 is offered as an upgrade to existing Blueboard customers for an
additional payment, thus enabling existing customers to enjoy the higher
productivity available to new customers.

      The Company is currently developing a new printer, the Fresco 100. In
September 1998, the Company purchased technology from Meital, which it plans to
incorporate into the Fresco 100. The Company believes that, if developed, such
implementation will enable the Company to approach the LF screen printing market
with a digital alternative to the traditional screen printing technology. The
Company purchased Meital's technology for an aggregate amount of $3 million, of
which payment of $0.85 million is conditional upon the success of the
technology, and $0.9 million will be paid in future installments. The Company
also undertook to handle any legal proceedings that may arise between Meital and
Idanit Ltd. ("Idanit"), an Israeli company.

      Total research and development expenses were approximately $1.04 million,
$1.53 million, $1.73 million and $1.59 million in the years ended December 31,
1995, 1996, 1997 and the six months ended June 30, 1998, respectively. Research
and development expenditures are comprised principally of salaries for
employees, the hiring of sub-contractors, capital investment in infrastructure
for software and electronic designs, and prototype material costs. Initially,
the Company relied on outside research and development. The Company began its
own research and development operations in early 1994. Nur Europe received a
grant from local authorities in Belgium for reimbursement of up to 70% of its
total research and development investment which 

                                       42
<PAGE>

it carries out in Belgium, up to approximately $1 million. If no revenues are
derived from the technologies and no products are developed by Nur Europe as a
result thereof, then no repayment of the grant is required. Should revenues be
recognized from the research and development efforts, a progressive 5-year
repayment program would be implemented. Nur Media Solutions has established a
research and development center in Belgium dedicated for the research and
development of print substrates and inks for use with the Company's Printers.

      In the past, the Company has received grants from OCS for the development
of its systems and products, including the Outboard Printer. The Company
received approximately $0.31 million, $0.37 million, $0.04 million and $0.0
million in research and development grants from the OCS in the years ended
December 31, 1995, 1996 and 1997 and the six months ended June 30, 1998,
respectively. The OCS awards grants of up to 50% (and in certain circumstances
up to 66%) of a project's approved expenditures in return for royalties. Under
the terms of the Company's funding from the OCS, royalties are payable generally
at a rate of 2% to 3% on sales of products developed from the funded project and
ending when 100% to 150% of the dollar value of the grant is repaid. During the
year ended December 31, 1995, the Company paid approximately $0.10 million in
royalties in respect of such grants to the OCS. No payments were made to OCS in
the years ended December 31, 1996 and 1997. As of June 30, 1998, the Company had
a contingent liability to pay OCS $0.99 million in future royalty payments. The
terms of these grants prohibit the manufacture of products developed with
government grants to be performed outside of Israel or the transfer out of
Israel of the technology developed pursuant to these grants without the prior
consent of the OCS. These restrictions do not bar exports from Israel of
products developed with such technologies. In addition, the know-how from the
research and development that is used to produce the product may not be
transferred to third parties or out of Israel without the approval of the OCS.

Competition

      The Company's Printers are targeted primarily at the market for short-run,
LF and VLF printing. In addition to competition from other manufacturers of LF
and VLF digital printers, the Company's products also face competition from
existing traditional LF and VLF printing methods, and from a provider of
printing services which uses its own proprietary digital printing technology.

      The most significant competition for the Company's Printers is based on
digital air brush, electrostatic, drop-on-demand, and thermal transfer
technology. In particular, the Company's VLF printers face substantial
competition from the printers using the DOD technology, and printers using
airbrush technology.

      Airbrush printers are generally sold at slightly lower prices than the
Company's Printers. Two manufacturers of airbrush printers produce a printer
that can also print on both sides of a poster at the same time. This feature is
important for signs that are backlit. However, airbrush printers have several
drawbacks, including producing prints with blurred details and text, and
requiring the changing of print head and print speed when altering print
resolution. In addition, airbrush printers do not produce copies with a high
level of color consistency and may require corrections and calibrations in order
to produce consistent quality copies. Finally, airbrush 

                                       43
<PAGE>

printers are slower than the Company's Printers. The principal manufacturers of
airbrush printers are Signtech Inc. and Vutek Inc.

      The Company also competes to a lesser extent with manufacturers of
electrostatic printers, including 3M and Raster Graphics, Inc. Although
electrostatic printing technology is considered to produce high resolution and
good quality color prints, this technology is considered highly sensitive and
requires an environment where the temperature and humidity must be controlled.
The output of electrostatic printers is significantly more expensive than that
of the Company's Printers. In addition, electrostatic printing is often not
suitable for the outdoors, unless the print is laminated at an additional cost,
further adding to the cost of a print.

      During 1997, both VLF largest competitors, Signtech and Vutek, as well as
one new competitor, Matan Digital Printing, introduced DOD based printers for
the VLF market. See "--Legal Proceedings." Idanit, a wholly owned subsidiary of
Scitex, is marketing an LF DOD printer that offers a speed higher than the speed
of the Company's Printers, and at a comparable output cost. The Idanit printer
is currently limited to a print width of 5 feet.

      The printing industry is large, and many of the Company's competitors
possess greater management, financial, technical, manufacturing, marketing,
sales, distribution, and other resources than those of the Company. As a result,
there can be no assurance that competitors will not develop and market products
utilizing new technology that are competitive in price and performance with the
Company's Printers, and there can be no assurance that the Company could compete
effectively with such products.

Trade Secrets, Patents and Proprietary Rights.

      The Company currently relies on a combination of trade secrets, licenses,
and patents, together with non-disclosure and confidentiality agreements, to
establish and protect its proprietary rights in its products. No assurance can
be given that the Company's existing patents or any future patents by the
Company will not be challenged, invalidated, or circumvented, or that the
Company's competitors will not independently develop or patent technologies that
are substantially equivalent or superior to the Company's technology. See
"--Legal Proceedings." There can be no assurance that further patent protection
will be obtained in Israel, the United States, or elsewhere, for existing or new
products or applications, or that such further protection, if obtained, will be
effective. In some countries, meaningful patent protection is not available. The
Company is not aware of any claims that its products infringe upon the
proprietary rights of third parties. However, there can be no assurance that
third parties will not assert infringement claims against the Company in the
future, and the cost of responding to such assertions, regardless of their
validity, could be significant. In addition, such claims may be found to be
valid and could result in awards against the Company, which could have a
material effect on the Company's business. As a result, the cost to the Company
of protecting its patent rights could be substantial. The Company believes that
its success is less dependent upon the legal protection afforded by patent and
other proprietary rights than on the knowledge, ability, experience, and
technological expertise of its employees and its key suppliers. It is the
Company's policy to have employees sign confidentiality agreements, to have
selected parties, including key suppliers, sub-contractors, and distributors,
sign non-competition agreements, and to have third parties sign non-disclosure
agreements. Although the Company takes precautionary measures to maintain its
trade secrets, no assurance can be given that others will not acquire equivalent
trade secrets or 

                                       44
<PAGE>

otherwise gain access to or disclose the Company's proprietary technology, or
that the Company can meaningfully protect its rights to such proprietary
technology not subject to patent protection.

Employees

      As of September 30, 1998, the Company employed 110 persons worldwide,
about 25% of which in research and development. All of the Company's employees
who have access to confidential information are required to sign a
non-disclosure agreement covering all Company confidential information that they
might possess or to which they might have access.

      The Company believes its labor relations are satisfactory. The Company
believes its future success will depend, in part, on its ability to continue to
attract, retain, motivate, and develop highly qualified technical, marketing and
sales, and management personnel.

      Israeli law generally requires severance pay equal to one month's salary
for each year of employment upon the termination of employment. The Company's
liability for future severance pay obligations is fully provided for by payments
equal to 8.33% of an employee's salary each month made to various managers'
insurance policies and by accrual. The employees of the Company are usually
provided with an additional contribution towards their retirement that amounts
to 10% of wages, of which the employees' and the employer each contributes half.
Furthermore, Israeli employees and employers are required to pay predetermined
sums to the National Insurance Institute, which is similar to the United States
Social Security Administration, and additional sums towards compulsory health
insurance.

Facilities

Israel

      The Company's main facilities in Israel include two adjacent buildings,
each building of approximately 6,500 square feet which the Company uses as its
headquarters and as a research and development facility. The buildings are
situated on a plot of land leased to Moshe Nur and his wife by the Israel Lands
Authority, located near Ben-Gurion International Airport.

      In September of 1998, the Company reached an agreement with Moshe Nur's
receiver (and certain creditors) pursuant to which the Company may continue to
lease the aforementioned facility until July 2000 without payment of rent. This
rent-free use of facilities was granted to the Company as set against payment
previously made and accounted for as pre-paid rent. See "--Legal Proceedings."

      In addition, the Company subleases an area of approximately 1,780 square
feet at the facilities of the assembler of the Blueboard Printers in Rosh
Ha'ain. The Company uses this facility to conduct software installation and
system integration operations for the Blueboard Printers.

Germany

      Nur Germany occupies facilities in Kassel, Germany, consisting of one
building of approximately 3,500 square feet. Nur Germany does not currently have
a formal lease agreement for the facilities.

                                       45
<PAGE>

United States

      Nur America leases office space in Newton Centre, Massachusetts consisting
of two office suites. Unless terminated by written notice, the lease is
automatically extended in one-year increments. Nur America originally leased one
suite in the building beginning in June 1996. In September 1997, Nur America
occupied a second office suite.

Belgium

      The Company has a fifteen-year lease on approximately 6,000 square feet of
office space in Brussels, Belgium expiring in March 2012, with an option to
purchase the property at the end of the lease term under certain conditions. If
such option is not exercised, the Company has the right to extend the term of
the lease for another three years under the same terms and conditions as the
initial lease. Rent for the facility is currently approximately $5,200 per
month. The rent is subject to adjustment annually and subject to an increase of
15% on January 1, 2000. The Company is also obligated to pay all taxes for the
adjusted value of the lease, all utilities and building depreciation and
accompanying taxes for the building and equipment.

      The Company has granted several security interests in its assets to
various banks and leasing companies to secure bank credit lines and lease
facilities.

      Aggregate rental expenses were $42,000, $244,000 and $350,000 for the
years ended December 31, 1995, 1996, and 1997 and $779,000 for the six months
ended June 30, 1998.

Insurance

      The Company believes that the insurance coverage for its business is in
accordance with industry standards and is adequate and appropriate in light of
the Company's businesses and the risks to which they are subject.

Legal Proceedings

      In September, 1998, the district court of Tel Aviv approved a settlement
agreement among the Company and several other parties that, together with other
settlement agreements, resolved all material claims relating to Mr. Moshe Nur
and his affiliated companies. Mr. Nur served until April 1997 as the Company's
Chairman and was its major shareholder.

      The parties to the court approved settlement agreement were the Company,
the special manager for Moshe Nur's assets in his bankruptcy proceedings, Moshe
Nur, and other of his family members. The parties to the other settlement
agreements included two Israeli banks, and the temporary receiver of Nur Outdoor
Advertising Ltd. (a company formerly affiliated with Mr. Nur).

      According to the agreements, all material claims against the Company
relating to the lease of its facilities in Magshimim (including confirmation of
the Company's pre-payment of lease until July 2000), alleged breach of contracts
and alleged debts owed to any of the above mentioned parties were dismissed.
Separately, claims related to the ownership of the Company's shares have been
resolved and the temporary injunction on the issuance of securities by the
Company was lifted.

      As part of the various settlement agreements, the Company will pay an
aggregate of $100,000 and will withdraw its lawsuit against the First
International Bank.

                                       46
<PAGE>

      In December 1997, the Company filed suit against the developer of the
Outboard Printer and the Wideboard Printer, Rami Dochovna, and three companies
controlled by Mr. Dochovna (such companies and Mr. Dochovna are hereinafter
sometimes referred to herein as the "Dochovna Group"). The suit claims monetary
damages of approximately $1,200,000 for breach of contract relating mainly to
support and development of the Outboard Printer and the Wideboard Printer and
seeking injunctive relief in preventing the Dochovna Group from using the
Company's commercial knowledge relating to the Company's Printers and its
clients. In January 1998, the Dochovna Group filed suit against the Company
seeking approximately $376,000 in claims of alleged nonpayment and delayed
payments for services and products relating to printers supplied to the Company
and approximately $1.063 million in claims of alleged miscalculation of
royalties due on sales of the Company's Wideboard Printer. The Dochovna Group
also alleges that the Blueboard Printer is identical to the Wideboard Printer,
which the Company is allegedly prohibited from manufacturing without the
Dochovna Group's consent. In connection with such claim, the Dochovna Group
seeks to enjoin the Company from manufacturing and marketing the Blueboard
Printer and demands financial information as to royalties that he claims for
himself due to Blueboard Printer sales. The Company intends to vigorously defend
such claims and believes it has set aside adequate provisions in respect
thereof.

      In connection with the two mentioned suits a partial settlement was
reached between the Company and the Dochovna Group, according to which all
parties shall not apply for interim remedies or attachments against each other
or against companies controlled by the parties, in Israel or abroad, concerning
the facts founding the two suits and concerning the alleged breach of an Israeli
Patent number 98560 owned by the Company or any other parallel patent abroad.
According to this settlement it was also agreed, that the Dochovna Group shall
deposit in escrow an up to date version of the Outboard Printer source code and
up to date version of the Wideboard Printer source code, flow charts and
production file. The data in escrow could be released to the Company in certain
limited situations described in previous agreements between the parties. Should
the Dochovna Group cease to provide adequate maintenance for the software or
cause delays in the installation of the software, or not provide the source code
to the Company, there would be a material adverse effect on the Company's
business in that the Company may be unable to correct any defects in the
software. The software of the Blueboard Printer, which was the Company's main
source of revenue in the year ended December 31, 1997 and the six months ended
June 30, 1998, is fully controlled by the Company.

      In June 1998, Quantum Securities Ltd. ("Quantum") filed a suit against the
Company claiming that the Company breached an alleged investor relations
agreement between Quantum and the Company. In the suit Quantum claims $33,380 in
monetary damages and the right to Ordinary Share purchase warrants to purchase
100,000 Ordinary Shares of the Company at $1.75 per share and 100,000 Ordinary
Shares of the Company at $2.00 per share. The Company has denied that such an
agreement with Quantum exists with the Company and plans to defend itself
vigorously. The Company has also counterclaimed for reimbursement of
approximately $17,000 paid to Quantum in the past.

                                       47
<PAGE>

                                   MANAGEMENT


      The executive officers and directors of the Company are:

<TABLE>
<CAPTION>
Name                    Age     Position with the Company
- - - - - - ----                    ---     -------------------------
<S>                     <C>     <C>                                       
Dan Purjes(1)           48      Chairman of the Board of Directors
Erez Shachar            35      President, Chief Executive Officer and Director
Eitan Padan             35      Chief Financial Officer, Vice President 
                                of Finance and Secretary
Eyal Israeli            44      Vice President of Operations
Amir Noy                37      Vice President of Marketing
Yoram Ben-Porat         43      Director
Robert L. Berenson(2)   58      Director
Roni Ferber (1)(2)      55      Director
Robert Hussey(1)(2)     49      Director
</TABLE>

- - - - - - ---------

(1) Member of the Company's Stock Option Committee.
(2) Member of the Company's Audit Committee.

      Dan Purjes has served as the Chairman of the Board of the Company since
April 1997. Mr. Purjes is Chairman and Chief Executive Officer of Josephthal, an
investment banking and brokerage firm which is a member of the New York Stock
Exchange. Prior to joining Josephthal in 1985, Mr. Purjes was a Vice President
with a number of securities firms, including Bear Stearns & Co. and L.F.
Rothschild Unterberg Towbin, in their corporate finance and brokerage sales
divisions. He began his Wall Street career at Morgan Stanley & Co. in 1978 as a
director of their computer systems department. Prior to that, Mr. Purjes was a
manager at Citibank and at Philip Morris International in their computer systems
areas. Mr. Purjes earned B.S. and M.S. degrees in computer science from the City
College of New York School of Engineering.

      Erez Shachar has served as the Company's President and Chief Executive
Officer since October 1997 and as a Director of the Company since October 1997.
Mr. Shachar has also served as a Director of Nur Europe, Nur America and Nur
Media Solutions since January 1998. Prior to joining the Company, from 1989 to
1997 Mr. Shachar has served in various research and development, marketing,
sales, and senior management positions with Scitex. Mr. Shachar's last position
in Scitex was Vice President of Sales and Marketing of Scitex Europe, and prior
thereto Mr. Shachar held several positions in the marketing organization of
Scitex Europe. Prior to joining Scitex Europe, Mr. Shachar was a software
developer within the research and development group of Scitex. Mr. Shachar holds
a B.Sc. in mathematics and computer science from Tel Aviv University, and a
M.B.A. degree from INSEAD, France.

      Eitan Padan has served as the Chief Financial Officer, Vice President of
Finance and Secretary of the Company since October 1997. From 1995 to October
1997 Mr. Padan was Vice President Economics and CFO of Bezeq International,
Israel's largest long distance telecommunications carrier. In 1995 Mr. Padan was
Director of Business Development for International Projects in Bezeq and from
November 1992 to 1995 Senior Assistant to the Chairman of the Board of Bezeq,
the Israeli Telecommunications Company. Between 1989 and 

                                       48
<PAGE>

1992, Mr. Padan headed the economics department of Co-Op Blue-Square (NYSE:
BSI), and a member of management of Co-Op Blue Square. Mr. Padan holds a B.A. in
management and economics from Tel Aviv University, and has completed course
credits towards an M.B.A. degree from Tel Aviv University.

      Eyal Israeli has served as the Vice President of Operations since June
1996. Prior thereto, since January 1995, Mr. Israeli served as the Director of
Customer Support for Indigo Electronic Printing Systems Ltd. From February 1993
to January 1995, Mr. Israeli served as the Manager of Corporate Customer Support
for Orbotech Ltd. In addition, from January 1989 to 1993, Mr. Israeli served as
Vice President of Customer Support for Optrotech Inc., the U.S. subsidiary of
Optrotech Ltd. Mr. Israeli holds a B.Sc. degree in electronic engineering from
Ben-Gurion University and a M.Sc. degree in electronic systems from Tel Aviv
University.

      Amir Noy has served as the Vice President of Marketing since March 1996.
From March 1994 to March 1996, Mr. Noy was the Vice President of Research and
Development of the Company. From 1989 to March 1994, Mr. Noy served as Research
and Development Project Manager with Scitex. Between 1984 and 1989, Mr. Noy
served as a technical officer for communication with the Israeli Air Force. Mr.
Noy holds B.Sc. and M.Sc. degrees in electrical engineering from the Technion,
Israel Institute of Technology, and a M.B.A. degree from Tel Aviv University.

      Yoram Ben-Porat has served as a Director of the Company since March 1991.
Since October 1993, Mr. Ben-Port has served as Director and President of Nur
Media Solutions. Since October 1993, Mr. Ben-Porat has served as the Chief
Executive Officer and Deputy Chairman of the Board of Directors of Nur
International. He was among the founders of the Company and between January and
September 1993, he served as the Chief Executive Officer of the Company. From
1987 until December 1992, Mr. Ben-Porat served as Research and Development and
Business Development Manager of Nur Outdoor and Nur Focus. Prior thereto, he was
an independent consultant to metal finishing process companies in the high
technology industry. Mr. Ben-Porat holds a degree in economics and marketing
from the Tel Aviv College of Management and Administration.

      Robert L. Berenson has served as a Director of the Company since July
1998. Mr. Berenson is President of Grey Advertising Inc., the second largest
advertising agency in the United States and sixth largest in the world. He
joined Grey 34 years ago as an Assistant Account Executive, rose through the
ranks to become the youngest Executive Vice President in the company's history
in 1977 and took his present position as President in 1989. Mr. Berenson is also
a Director of the Better Busines Bureau of New York, the Advertising Educational
Foundation and the Federal Law Enforcement Foundation. He holds a B.S./B.A.
degree in journalism and marketing from Syracuse University and an M.S. degree
in journalism from the Medill School at Northwestern University.

      Roni Ferber has served as a Director of the Company since July 1998. Since
1991, Mr. Ferber has served as a Financial and Economic Consultant. In addition
to the Company, Mr. Ferber serves on the Board of Directors of Omnitech Eichut
Ltd., International Software Group Ltd., Zvi Zorfati Ltd. and Aflkim Consulting
and Investments Ltd. From 1986 to 1992, Mr. Ferber served as a Director and
member of the executive committee and of the investment committee of Caesarea -
Edmond Benjamin de Rothschild Foundation. During that time he also 

                                       49
<PAGE>

served as a Director and member of the executive committee of the Caesarea
Development Corporation. From 1967 to 1991, Mr. Ferber served as a Director and
co-founder of Nikuv Computers Ltd., the first Israeli software company to be
listed on the Tel Aviv Stock Exchange. From 1986 to 1991, Mr. Ferber served as
CEO of Nikuv Computers Ltd. Mr. Ferber holds a B.A. in economics from Hebrew
University and a B.A. in Semitic languages from Tel Aviv University. Mr. Ferber
is fluent in Hebrew, Arabic, English, French, German and Italian.

      Robert Hussey has served as a Director of the Company since the fourth
quarter of 1997. Prior to joining the Company, from June 1991 to April 1997, Mr.
Hussey served as the President and Chief Financial Officer of Metrovision of
North America. Prior to thereto, from 1984 to 1991, Mr. Hussey served as the
President, Chief Executive Officer and Director of POP Radio Corp., a company
which he helped form. From 1979 to 1984, Mr. Hussey served as the Vice
President/Management Supervisor for Grey Advertising, Inc. From 1977 to 1979,
Mr. Hussey was the Director of Financial Advertising for E.F. Hutton. Prior to
thereto, from 1973 to 1977, Mr. Hussey served as a Senior Financial Analyst and
Product Manager for American Home Products, Inc. Mr. Hussey holds a B.S.B.A
degree in finance and a M.B.A. degree in international finance from Georgetown
University.

Terms of Directors

      The members of the Board are elected annually at the Company's general
meeting and remain in office until the next annual general meeting of the
Company, unless the director has previously resigned, vacated his office, or was
removed in accordance with the Company's Articles of Association. In addition,
the Board may elect additional members to the Board.

Alternate Directors

      The Company's Articles of Association provide that, subject to the Board's
approval, a director may appoint, by written notice to the Company, any
individual (whether or not such person is then a member of the Board) to serve
as an alternate director. Any alternate director shall have all of the rights
and obligations of the director appointing him or her, except the power to
appoint an alternate (unless the instrument appointing him or her expressly
provides otherwise). The alternate director may not act at any meeting at which
the director appointing him or her is present. Such alternate may act as the
alternate for several directors and have the corresponding number of votes.
Unless the appointing director limits the time period or scope of any such
appointment, such appointment is effective for all purposes and for an
indefinite time, but will expire upon the expiration of the appointing
director's term.

Audit Committee

      In 1993, the Company established the Audit Committee. The Audit Committee
is charged with reviewing the annual audit and transactions between the Company
and related parties and with meeting with the Company's accountants to review
the Company's internal financial controls and financial managerial practices.
The Audit Committee is presently comprised of three members: Roni Ferber, Robert
Berenson and Robert Hussey. The Audit Committee must be comprised of
"independent members" and neither employees of the Company nor holders, directly
or indirectly through family members, of more than five percent of the Ordinary
Shares 

                                       50
<PAGE>

may constitute a majority of the Audit Committee. The Company is required to
maintain the Audit Committee as a result of the inclusion for quotation of the
Ordinary Shares on Nasdaq.

Stock Option Committee

      In March 1998, the Company established the Stock Option Committee. The
Stock Option Committee is charged with administering and overseeing the
allocation and distribution of stock options under the approved stock option
plans of the Company. The Stock Option Committee is presently comprised of three
members: Dan Purjes, Roni Ferber and Robert Hussey.

Compensation of Directors and Officers

      For the year ended December 31, 1995, the aggregate compensation paid by
the Company to the directors and executive officers of the Company (a total of 6
persons) amounted to $330,000. For the year ended December 31, 1996, the
aggregate compensation paid by the Company to the directors and executive
officers of the Company (a total of 7 persons) amounted to approximately
$523,000. For the year ended December 31, 1997, the aggregate compensation paid
by the Company to the directors and executive officers of the Company (a total
of 13 persons) amounted to approximately $813,000.

      In October 1997, the Company undertook to pay its Board members who are
not employees of the Company remuneration for their services as directors. This
remuneration includes an annual payment of $5,000 and an additional payment of
approximately $250 per meeting.

Options to Purchase Securities from Registrant or Subsidiaries

Outstanding Warrants and Options

      Following the initial public offering of the Company's shares in October
1995, the Company issued warrants to Josephthal exercisable to purchase 155,000
Ordinary Shares of the Company, at an exercise price of $7.20 per share, no
later than October 2000. Of these warrants, approximately 110,000 have been
transferred to directors and officers of the Company. Between September and
December 1997, the Company effected a private offering of its Ordinary Shares
for which Josephthal acted as exclusive placement agent. As part of its
compensation, Josephthal received warrants to purchase 400,000 Ordinary Shares
at an exercise price of $1.00 per share, none of which have been transferred to
directors and officers.

      In 1997, the Company granted 825,000 options to its officers and
directors. The Company has outstanding a total of 1,342,339 options to purchase
Ordinary Shares under the Company's 1995 Flexible Stock Incentive Plan and the
Company's 1997 Stock Option Plan. These options, which are subject to vesting
requirements, have been issued at exercise prices ranging from $0.30 to $1.75
with various expiration dates. Current directors and officers as a group hold
635,000 of these options.

                                       51
<PAGE>

1995 Stock Option Plan

      In 1995, the Company's Board adopted a Flexible Stock Incentive Plan (the
"1995 Plan") that provides for grants to employees and consultants of the
Company of stock options. An aggregate amount of not more than 500,000 stock
options is available for grant under the 1995 Plan, including options for future
services (such options, "Service Options"), options for performance (such
options, "Performance Options"), and options to consultants for service or
performance (such options, "Consultant Options").

      The Company's Board determines the employees and consultants who are
granted options under the 1995 Plan, the timing of such grants, the terms
thereof, and the number of shares to be covered thereby. The Board also
determines the exercise price for Ordinary Shares subject to the Performance and
Consultants Options under the 1995 Plan and the exercise price for the Service
Options, provided that in no case shall the exercise price of any Service Option
be less than 80% of the fair market value of such Ordinary Shares at the date of
grant (the "Date of Grant"). Service Options vest over a four-year period.
One-third of the Service Options vest after the second annual anniversary of the
Date of Grant with an additional one-third vesting on the third and fourth
anniversary of the Date of Grant, respectively. Performance Options vest under
the same terms as applicable to the Service Options. Consultants Options vest
over a specified period of time based on past or future services rendered or
performance targets to be achieved by the Company as determined by the Board.
Notwithstanding the foregoing, the Consultants Options vest ten years following
the Date of Grant. No option may be assigned or transferred except by will or
the laws of descent and distribution.

      Under the 1995 Plan for Israeli employees, all options and Ordinary Shares
issuable upon the exercise of options granted to Israeli employees of the
Company are held in a trust until the payment of all taxes due with respect to
the grant and exercise (if any) of such options.

1997 Stock Option Plan

      The Company's 1997 Stock Option Plan (the "1997 Plan") provides that it is
to be administered by the Board or by a committee appointed by the Board (the
"Committee"). The Committee currently consists of Robert Hussey and Robert
Berenson. The Committee has broad discretion to determine the persons entitled
to receive options under the 1997 Plan, the terms and conditions on which
options are granted, and the number of Ordinary Shares subject thereto, up to an
aggregate amount of 1,200,000 Ordinary Shares. The Committee also has discretion
to determine the purchase price to be paid upon the exercise of an option
granted under the 1997 Plan.

      The exercise price of the option shares under the 1997 Plan is determined
by the Committee; provided, however, that the exercise price of any option
granted shall not be less than eighty percent (80%) of the Stock Value (as
defined below) at the time of the issuance of such options (the "Date of
Grant"). The "Stock Value" at any time is equal to the then current Fair Market
Value (as defined below) of the Company's Ordinary Shares. For purposes of the
1997 Plan, the "Fair Market Value" means, as of any date, the last reported sale
price, on such date, of the Ordinary Shares on such principal securities
exchange of the most recent prior date on which a sale of the Ordinary Shares
took place.

                                       52
<PAGE>

      The Committee determines the term of each option granted under the 1997
Plan; provided, however, that the term of an option shall not be for more than
ten (10) years. Upon termination of employment, all unvested options lapse. All
options granted vest over a four-year period. One-third of such options vest
after the second anniversary of the Date of Grant, one-third after the third
anniversary, and the final third after the fourth anniversary of the Date of
Grant. Notwithstanding the foregoing, the Committee may determine different
vesting scheduled for consultant options in special circumstances.

      The options granted are subject to restrictions on transfer, sale, or
hypothecation. All options and Ordinary Shares issuable upon the exercise of
options granted to Israeli employees of the Company are held in trust for a
minimum of two years in accordance with Section 102 of the Israel Income Tax
Ordinance.

                                       53
<PAGE>

                             PRINCIPAL SHAREHOLDERS

      The following table sets forth certain information regarding the
beneficial ownership of the Company's Ordinary Shares as of October 9, 1998, by
(i) each person known by the Company to be the beneficial owner of more than 10%
of the outstanding Ordinary Shares and (ii) all of the Company's executive
officers and directors as a group (9 persons). All of the information with
respect to beneficial ownership by the Company's directors, executive officers
and beneficial owners has been furnished by the respective director, executive
officer, or beneficial owner, as the case may be. The Company believes that the
persons named in this table have sole voting and investment power with respect
to the Ordinary Shares indicated.

<TABLE>
<CAPTION>
                                  Ordinary Shares      Percentage of Ordinary
                                  Beneficially Owned   Shares Beneficially Owned
                                  ------------------   -------------------------
<S>                                   <C>                      <C>   
Dan Purjes*                           3,410,399                30.09%
                                                          
All current executive officers and                        
directors as a group (9 persons)      4,462,954                38.43%
</TABLE>

- - - - - - ---------------------------
*Dan Purjes is Chairman of the Company and Chairman of Josephthal & Co. Inc. See
"Certain Transactions."


                                       54
<PAGE>

                              SELLING SHAREHOLDERS

      The Ordinary Shares offered hereby are owned by the Selling Shareholders.
The following table sets forth certain information with respect to the ownership
of the Ordinary Shares by each Selling Shareholder as of October 9, 1998.

<TABLE>
<CAPTION>

                                                   
                                                      Shares Beneficially                               Shares Beneficially 
                                                          Owned Before                                      Owned After     
                                                        the Offering(1)                                   the Offering(1)   
Name and Address                                   --------------------------     Shares          -------------------------------
of Beneficial Owner                                Shares(2)    Percent(2)(3)   Offered(4)         Shares              Percent(3)
- - - - - - -------------------                                ---------      ----------    ----------        ---------            ----------
<S>                                                 <C>               <C>         <C>             <C>                    <C>  
Purjes, Dan(5)(6)                                 3,410,399           30.09       649,119         2,761,280               24.35
Ben Porat, Yoram(16)                                538,442            4.95        25,000           513,442                4.72
Trefoil Israel Investments, LLC                     500,000            4.60       500,000                 0                 *
Shachar, Erez(5)(7)                                 300,000            1.81       300,000                 0                 *
WBM LLC(5)(8)                                       300,000            2.70       220,000            80,000                 *
Carafe Investment Co. Ltd.                          250,000            2.30       250,000                 0                 *
Omotsu Holdings Limited                             250,000            2.30       250,000                 0                 *
Fuchs, David(5)(9)                                  215,000            1.98       215,000                 0                 *
Purjes, Esther                                      200,000            1.84       200,000                 0                 *
Horizon Fund Ltd.                                   171,240            1.57       171,240                 0                 *
Sarig, Ehud                                         161,539            1.48       161,539                 0                 *
Clalit Capital Fund L.P.                            150,000            1.38       150,000                 0                 *
Weisman, Scott(5)(10)                               131,169            1.21       131,169                 0                 *
Owesh, Tajunnisa                                    125,000            1.15       125,000                 0                 *
Balk, Mathew(5)(11)                                 108,843            1.00       108,843                 0                 *
Hussey, Robert F.(12)                               100,000            *          100,000                 0                 *
Padan, Eitan(5)(13)                                  75,000            *           75,000                 0                 *
Gross, Joy                                           75,000            *           75,000                 0                 *
Scibelli, James                                      75,000            *           75,000                 0                 *
Avnon, Alon(5)(14)                                   70,000            *           70,000                 0                 *
Gelman, Gary                                         60,000            *           60,000                 0                 *
Davis, Peter S.                                      50,000            *           50,000                 0                 *
Dorigal, S.A.                                        50,000            *            50,000                0                  *
Duggal, Baldev                                       50,000            *            50,000                0                  *
Eastlane Corporation Ltd.                            50,000            *            50,000                0                  *
Everest Holding                                      50,000            *            50,000                0                  *
First Comet Corporation                              50,000            *            50,000                0                  *
Holistica International Ltd.                         50,000            *            50,000                0                  *
Margolin, Michael & Shoshana                         50,000            *            50,000                0                  *
Ornstein, Richard                                    50,000            *            50,000                0                  *
Noy, Amir(5)(14)                                     50,000            *            50,000                0                  *
Paneco S.A.                                          50,000            *            50,000                0                  *
Sagiv, Schlomo(5)(14)                                50,000            *            50,000                0                  *
Sheib, Fredda                                        50,000            *            50,000                0                  *
Weinrab, Efi(5)                                      50,000            *            50,000                0                  *
Card Investment Group, Inc.                          40,000            *            40,000                0                  *
Rice, Lawrence R.(5)(11)                             32,516            *            32,516                0                  *
Barnea, Michael(5)(15)                               30,000            *            30,000                0                  *
Grotenstein, Alan                                    30,000            *            30,000                0                  *
Israeli, Eyal(5)                                     30,000            *            30,000                0                  *
Roden, Charles(5)(11)                                25,319            *            25,319                0                  *
Berman, Michael                                      25,000            *            25,000                0                  *
Birn, Dora                                           25,000            *            25,000                0                  *
Chnapko, Joseph P.                                   25,000            *            25,000                0                  *
Gell, Brian D.                                       25,000            *            25,000                0                  *
Heymann, Jerry                                       25,000            *            25,000                0                  *
Padan, Uzi                                           25,000            *            25,000                0                  *
Purjes, Esther IRA Delaware Charter                  25,000            *            25,000                0                  *
JLR Profit Sharing Plan C(6) FBO Frank Garriton      25,000            *            25,000                0                  *
Sheib, James C.                                      25,000            *            25,000                0                  *
Trokel, Michael                                      25,000            *            25,000                0                  *
Vitullo, Mary(11) & Purjes, Dan(6)                   25,000            *            25,000                0                  *
Wagner, John P. Jr.                                  25,000            *            25,000                0                  *
Dovrat, Shrem Sky Fund                               22,830            *            22,830                0                  *
Dovrat, Shrem Rainbow Fund, Ltd.                     20,930            *            20,930                0                  *
Ben-Moshe, Boaz & Susan                              20,000            *            20,000                0                  *
Gold, Dahlia                                         20,000            *            20,000                0                  *
</TABLE>
        
                                       55                                 
<PAGE>                                                                    
                                                                          
<TABLE>                                                                   
<CAPTION>
                                                         Shares Beneficially                            Shares Beneficially
                                                             Owned Before                                   Owned After
                                                           the Offering(1)                                the Offering(1)
Name and Address                                      --------------------------     Shares       -------------------------------
of Beneficial Owner                                   Shares(2)    Percent(2)(3)   Offered(4)      Shares              Percent(3)
- - - - - - -------------------                                   ---------      ----------    ----------     ---------            ----------
<S>                                                    <C>               <C>         <C>               <C>                   <C>  
Darbyshire, Chris                                       20,000            *          20,000            0                     *
Murphy, William F.                                      20,000            *          20,000            0                     *
Nano-Cap Hyper Growth Partnership, L.P.                 20,000            *          20,000            0                     *
Ordinance Capital, L.P.                                 20,000            *          20,000            0                     *
Stein, Dr. Raymond                                      20,000            *          20,000            0                     *
Trokel, Stephen L.                                      20,000            *          20,000            0                     *
Wiener, David M.                                        20,000            *          20,000            0                     *
Chenes, Charles A.                                      15,000            *          15,000            0                     *
Continental Stock Transfer Corp.                        15,000            *          15,000            0                     *
Vardi, Gabi(5)                                          15,000            *          15,000            0                     *
Adriane Bailey Beck(11) & Dan Purjes(6)                 12,500            *          12,500            0                     *
Friedland, Stephen                                      12,500            *          12,500            0                     *
Jacob, Varughese & Leela                                12,500            *          12,500            0                     *
Khan, Khurshid                                          12,500            *          12,500            0                     *
Palma, Susan                                            12,500            *          12,500            0                     *
The Shaar Fund Ltd.                                     12,500            *          12,500            0                     *
Achiemeir, Shimshon(5)                                  12,000            *          12,000            0                     *
Feinschmidt, Avi(5)                                     12,000            *          12,000            0                     *
Itzik, Rovien(5)                                        12,000            *          12,000            0                     *
Wollfgor, Ronen(5)                                      12,000            *          12,000            0                     *
Cohen, Morris                                           10,000            *          10,000            0                     *
Colbert, James IRA                                      10,000            *          10,000            0                     *
Handa, Sameer                                           10,000            *          10,000            0                     *
Loew, Michael(17)                                       10,000            *          10,000            0                     *
Lowe, James F.                                          10,000            *          10,000            0                     *
Mahtani, Gordan G.                                      10,000            *          10,000            0                     *
Mahtani, Jiwat & Pushpa                                 10,000            *          10,000            0                     *
Arvai, Emila(11)                                        10,000            *          10,000            0                     *
Mayer, Charles                                          10,000            *          10,000            0                     *
Messing, Andrew                                         10,000            *          10,000            0                     *
Morgan, John R.                                         10,000            *          10,000            0                     *
Naz, Mohammad & Rasheeda                                10,000            *          10,000            0                     *
Patel, Chandu & Kala                                    10,000            *          10,000            0                     *
Rao, Dr. Sanjeeva                                       10,000            *          10,000            0                     *
Relyea, William(5)(11)                                  10,000            *          10,000            0                     *
Weisner, Gary(11)                                       10,000            *          10,000            0                     *
White, Laurence                                         10,000            *          10,000            0                     *
Zimmerman, Bernard                                      10,000            *          10,000            0                     *
Lifiland, Michael(5)                                     9,000            *           9,000            0                     *
Miakinkoff, Regina                                       8,000            *           8,000            0                     *
Estate of Peter Sheib(5)                                 7,549            *           7,549            0                     *
HSB Capital                                              7,500            *           7,500            0                     *
JLR Profit Sharing Plan C(6) FBO Ursula D. Mell          7,500            *           7,500            0                     *
Shaw, Larry & Winstead, Dennis                           7,500            *           7,500            0                     *
Porush, Naftali & Elaine                                 7,000            *           7,000            0                     *
Porush, Naomi                                            7,000            *           7,000            0                     *
Sectal Capital Markets, Ltd.(5)                          6,400            *           6,400            0                     *
Antoniades, Adam(11)                                     5,000            *           5,000            0                     *
Bear Stearns Securities Corp. FBO Cindy L. Cerruto IRA   5,000            *           5,000            0                     *
Bear Stearns Securities Corp. FBO James C. Welton IRA    5,000            *           5,000            0                     *
Bear Stearns Securities Corp. FBO James I. Zogby IRA     5,000            *           5,000            0                     *
Block Reed, Annmary                                      5,000            *           5,000            0                     *
Dransfield, Mark(11)                                     5,000            *           5,000            0                     *
Gilbert, Jonathan R.                                     5,000            *           5,000            0                     *
Hawryluk, James B.(11)                                   5,000            *           5,000            0                     *
JLR Profit Sharing Plan B(6) FBO Anthony Guzzi           5,000            *           5,000            0                     *
JLR Profit Sharing Plan C(6) FBO Ralph De Marco          5,000            *           5,000            0                     *
JLR Profit Sharing Plan C(6) FBO Salvatore Agosta        5,000            *           5,000            0                     *
JLR Profit Sharing Plan C(6) FBO Lloyd Kagin             5,000            *           5,000            0                     *
JLR Profit Sharing Plan C(6) FBO Raymond A. Mando        5,000            *           5,000            0                     *
Larkin Investors                                         5,000            *           5,000            0                     *
Malone, Ena                                              5,000            *           5,000            0                     *
Menikdiwela, G.(17)                                      5,000            *           5,000            0                     *
Volpe, Michael(11)                                       5,000            *           5,000            0                     *
Fitzgerald, Paul(5)(11)                                  4,546            *           4,546            0                     *
Larkin, Sherwood P.(5)(11)                               4,435            *           4,435            0                     *
Cohen, Bat-Sheva(5)                                      4,000            *           4,000            0                     *
JLR Profit Sharing Plan C(6) FBO Robert N. Martz         3,500            *           3,500            0                     *
Araki, Muhamad(5)                                        3,000            *           3,000            0                     *
Adriane Bailey-Beck IRA(11)                              3,000            *           3,000            0                     *
</TABLE>
                                                                             
                                       56                                    
<PAGE>                                                                       
                                                                             
<TABLE>                                                                      
<CAPTION>                                                                    
                                                      Shares Beneficially                               Shares Beneficially
                                                          Owned Before                                      Owned After
                                                        the Offering(1)                                   the Offering(1)
Name and Address                                   --------------------------     Shares          -------------------------------
of Beneficial Owner                                Shares(2)    Percent(2)(3)   Offered(4)         Shares              Percent(3)
- - - - - - -------------------                                ---------      ----------    ----------        ---------            ----------
<S>                                                 <C>               <C>         <C>                 <C>                   <C>  
Futernik, Alexander                                   3,000            *          3,000               0                     *
Goodfriend, David(11)                                 3,000            *          3,000               0                     *
Housner, Robert IRA BSSO Custodian                    3,000            *          3,000               0                     *
Kanovich, Sergei(14)                                  3,000            *          3,000               0                     *
JLR Profit Sharing Plan C(6) FBO Kenneth P. Cerruto   3,000            *          3,000               0                     *
Mench, James Frederick & Dorothy                      3,000            *          3,000               0                     *
Pallen, Glenn F. IRA Rollover(11)                     3,000            *          3,000               0                     *
Pine, Lawrence D.(17)                                 3,000            *          3,000               0                     *
Dolev, Roni(5)                                        2,300            *          2,300               0                     *
Plat, Lior(5)                                         2,300            *          2,300               0                     *
Gilboa, Pnina(5)                                      2,300            *          2,300               0                     *
Hagoon, Shimon(5)                                     2,300            *          2,300               0                     *
Ofir, Yaakov(5)                                       2,300            *          2,300               0                     *
Ben-Yosef, Zeev(5)                                    2,300            *          2,300               0                     *
Adamo, Frank(11)                                      2,000            *          2,000               0                     *
Caparelli, Richard F.(11)                             2,000            *          2,000               0                     *
Chapman, Sandra L.                                    2,000            *          2,000               0                     *
West, John L.(11)                                     2,000            *          2,000               0                     *
Satloff, Averell W.(5)(17)                            1,528            *          1,528               0                     *
Borgman, Lawrence(5)(11)                                156            *            156               0                     *
Burke, Dennis(5)(11)                                    156            *            156               0                     *
Kowitski, Steve(5)(11)                                  156            *            156               0                     *
Guzzi, Anthony(5)(11)                                    67            *             67               0                     *
Mando, Raymond A.(5)(11)                                 45            *             45               0                     *
</TABLE>

- - - - - - ----------

*     Less than 1.00%

(1)   Unless otherwise indicated, each shareholder has sole voting and
      investment power with respect to the Shares indicated as beneficially
      owned thereby.

(2)   These share amounts include up to an aggregate of 555,000 Shares which may
      be issued to certain Selling Shareholders upon the exercise of the
      Warrants and 1,342,339 Shares which may be issued upon exercise of
      Options.

(3)   In accordance with Rule 13d-3 of the Exchange Act, shares that are not
      outstanding, but that are issuable pursuant to the exercise of outstanding
      Warrants, all of which are exercisable within 60 days of the date of this
      Prospectus, have been deemed to be outstanding for the purpose of
      computing the percentage of outstanding shares owned by the individual
      having such right, but have not been deemed outstanding for the purpose of
      computing the percentage for any other person. See "Description of
      Securities."

(4)   With respect to the Selling Shareholders, it has been assumed that all
      Shares so offered will be sold.

(5)   Includes Shares underlying Warrants and/or Options.

(6)   Dan Purjes is Chairman of the Company and Chairman of Josephthal & Co.
      Inc. See "Certain Transactions."

(7)   Erez Shachar is President, Chief Executive Officer and a Director of the
      Company.

(8)   WBM LLC is controlled by persons affiliated with Josephthal & Co. Inc. See
      "Certain Transactions."

(9)   David Fuchs is a former Director of the Company, acted as the Company's
      Chief Financial Officer from April through October 1997 and is employed
      with Josephthal & Co. Inc. See "Certain Transactions."

(10)  Scot Weisman is a former Director of the Company and is employed with
      Josephthal & Co. Inc. See "Certain Transactions."

(11)  Employee of Josephthal & Co. Inc. See "Certain Transactions."

(12)  Robert F. Hussey is a Director of the Company.

(13)  Eitan Padan is the Company's Chief Financial Officer, Vice President of
      Finance and Secretary.

(14)  Employee of the Company.

(15)  Michael Barnea acts as legal counsel in Israel to the Company through
      Shimonov Barnea & Co. See "Legal Matters."

(16)  Yoram Ben Porat is a Director of the Company.

(17)  Former employee of Josephthal & Co. Inc. See "Certain Transactions."

                                       57
<PAGE>

                              CERTAIN TRANSACTIONS

      Between September and December 1997, the Company effected a private
offering of its Ordinary Shares in the United States, for which Josephthal acted
as exclusive placement agent. The chairman of Josephthal, Dan Purjes,
beneficially owns approximately 30.09% of the Company's Ordinary Shares, and
other individuals affiliated with Josephthal beneficially own approximately
8.11% of the Company's Ordinary Shares. In addition, the chairman of Josephthal,
Dan Purjes, is the Company's Chairman. As compensation for its services as the
Company's exclusive placement agent, Josephthal received fees of $339,000 and
warrants to purchase 400,000 Ordinary Shares at an exercise price of $1.00 per
share. Payment to Josephthal in consideration for the banking services rendered
by Josephthal to the Company has been approved by the Company's shareholders. An
individual employed by Josephthal was the Company's acting Chief Financial
Officer from April through October 1997 for which he received compensation of
approximately $45,000 and another individual employed by Josephthal received
$20,000 in compensation for his services as Chairman of the Board of Directors
from April through October 1997. Three individuals that are either directors or
former directors of the Company are also officers of Josephthal have been
granted options under a company stock option plan to purchase in the aggregate
500,000 Ordinary Shares of Company at $1.25 per share.

      For a lease agreement with a former shareholder, see
"Business--Facilities" and "Business--Legal Proceedings."

      With regard to transactions involving Moshe Nur, also see notes 16h and 20
to the Financial Statements attached hereto.


                            DESCRIPTION OF SECURITIES

      Set forth below is a summary of certain information concerning the
Company's capital stock and a brief description of certain provisions contained
in the Memorandum of Association, the Articles of Association and certain
statutory provisions. The Memorandum of Association and the Articles of
Association have been filed as exhibits to the Registration Statement. Such
summary and description do not purport to be complete statements of these
provisions and are qualified in their entirety by reference to such exhibits.

      The authorized share capital of the Company consists of 20,000,000
Ordinary Shares, 10,880,000 of which are issued and outstanding, fully paid and
non-assessable. See "Capitalization."

      Non-residents of Israel may freely hold and trade the Ordinary Shares
pursuant to general and specific permits issued under Israel's Currency Control
Law, 1978. Neither the Memorandum of Association nor the Articles of Association
make any distinction between residents and non-residents of Israel with respect
to the ownership of Ordinary Shares. None of the Memorandum of Association, the
Articles of Association nor Israeli law make any distinction between residents
and non-residents of Israel with respect to the voting rights related thereto.

                                       58
<PAGE>

      Holders of paid-up Ordinary Shares are entitled to participate equally in
the payment of dividends and other distributions and, in the event of
liquidation of the Company, in the distribution of assets after the discharge of
liabilities to creditors. The Board may declare interim dividends, and may
propose the final dividend with respect to any year out of unconsolidated
profits available for dividends after statutory appropriation to capital
reserves. Shareholder approval, in the form of an ordinary resolution (see
below), is required for the declaration of a final dividend. The shareholders
may approve a final dividend in the amount recommended by the Board or in a
lesser amount (but not in a greater amount). If the shareholders do not approve
the final dividend recommended by the Board, in whole or in part, the interim
dividend may have to be returned. Ordinary Shares do not entitle their holders
to preemptive rights.

      Each Ordinary Share is entitled to one vote on all matters to be voted on
by shareholders, including the election of directors. The quorum required for
action to be taken at a meeting of shareholders consists of two shareholders
present in person or by proxy and holding in the aggregate more than 50% of all
the outstanding voting rights of the Company. If a meeting is adjourned due to
the lack of a quorum, one or more shareholders, holding not less than 33-1/3%
of all the outstanding voting power attached to the Ordinary Shares, present in
person or by proxy at the subsequent adjourned meeting will constitute a quorum.
An ordinary resolution (for example, a resolution to approve the financial
statements, to approve final dividends or to appoint the auditors) requires the
affirmative vote of shareholders present and holding in person or by proxy a
majority of the shares present. A special resolution (for example, a resolution
to amend the Articles of Association, to authorize a change in capitalization or
to adopt certain other major changes as specified in the Israeli Companies
Ordinance) requires the affirmative vote of shareholders present in person or by
proxy and holding shares conferring at least 75% of the votes cast with respect
to the special resolution, at a meeting convened upon at least 21 days' notice.
Certain resolutions relating to transactions involving principal shareholders
require special approvals and disinterested shareholder approval. See "Certain
Transactions."

      Holders of the Ordinary Shares do not have cumulative voting rights in the
election of directors. Consequently, the holders of Ordinary Shares in the
aggregate conferring more than 50% of the voting power represented in person or
by proxy will have the power to elect all the directors. Holders of the
remaining Ordinary Shares will not be able to elect any directors. The current
principal shareholders of the Company may be able to elect all the members of
the Board of Directors.

      Continental Stock Transfer & Trust Company is the transfer agent and
registrar for the Ordinary Shares.

      The Ordinary Shares are on the Nasdaq National Market. However, there can
be no assurance that an active public market for the Ordinary Shares will be
sustained after the Offering. The Company currently has no present intention to
list or quote its securities in Israel or other markets outside the United
States; however, the Company may seek such listings if the Board determines that
it is in the best interest of the Company to do so.

                                       59
<PAGE>

       COMMISSION POSITION ON INDEMNIFICATION FOR SECURITY ACT LIABILITIES

      Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers or persons controlling the
registrant pursuant to the foregoing provisions, the registrant has been
informed that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is
therefore unenforceable.


                         SHARES ELIGIBLE FOR FUTURE SALE

      The Company has 10,880,000 Ordinary Shares outstanding. Of these shares,
the 4,000,000 shares sold in this offering will be immediately freely tradable
in the public market without restriction under the Securities Act, except for
any shares purchased by an affiliate of the Company (as that term is defined
under the rules and regulations of the Securities Act) which will be subject to
the resale limitations of Rule 144 promulgated under the Securities Act. All of
the remaining Ordinary Shares to be outstanding after the offering, 6,880,000
Ordinary Shares, will be "restricted securities" as that term in defined under
Rule 144 and will not have been registered under the Securities Act. Such
restricted shares may not be sold unless they are registered under the
Securities Act or unless an exemption from registration is available under Rule
144 or otherwise under the Securities Act.

      In general, under Rule 144 as currently in effect, a person (or persons
whose shares are aggregated), including a person who may be deemed to be an
"affiliate" of the Company as that term is defined under the Securities Act, is
entitled to sell, within any three-month period, a number of restricted Ordinary
Shares as to which at least two years have elapsed from the later of the
acquisition of such shares or in an amount that does not exceed the greater of
(i) one percent of the then outstanding shares of Ordinary Shares (108,800
shares based upon 10,880,000 shares outstanding), or (ii) if the Ordinary Shares
are then quoted on Nasdaq or a national securities exchange, the average weekly
trading volume of the Ordinary Shares during the four calendar weeks preceding
such sale. Sales under Rule 144 are also subject to certain requirements as to
the manner of sale, notice, and the availability of current public information
about the Company. However, a person who is not deemed to have been an affiliate
of the Company during the three months prior to a sale by such person and at
least three years have lapsed from the acquisition of the shares is entitled to
sell them without regard to the volume, manner of sale, or notice requirements
of Rule 144.


                     EXCHANGE CONTROLS AND OTHER LIMITATIONS
                           AFFECTING SECURITY HOLDERS

       Non-residents of Israel will be able to receive dividends, if declared,
and any amounts payable upon the dissolution, liquidation or winding-up of the
affairs of the Company. Any such payments will be paid in freely repatriable
non-Israeli currencies (including U.S. dollars). Such payments, if made, shall
be made pursuant to a general permit issued by the Controller under the Currency
Control Law,

                                       60
<PAGE>

1978 (the "Currency Control Law").

      In May 1998, a new "general permit" was issued, which removed most of the
restrictions prohibited under the law, and thus enabled Israeli citizens to
freely invest outside of Israel and freely convert Israeli currency into
non-Israeli currencies.


                ISRAELI TAXATION AND FOREIGN EXCHANGE REGULATIONS

      The following is a summary of the current tax laws of the State of Israel
as they relate to the Company and its shareholders. This summary does not
discuss all aspects of Israeli tax law that may be relevant to a particular
investor in light of his personal investment circumstances or to certain types
of investors subject to special treatment under Israeli law (for example,
traders in securities or persons that own, directly or indirectly, 10% or more
of the Company's outstanding voting stock). The following also includes a
discussion of certain Israeli government programs benefiting various Israeli
businesses such as the Company. To the extent that the discussion is based on
new legislation yet to be subject to judicial or administrative interpretation,
there can be no assurance that the views expressed herein will accord with any
such interpretation in the future. This discussion is not intended and should
not be construed as legal or professional tax advice, and does not cover all
possible tax considerations.

General Corporate Tax Structure

      The Company is subject to corporate tax in Israel. Commencing in the tax
year 1993 through and including 1996, the regular rate of corporate tax to which
Israeli companies are subject decreased 1% each year, i.e., from 39% in 1993
down to 36% in 1996 and thereafter. However, the effective rate payable by a
company which derives income from an "Approved Enterprise" (as further discussed
below) may be considerably less. See "--Law for the Encouragement of Capital
Investments, 1959."

Taxation Under Inflationary Conditions

      The Income Tax Law (Adjustment for Inflation), 1985 (the "Adjustment for
Inflation Law") attempts to overcome some of the problems experienced in a
traditional tax system by an economy experiencing rapid inflation, which was the
case in Israel at the time the Adjustment for Inflation Law was enacted.
Generally, the Adjustment for Inflation Law was designed to neutralize for
Israeli tax purposes the erosion of capital investments in businesses and to
prevent unintended tax benefits resulting from the deduction of inflationary
financing expenses. The Adjustment for Inflation Law applies a supplementary set
of inflationary adjustments to a normal taxable profit computed according to
regular historical cost principles.

      The Adjustment for Inflation Law introduced a special tax adjustment for
the preservation of equity based on changes in the Israeli CPI whereby certain
corporate assets are 

                                       61
<PAGE>

classified broadly into fixed (inflation resistant) assets and non-fixed assets.
Where shareholders' equity, as defined in the Adjustment for Inflation Law,
exceeds the depreciated cost of fixed assets, a corporate tax deduction which
takes into account the effect of inflationary change on such excess in allowed
(up to a ceiling of 70% of taxable income for companies in any single tax year,
with the unused portion permitted to be carried forward on a linked basis with
no ceiling). If the depreciated cost of fixed assets exceeds shareholders'
equity, then such excess multiplied by the annual rate of inflation is added to
taxable income.

      In addition, subject to certain limitations, depreciation on fixed assets
and losses carried forward are adjusted for inflation based on changes in the
Israeli CPI. The net effect of the Adjustment for Inflation Law on the Company
might be that the Company's taxable income, as determined for Israeli corporate
tax purposes, will be different than the Company's U.S. dollar income, as
reflected in its financial statements, due to the difference between the annual
changes in the CPI and in the NIS exchange rate with respect to the U.S. Dollar,
causing changes in the actual tax rate.

Law for the Encouragement of Industry (Taxes), 1969

      The Company currently qualifies as an "Industrial Company" within the
definition of the Law for the Encouragement of Industry (Taxes), 1969 (the
"Industry Encouragement Law"). According to the Industry Encouragement Law, an
"Industrial Company" is a company resident in Israel, at least 90% of the income
of which in any tax year (exclusive of income from defense loans, capital gains,
interest and dividends), is derived from an "Industrial Enterprise" owned by it.
An "Industrial Enterprise" is defined by that law as an enterprise whose major
activity in a given tax year is industrial production activity.

      Included among the tax benefits for an Industrial Company are deductions
of 12.5% per annum of the purchase price of a good-faith acquisition of a patent
or of know-how, an election under certain conditions to file a consolidated
return and accelerated depreciation rates on equipment and buildings.

      Eligibility for the benefits under the Industry Encouragement Law is not
subject to receipt of prior approval from any governmental authority. No
assurance can be given that the Company will continue to qualify as an
"Industrial Company" or that the benefits described above will be available in
the future.

Law for the Encouragement of Capital Investments, 1959

      The Law for the Encouragement of Capital Investments, 1959, as amended
(the "Investment Law") provides that a capital investment in production
facilities (or other eligible facilities) may, upon application to the Israel
Investment Center, be designated as an Approved Enterprise. Each certificate of
approval for an Approved Enterprise relates to a specific program delineated
both by its financial scope, including its capital sources, and its physical
characteristics, i.e., the equipment to be purchased and utilized pursuant to
the program. The tax benefits derived from any such certificate of approval
relate only to taxable profits attributable to the specific Approved Enterprise.

                                       62
<PAGE>

      Taxable income of a company derived from an Approved Enterprise designated
as such after October 30, 1978, is subject to corporate tax at the rate of 25%
(rather than the 1998 regular corporate tax rate of 36%) throughout the "Benefit
Period"--a period of seven years commencing with the year in which the Approved
Enterprise first generated taxable income (limited to the earlier of twelve
years from the commencement of production or fourteen years from the date of
approval) and, under certain circumstances, extending to a maximum of ten years
therefrom. In the event a company operates under more than one approval or only
part of its capital investments are approved (a "Mixed Enterprise"), its
effective corporate tax rate is the result of a weighted combination of the
various applicable rates.

      In addition, a company owning an Approved Enterprise approval after April
1, 1986 (or prior thereto, provided no government grants or loans had previously
been granted in respect to such enterprise) may elect to forego certain
government grants extended to its Approved Enterprise in exchange for an
"alternative package" of tax benefits (the "Alternative Package"). Under the
Alternative Package, a company's undistributed income derived from an Approved
Enterprise will be exempt from corporate tax for a period of between two and ten
years, depending on the geographic location of the Approved Enterprise within
Israel, and such company will be eligible for the tax benefits under the
Investment Law described above for the remainder of the Benefits Period.

      Part of the Company's production facilities have been granted the status
of "Approved Enterprise" under the Investment Law, under two separate investment
plans. The implementation of the investments under the first plan was finalized
in 1993. The implementation of the second plan is expected to be finalized in
1998.

      According to the provisions of the Investment Law, the Company chose to
enjoy "alternative benefits"--waiver of grants in return for tax exemption.
Accordingly, the Company's income from the Approved Enterprise will be
tax-exempt for a period of two and four years for the first and second plans,
respectively, commencing with the year it first earns taxable income, and
subject to corporate tax at the rate of 25%, for additional periods of five and
three years, for the first and second plans, respectively.

      The period of tax benefits, detailed above, is subject to limits of 12
years from the commencement of production, or 14 years from receiving the
approval, whichever is earlier. Given the above mentioned conditions, the period
of benefits for the first plan commenced in the year 1994 and will terminate in
the year 2000, and the period of benefits for the second plan has not yet
commenced.

      If dividends are distributed out of such tax-exempt profits, the Company
will be liable for corporate tax at the rate which would have been applied if it
had not chosen the alternative tax benefits (currently 25% for an "Approved
Enterprise"). Therefore, income derived from the

                                       63
<PAGE>

Company's "Approved Enterprise" status is not available for distribution to
shareholders as a dividend. See Note 20(a) to the Company's Financial
Statements.

      The dividend recipient is taxed at the reduced rate applicable to
dividends from Approved Enterprises (15%), if the dividend is distributed during
the tax exemption period or within a specified period thereafter, or for an
unlimited period in the case of a "Foreign Investors' Company" -- a company over
25% foreign-owned with an approved enterprise. This tax must be withheld by the
company at source, regardless of whether the dividend is converted into foreign
currency. See "--Capital Gains and Income Taxes Applicable to Non-Israeli
Shareholders."

      Subject to certain provisions concerning income subject to the Alternative
Package, all dividends are considered to be attributable to the entire
enterprise, and the effective tax rate is the result of a weighted combination
of the various applicable tax rates.

      The Investment Law also provides that an Approved Enterprise is entitled
to accelerated depreciation on its property and equipment that are included in
an approved investment program.

      Grants and certain other incentives received by a company in accordance
with the Investment Law remain subject to final ratification by the Israel
Investment Center, such ratification being conditional upon fulfillment of all
terms of the approved program. Failure to comply with all such terms may require
the return of such grants and incentives (inclusive of interest as of the date
of the grant).

      Receipt of grants and tax benefits from the OCS and the Marketing Fund and
under the Company's existing "Approved Enterprise" status and any new programs,
if and when approved, are or will be, as the case may be, subject to various
conditions. The tax benefits derived from the Company's "Approved Enterprise"
status are conditioned upon fulfillment of the conditions stipulated by the
Investment Law, the regulations promulgated thereunder and the criteria set
forth in the certificate of approval issued pursuant to the Investment Law. In
the event of a failure by the Company to comply with these conditions and
criteria, the grants and tax benefits could be canceled, in whole or in part,
and the Company would be required to refund the amount of the canceled benefits,
adjusted for inflation and interest. Management believes that the Company has
operated and will continue to operate in compliance with all the "Approved
Enterprise" conditions and criteria applicable to it from the OCS, the Marketing
Fund and its "Approved Enterprise" status, although there can be no assurance of
this, and that the likelihood is remote that it will be required to refund
grants or tax benefits that it derives from the OCS, the Marketing Fund and
under its "Approved Enterprise" status. There can be no assurance that the
funding and tax benefits will continue. See "Risk Factors--We Rely Upon
Government Grants, Tax Benefits, and Other Funding From Third Parties" and
"Business--Research and Development."

                                       64
<PAGE>

Capital Gains and Income Taxes Applicable to Non-Israeli Shareholders

      Under existing regulations, any capital gain realized by an individual
shareholder with respect to the Ordinary Shares acquired on or after the
registration of such shares will be exempt from Israeli Capital Gains Tax if the
Ordinary Shares are listed on an approved foreign securities market (which term
includes the Nasdaq in the United States) and provided that the Company
continues to qualify as an Industrial Company under Israeli law, and provided
the individual does not hold such shares for business purposes.

      Upon a distribution of dividends other than bonus shares (stock
dividends), income tax is generally withheld at source at the rate of 25% (or
the lower rate payable with respect to Approved Enterprises, see "--Law for the
Encouragement of Capital Investments, 1959"), unless a double taxation treaty is
in effect between Israel and the shareholder's country of residence that
provides for a lower tax rate in Israel on dividends.

      A tax treaty between the United States and Israel (the "Treaty"),
effective since January 1, 1995, provides for a maximum tax of 25% on dividends
paid to a resident of the United States (as defined in the Treaty). Dividends
distributed by an Israeli company and derived from the income of an approved
enterprise are subject to a 15% dividend withholding tax. The Treaty further
provides that a 12.5% Israeli dividend withholding tax would apply to dividends
paid to a United States corporation owning 10% or more of an Israeli company's
voting stock. The 12.5% rate applies only on dividends from a company that does
not have an "Approved Enterprise" in the applicable period.

      A non-resident of Israel who has had dividend income derived or accrued in
Israel from which tax was withheld at source is currently exempt from the duty
to file an annual Israeli tax return with respect to such income, provided such
income was not derived from a business carried on in Israel by such non-resident
and that such non-resident does not derive other non-passive income from sources
in Israel. Proposals are being formulated to expand the requirement to file
annual Israeli tax returns.

Tax Benefits for Research and Development

      Israeli tax law allows under certain conditions a tax deduction in the
year incurred for expenditures (including non-depreciable capital expenditures)
in scientific research and development projects, if the expenditures are
approved by the relevant Israeli Government Ministry (determined by the field of
research) and the research and development is for the promotion of the
enterprise and is carried out by or on behalf of the company seeking such
deduction. Expenditures not so approved are deductible over a three-year period.
However, according to recent Israeli Supreme Court decisions, expenditures made
out of the proceeds of government grants are not deductible, i.e., the Company
will be able to deduct the unfunded portion of the research and development
expenditures and not the gross amount.

                                       65
<PAGE>

                U.S. TAX CONSIDERATIONS REGARDING ORDINARY SHARES

      The following summary describes certain of the principal United States
federal income tax consequences relating to an investment in Ordinary Shares as
of the date hereof. The summary is based on the Internal Revenue Code of 1986
(the "Code"), and existing final, temporary and proposed Treasury Regulations,
Revenue Rulings and judicial decisions, all of which are subject to prospective
and retroactive changes. The Company will not seek a ruling from the Internal
Revenue Service (the "IRS") with regard to the United States federal income tax
treatment relating to an investment in Ordinary Shares and, therefore, there can
be no assurance that the IRS will agree with the conclusions set forth below.
The summary does not purport to address all federal income tax consequences that
may be relevant to particular investors. For example, the summary applies only
to Holders who hold Ordinary Shares as a capital asset within the meaning of
Section 1221 of the Code, and does not address the tax consequences that may be
relevant to investors in special tax situations (including, for example,
insurance companies, tax-exempt organizations, dealers in securities or
currency, banks or other financial institutions, investors that hold Ordinary
Shares as part of a hedge, straddle or conversion transaction, or Holders that
own, directly or indirectly, five percent or more of the Company's outstanding
Ordinary Shares). Further, it does not address the alternative minimum tax
consequences of an investment in Ordinary Shares or the indirect consequences to
Holders of equity interests in investors in Ordinary Shares. ACCORDINGLY,
PERSONS CONSIDERING THE PURCHASE OF ORDINARY SHARES SHOULD CONSULT THEIR OWN TAX
ADVISORS CONCERNING THE APPLICATION OF UNITED STATES FEDERAL INCOME TAX LAWS, AS
WELL AS THE LAWS OF ANY STATE, LOCAL OR FOREIGN TAXING JURISDICTION, TO THEIR
PARTICULAR SITUATIONS.

      For purposes of this discussion, "Company" refers to NUR Macroprinters
Ltd., and "U.S. Holder" means a Holder of Ordinary Shares that is a citizen or
resident of the United States, a partnership or corporation created or organized
in the United States or any State thereof (including the District of Columbia),
or an estate or trust the income of which is subject to United States federal
income tax on a net income basis with respect to Ordinary Shares. The term
"non-U.S. Holder" refers to any Holder of Ordinary Shares other than a U.S.
Holder.

                                       66
<PAGE>

Taxation Of U.S. Holders

      Distributions on Ordinary Shares. Distributions made by the Company with
respect to Ordinary Shares generally will constitute dividends for federal
income tax purposes and will be taxable to a U.S. Holder as ordinary income to
the extent of the Company's undistributed current or accumulated earnings and
profits (as determined for United States federal income tax purposes).
Distributions in excess of the Company's current or accumulated earnings and
profits will be treated first as a nontaxable return of capital reducing the
U.S. Holder's tax basis in the Ordinary Shares, thus increasing the amount of
any gain (or reducing the amount of any loss) which might be realized by such
Holder upon the sale or exchange of such Ordinary Shares. Any such distributions
in excess of the U.S. Holder's tax basis in the Ordinary Shares will be treated
as capital gain to the U.S. Holder and will be either long term or short term
capital gain depending upon the U.S. Holder's federal income tax holding period
for the Ordinary Shares. Dividends paid by the Company generally will not be
eligible for the dividends received deduction available to certain United States
corporate shareholders under Code Sections 243 and 245. The amount of any cash
distribution paid in a foreign currency will equal the U.S. dollar value of the
distribution, calculated by reference to the exchange rate in effect at the time
the dividends are received. A U.S. Holder should not recognize any foreign
currency gain or loss if such foreign currency is converted into U.S. dollars on
the day received. If a U.S. Holder does not convert the foreign currency into
U.S. dollars on the date of receipt, however, such Holder may recognize gain or
loss upon a subsequent sale or other disposition of the foreign currency
(including an exchange of the foreign currency for U.S. dollars). Such gain or
loss, if any, will be ordinary income or loss for United States federal income
tax purposes.

      Subject to certain conditions and limitations, any Israeli withholding tax
imposed upon distributions which constitute dividends under United States income
tax law will be eligible for credit against a U.S. Holder's federal income tax
liability. Alternatively, a U.S. Holder may claim a deduction for such amount,
but only for a year in which a U.S. Holder elects to do so with respect to all
foreign income taxes. The overall limitation on foreign taxes eligible for
credit is calculated separately with respect to specific classes of income. For
this purpose, dividends distributed by the Company with respect to Ordinary
Shares will generally constitute "passive income."

      Sale or Exchange of Ordinary Shares. A. U.S. Holder of Ordinary Shares
generally will recognize capital gain or loss upon the sale or exchange of the
Ordinary Shares measured by the difference between the amount realized and the
U.S. Holder's tax basis in the Ordinary Shares. Gain or loss will be computed
separately for each block of shares sold (shares acquired separately at
different times and prices). The gain or loss on such disposition will be long
term capital gain or loss if the Ordinary Shares had been held for more than one
year. The deductibility of capital losses is restricted and generally may only
be used to reduce capital gains to the extent thereof. However, individual
taxpayers generally may deduct annually $3,000 of capital losses in excess of
their capital gains.

      Passive Foreign Investment Company. A foreign corporation generally will
be treated as a "passive foreign investment company" ("PFIC") if, after applying
certain "look-through" rules, either (i) 75% or more of its gross income is
passive income or (ii) 50% or more of the average 

                                       67
<PAGE>

value of its assets is attributable to assets that produce or are held to
produce passive income. Passive income for this purpose generally includes
dividends, interest, rents, royalties and gains from securities and commodities
transactions. The look-through rules require a foreign corporation that owns at
least 25%, by value, of an operating subsidiary to treat that proportion of the
subsidiaries assets and income as held or received directly by the foreign
parent.

      The Company does not believe that it is currently a PFIC nor does it
anticipate that it will be a PFIC in the future because it expects that less
than 75% of its annual gross income will be passive income and less than 50% of
its assets will be passive assets, based on the look-through rules, the current
income and assets of the Company and its subsidiaries, and the manner in which
the Company and its subsidiaries are anticipated to conduct their businesses in
the future. However, there can be no assurance that the Company is not or will
not be treated as a PFIC in the future. If the Company were to be treated as a
PFIC, all U.S. Holders may be required, in certain circumstances, to pay an
interest charge together with tax calculated at maximum rates on certain "excess
distributions," including any gain on the sale of Ordinary Shares. In order to
avoid this tax consequence, a U.S. Holder (i) may be permitted to make a
"qualified electing fund" election, in which case, in lieu of such treatment
would be required to include in their taxable income certain undistributed
amounts of the Company's income or (ii) may elect to mark-to-market the Ordinary
Shares and recognize ordinary income (or possible ordinary loss) each year with
respect to such investment and on the sale or other disposition of the Ordinary
Shares. Neither the Company nor its advisors have the duty to or will undertake
to inform U.S. Holders of changes in circumstances that would cause the Company
to become a PFIC. U.S. Holders should consult their own tax advisors concerning
the status of the Company as a PFIC at any point in time after the date of this
Prospectus. The Company does not currently intend to take the action necessary
for a U.S. Holder to make a "qualified electing fund" election in the event the
Company is determined to be a PFIC.

      Foreign Personal Holding Company. A foreign corporation may be classified
as a foreign personal holding company (a "FPHC") for federal income tax purposes
if both of the following tests are satisfied: (i) at any time during the taxable
year five or fewer individuals who are United States citizens or residents own
or are deemed to own (under certain attribution rules) more than 50% of its
stock (vote or value) and (ii) at least 60% (50% for years subsequent to the
year in which it becomes a FPHC) of its gross income (regardless of its source),
as specifically adjusted, "is foreign personal holding company income," which
includes dividends, interest, rents, royalties and gain from the sale of stock
or securities.

      The Company does not believe that it is currently a FPHC nor does it
anticipate that it will be a FPHC in the future; however, no assurance can be
given that the Company is not or will not become a FPHC as a result of future
changes of ownership or changes in the nature of the income of the Company. If
the Company were to be classified as a FPHC, each U.S. Holder would be required
to include in income as a taxable constructive dividend its pro rata share of
the Company's undistributed foreign personal holding company income.

Taxation Of Non-U.S. Holders

      Distributions on Ordinary Shares. Distributions made by the Company with
respect to the Ordinary Shares to non-U.S. Holders who are not engaged in the
conduct of a trade or 

                                       68
<PAGE>

business within the United States will be subject to United States federal
income tax only if 25% or more of the gross income of the Company (from all
sources for the three-year period ending with the close of the taxable year
preceding the declaration of the distribution) was effectively connected with
the conduct of a trade or business in the United States by the Company. The
Company does not anticipate engaging in the conduct of a trade or business
within the United States, except through its subsidiaries. However, if the 25%
threshold for such period is exceeded, a portion of any distribution paid by the
Company to a non-U.S. Holder could be subject to federal income tax withholding
at the rate of 30%; the portion of the distribution that could be subject to
withholding would correspond to the portion of the Company's gross income for
the period that is effectively connected to its conduct of a trade or business
within the United States.

      Sale or Exchange of Ordinary Shares. A non-U.S. Holder will not be subject
to United States federal income tax on any gain realized upon the sale or
exchange of Ordinary Shares if such Holder has no connection with the United
States other than holding the Ordinary Shares and in particular (i) such gain is
not effectively connected with a trade or business in the United States of the
non-U.S. Holder, (ii) in the case of a non-U.S. Holder who is an individual
which has a "tax home" (as defined in Section 911(d)(3) of the Code) in the
United States, such non-U.S. Holder is not present in the United States for 183
days or more in the taxable year of such disposition, and (iii) the Company is
not and has not been at any time within 5 years preceding such disposition a
"U.S. real property holding corporation" (a "USRPHC") for federal income tax
purposes.

      The Company believes that it is not and does not currently intend to
become a USRPHC, but no assurance can be given that the Company is not or will
not become a USRPHC in the future. In general, if the Company is determined to
be a USRPHC then non-U.S. Holders may be subject to United States federal income
tax on the sale or exchange of the Ordinary Shares, and to withholding at a rate
of 10% on any such disposition. However, a non-U.S. Holder will not be subject
to these special rules even if the Company is determined to be a USRPHC provided
that (i) such non-U.S. Holder did not at any time during the five years ending
on the date of sale or disposition actually or constructively own more than 5%
of the Ordinary Shares of the Company and (ii) the Ordinary Shares are then
"regularly traded" on an established securities market in the United States.
Since the Ordinary Shares are traded on the Nasdaq stock market and since it is
regularly quoted by broker dealers, the Ordinary Shares should be considered to
be "regularly traded" on an established securities market. However, it is
possible to interpret the current Temporary Regulations as concluding that the
Ordinary Shares will not be considered "regularly traded" at any time during
which 50% or more thereof is owned by 100 or fewer persons, which will be the
case as of the date of this Prospectus.

      United States Business. A non-U.S. Holder engaged in a trade or business
in the United States whose income from the Ordinary Shares (including gain from
the sale or exchange thereof) is effectively connected with the conduct of such
trade or business will generally be subject to regular United States federal
income tax on such income in the same manner as if it were a U.S. Holder. In
addition, if such a Holder is a foreign corporation, it may be subject to a
branch profits tax equal to 30% of its effectively connected earnings and
profits for the taxable year, subject to adjustments.

                                       69
<PAGE>

Backup Withholding

      Distributions made by the Company with respect to the Ordinary Shares and
the gross proceeds received from the disposition of the Ordinary Shares may be
subject to certain information reporting to the IRS and to a 31% backup
withholding tax. However, backup withholding generally will not apply to
payments made to certain exempt recipients (such as a corporation or financial
institution) or to a Holder who furnishes a correct taxpayer identification
number or provides a certificate of foreign status and provides certain other
required information. If backup withholding applies, the amount withheld is not
an additional tax, but is credited against such Holder's United States federal
income tax liability.


                              PLAN OF DISTRIBUTION

      This Prospectus covers the sale of Shares by the Selling Shareholders. As
used herein, "Selling Shareholders" includes donees and pledgees selling shares
received from a named Selling Shareholder after the date of this Prospectus. Any
distribution of any such securities by the Selling Shareholders, or by their
pledgees, donees, transferees or other successors in interest may be effected
from time to time in one or more of the following transactions: (a) to
underwriters who will acquire securities for their own account and resell them
in one or more transactions, including negotiated transactions, at a fixed
public offering price or at varying prices determined at the time of sale (any
public offering price and any discount or concessions allowed or reallowed or
paid to dealers may change from time to time); (b) through brokers, acting as
principal or agent, in transactions (which may involve block transactions) on
the Nasdaq National Market or on such other market or exchange on which the
securities are then listed, in special offerings, exchange distributions
pursuant to the rules of the applicable exchanges or in the over-the-counter
market or otherwise, at market prices prevailing at the time of sale, at prices
related to such prevailing market prices, at negotiated prices or at fixed
prices; (c) directly or through brokers or agents in private sales at negotiated
prices; (d) through put or call options transactions relating to the Shares, or
through short sales of Shares at market prices prevailing at the time of sale or
at negotiated prices; or (e) by any other legally available means.

      The Company will not receive any proceeds from the sale of the Shares
offered hereby. The aggregate proceeds to the Selling Shareholders from the
securities offered hereby will be the offering price less applicable commissions
or discounts, if any. There is no assurance that the Selling Shareholders will
sell any of the securities offered hereby.

      The Selling Shareholders and such underwriters, brokers, dealers or
agents, upon effecting a sale of securities, may be considered "underwriters" as
that term is defined in the Securities Act. The Selling Shareholders will be
subject to the Prospectus delivery requirements because the Selling Shareholders
may be deemed to be "underwriters" within meaning of Section 11 of the
Securities Act. Sales effected through agents, brokers or dealers will
ordinarily involve payment of customary brokerage commissions although some
brokers or dealers may purchase such securities as agents for others or as
principals for their own account. (Compensation as to a particular broker-dealer
might be in excess of customary commissions). The Selling Shareholders will pay
any sales commissions or similar selling expenses applicable to the sale of

                                       70
<PAGE>

Shares. A portion of any proceeds of sales and discounts, commissions or other
sellers' compensation may be deemed to be underwriting compensation for purposes
of the Securities Act.

      Selling Shareholders also may resell all or a portion of the Shares in
open market transactions in reliance upon Rule 144 under the Securities Act,
provided they meet the criteria and conform to the requirements of such Rule.

      Pursuant to applicable rules and regulations under the Exchange Act, any
person engaged in the distribution of the securities offered hereby may not
simultaneously engage in market activities for the Ordinary Shares for a period
of five business days prior to the commencement of such distribution. In
addition, each Selling Shareholder and any other person who participates in a
distribution of the securities will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M,
which provisions may limit the timing of purchases and may affect the
marketability of the securities and the ability of any person to engage in
market activities for the Ordinary Shares.

      At the time a particular offering of securities is made, to the extent
required, a Prospectus supplement will be distributed which will set forth the
number of securities being offered and the terms of the offering, including the
purchase price or the public offering price, the name or names of any
underwriters, dealers or agents, the purchase price paid by any underwriters for
securities purchased from the Selling Shareholders, any discounts, commissions
and other items constituting compensation from the Selling Shareholders and any
discounts, commissions or concessions allowed or reallowed or paid to dealers.
In addition, upon the Company being notified by a Selling Shareholder that a
donee or pledgee intends to sell more than 500 shares, a supplement to this
Prospectus will be filed.

      In order to comply with the securities laws of certain states, if
applicable, the securities will be sold in such jurisdictions, if required, only
through registered or licensed brokers or dealers. In addition, in certain
states the securities may not be sold unless the securities have been registered
or qualified for sale in such state or an exemption from registration or
qualification is available and the conditions of such exemption have been
satisfied.

      The Company has agreed that it will bear all costs, expenses and fees in
connection with the registration or qualification of the Shares under federal
and state securities laws. The Company and each Selling Shareholder have agreed
to indemnify each other and certain other persons against certain liabilities in
connection with the offering of the securities, including liabilities arising
under the Securities Act.


                                  LEGAL MATTERS

      Certain legal matters with respect to the Ordinary Shares offered hereby
will be passed upon for the Company by Shimonov Barnea & Co., Israel.

                                       71
<PAGE>

                                    EXPERTS

      The Consolidated Financial Statements of the Company at December 31, 1996
and 1997 and for each of the three years in the period ended December 31, 1997,
appearing in this Prospectus have been audited by Kost Forer & Gabbay (a member
of Ernst & Young International), independent auditors, as set forth in their
report thereon appearing elsewhere herein which, as to the years 1996 and 1997,
are based in part on the report of another, independent auditor. Such
Consolidated Financial Statements are set forth in reliance upon the report of
such firm given upon the authority as experts in auditing and accounting.


                             ADDITIONAL INFORMATION

      The Company has filed with the Commission a Registration Statement on form
F-1 under the Securities Act with respect to the Ordinary Shares offered hereby.
This Prospectus does not contain all of the information set forth in the
Registration Statement, certain parts of which are omitted in accordance with
the rules and regulations of the Commission. For further information with
respect to the Company and this offering, reference is made to the Registration
Statement and the exhibits and schedules filed as part thereof. The Registration
Statement, including the exhibits and schedules thereto, may be inspected,
without charge, at the Public Reference Section of the Commission at 450 Fifth
Street N.W., Washington, D.C., and at the regional offices of the Commission
located at 7 World Trade Center, 13th Floor, New York, New York, and 500 West
Madison Street, Suite 1400, Chicago, Illinois. Copies of all or any portion of
the Registration Statement can be obtained from the Public Reference Section of
the Commission at 450 Fifth Street, N.W., Washington, D.C. 20549, upon payment
of the prescribed fees. Such material may also be accessed electronically by
means of the Commission's home page on the Internet at http:\\www.sec.gov.
Descriptions contained in this Prospectus as to the contents of any contract or
other document filed as an exhibit to the Registration Statement are not
necessarily complete and each such description is qualified by reference to such
contract or document.

                                 ISA EXEMPTION

      The Company will request the Israel Securities Authority to grant the
Company an exemption from the obligation to publish this Prospectus in the
manner required pursuant to the prevailing laws of the State of Israel.

                                       72
<PAGE>


                                              NUR MACROPRINTERS LTD.
                                    (Formerly: Nur Advanced Technologies Ltd.)

                                           INDEX TO FINANCIAL STATEMENTS


CONSOLIDATED FINANCIAL STATEMENTS
<TABLE>
<CAPTION>
                                                                                                           Page
                                                                                                           ----

<S>                                                                                                    <C>
    Report of Independent Auditors                                                                          F-2

    Consolidated Balance Sheets as of December 31, 1996 and 1997                                         F-3 - F-4

    Statements of Operations for the Years Ended December 31, 1995, 1996 and 1997                           F-5

    Statements of Changes in Shareholders' Equity for the Years Ended December 31, 1995,
      1996 and 1997                                                                                         F-6

    Statements of Cash Flows for the Years Ended December 31, 1995, 1996 and 1997                        F-7 - F-9

    Notes to Consolidated Financial Statements                                                          F-10 - F-46


UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS


    Consolidated Balance Sheets as of June 30, 1997 and 1998                                            F-48 - F-49

    Consolidated Statements of Operations for the Six Months Ended June 30, 1997
      and 1998                                                                                             F-50

    Statements of Changes in Shareholders' Equity for the Six Months Ended June 30, 1997
      and 1998                                                                                             F-51

    Consolidated Statements of Cash Flows for the Six Months Ended June 30, 1997
      and 1998                                                                                          F-52 - F-53

    Notes to Consolidated Financial Statements                                                          F-54 - F-55
</TABLE>

                             - - - - - - - - - - - -

<PAGE>


[Letterhead Kost Forer & Gabbay]

                               KOST FORER & GABBAY
                                   A MEMBER OF
                           ERNST & YOUNG INTERNATIONAL


                         REPORT OF INDEPENDENT AUDITORS

                             To the Shareholders of

                             NUR MACROPRINTERS LTD.
                   (Formerly: Nur Advanced Technologies Ltd.)


         We have audited the accompanying consolidated balance sheets of Nur
Macroprinters Ltd. (formerly: Nur Advanced Technologies Ltd.) ("the Company")
and its subsidiaries as of December 31, 1996 and 1997 and the related
consolidated statements of operations, changes in shareholders' equity and
consolidated cash flows for the years then ended, and the statements of
operations, changes in shareholders' equity and cash flows of the Company for
the year ended December 31, 1995. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits. We did not audit the
financial statements of a subsidiary, whose statements reflect total assets
constituting 3.8% and 4.9% of consolidated total assets as of December 31, 1996
and 1997 and total revenues constituting 18% and 14% of the related consolidated
total revenues for the years ended December 31, 1996 and 1997, respectively.
These statements were audited by other auditors whose reports have been
furnished to us, and our opinion, insofar as is relates to data included for
these subsidiaries, is based solely on the reports of the other auditors.

         We conducted our audits in accordance with generally accepted auditing
standards in the United States and Israel, including those prescribed by the
Israeli Auditors' Regulations (Mode of Performance), 1973. Those standards
require that we plan and perform the audit to obtain reasonable assurance as to
whether the financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by the Company's
management, as well as evaluating the overall financial statement presentation.
We believe that our audits and the reports of the other auditors provide a
reasonable basis for our opinion.

         In our opinion, based on our audits and the reports of the other
auditors, the financial statements referred to above present fairly, in all
material respects, the consolidated financial position of the Company and its
subsidiaries as of December 31, 1996 and 1997 and the related consolidated
results of their operations and cash flows for the years then ended, and the
results of operations and cash flows of the Company for the years ended December
31, 1995, in conformity with generally accepted accounting principles in Israel.
As applicable to the Company's financial statements, generally accepted
accounting principles in the United States and in Israel are identical in all
material aspects.

Tel-Aviv, Israel                                KOST, FORER and GABBAY
March 9  , 1998                         Certified Public Accountants (Israel)
                                       A Member of Ernst & Young International
Except for comprehensive income data
included in the statements of  changes
in shareholders' equity for which date
is October 20, 1998.


                                     F - 2
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
CONSOLIDATED BALANCE SHEETS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                         December 31,
                                                                           ------------------------------------------
                                                                                1996                     1997
                                                                           ----------------        ------------------
                                                                                   U.S. dollars in thousands
                                                                           ------------------------------------------
<S>                                                                               <C>                     <C>  
    ASSETS

CURRENT ASSETS (Note 21):
  Cash and cash equivalents (Note 3)                                               1,738                   1,234
  Trade receivables (net of allowance for doubtful accounts:
    $ 606 and $ 540 as of December 31, 1996 and 1997,
    respectively) (Note 4)                                                         4,213                   5,981
  Other accounts receivable and prepaid expenses      (Note 5)                     1,749                   1,745
  Inventories (Note 6)                                                             2,569                   2,252
                                                                           ----------------        ------------------
Total current assets                                                              10,269                  11,212
                                                                           ----------------        ------------------
LONG-TERM INVESTMENTS:
  Restricted long term bank deposit                                                    -                     150
  Long-term trade receivables (Note 7)                                                90                       -
  Prepaid expenses                                                                   368                     137
  Severance pay funds (Note 15)                                                      224                     262
                                                                           ----------------        ------------------
Total long-term investments                                                          682                     549
                                                                           ----------------        ------------------
PROPERTY AND EQUIPMENT (Note 8):
  Cost                                                                             1,024                   2,444
  Less - accumulated depreciation                                                    343                     803
                                                                           ----------------        ------------------
                                                                                     681                   1,641
                                                                           ----------------        ------------------
OTHER ASSETS, net (Note 9)                                                           529                     381
                                                                           ----------------        ------------------
Total assets                                                                      12,161                  13,783
                                                                           ================        ==================
</TABLE>

The accompanying notes are an integral part of the financial statements.


                                     F - 3
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
CONSOLIDATED BALANCE SHEETS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                          December 31,
                                                                           --------------------------------------------
                                                                                1996                      1997
                                                                           ----------------        --------------------
                                                                                    U.S. dollars in thousands
                                                                           --------------------------------------------
<S>                                                                              <C>                     <C>
    LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES (Note 21):
  Short-term bank loans (Note 11)                                                  1,462                     652
  Current maturities of long-term bank loans (Note 14)                               818                     527
  Trade payables (Note 12)                                                         4,437                   3,216
  Accrued expenses and other liabilities (Note 13)                                 1,517                   2,126
  Customer advances                                                                1,345                      17
                                                                           ----------------        --------------------
Total current liabilities                                                          9,579                   6,538
                                                                           ----------------        --------------------
LONG-TERM LIABILITIES:
  Long-term bank loans, net (Note 14)                                                408                   1,076
  Accrued severance pay (Note 15)                                                    338                     358
                                                                           ----------------        --------------------
Total long-term liabilities                                                          746                   1,434
                                                                           ----------------        --------------------
MINORITY INTEREST                                                                      -                      26
                                                                           ----------------        --------------------
SHAREHOLDERS' EQUITY:
  Share capital (Note 19):
    Common Shares of NIS 1 per nominal value:
      Authorized: 20,000,000
      Issued and outstanding: 6,880,000 Common Shares
      as of December 31, 1996
      10,880,000 Common Shares as of December 31, 1997                             1,593                   2,729
  Additional paid-in capital                                                      11,916                  14,383
  Other comprehensive income                                                         109                     (30)
  Accumulated deficit                                                            (11,782)                (11,297)
                                                                           ----------------        --------------------
Total shareholders' equity                                                         1,836                   5,785
                                                                           ----------------        --------------------
Total liabilities and shareholders' equity                                        12,161                  13,783
                                                                           ================        ====================
</TABLE>

The accompanying notes are an integral part of the financial statements.

<TABLE>
<CAPTION>
        March 9, 1998
- - - - - - ---------------------------------          ----------------------------------          -------------------------------
<S>                                             <C>                                          <C>               
      Date of approval of                            Erez Shachar                                Dan Purjes
      financial statements                           President and                            Chairman of the
                                                Chief Executive Officer                      Board of Directors
</TABLE>


                                     F - 4
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
STATEMENTS OF OPERATIONS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                   Year ended December 31,
                                                                ---------------------------------------------------------------
                                                                       1995                   1996                  1997
                                                                -------------------    -------------------    -----------------
                                                                   The Company            Consolidated          Consolidated
                                                                -------------------    -------------------    -----------------
                                                                                  U.S. dollars in thousands,
                                                                                   except per share amounts
                                                                ---------------------------------------------------------------
<S>                                                                 <C>                    <C>                    <C>
Revenues (Note 22a-c)
  Sales of printers and related products                               13,824                 13,639                 18,874
  Sales of printed materials                                                -                  2,998                  3,085
                                                                -------------------    -------------------    -----------------
                                                                       13,824                 16,637                 21,959
                                                                -------------------    -------------------    -----------------
Cost of revenues:
  Cost of sales of printers and related products
    (Note 22d)                                                          9,374                 11,528                  9,627
  Cost of sales of printed materials (Note 22e)                             -                  2,008                  1,684
                                                                -------------------    -------------------    -----------------
                                                                        9,374                 13,536                 11,311
                                                                -------------------    -------------------    -----------------
Gross profit                                                            4,450                  3,101                 10,648
                                                                -------------------    -------------------    -----------------
Research and development expenses
  (Note 22f)                                                            1,040                  1,530                  1,726
Less - royalty-bearing grants                                             306                    372                     43
                                                                -------------------    -------------------    -----------------

Research and development expenses, net                                    734                  1,158                  1,683
                                                                -------------------    -------------------    -----------------
Selling and marketing expenses, net (Note 22g)                          1,039                  4,823                  4,620
General and administrative
  expenses (Note 22h)                                                   1,187                  2,560                  3,439
Write-off of debts of related parties (Note 22j)                            -                  3,757                      -
                                                                -------------------    -------------------    -----------------

                                                                        2,226                 11,140                  8,059
                                                                -------------------    -------------------    -----------------
Operating income (loss)                                                 1,490                 (9,197)                   906
Financial expenses, net (Note 22i)                                        205                    589                    320
Gain on marketable securities                                              12                     22                      -
Other income (expenses), net                                              110                     76                     (8)
                                                                -------------------    -------------------    -----------------

Income (loss) before taxes on income                                    1,407                 (9,688)                   578
Taxes on income (Note 20e)                                                221                    400                     67
                                                                -------------------    -------------------    -----------------

Income (loss) after taxes on income                                     1,186                (10,088)                   511
Minority interest in earnings of subsidiary                                 -                      -                    (26)
Equity in losses of a 50%-owned
  joint venture (Note 22k)                                             (1,125)                     -                      -
                                                                -------------------    -------------------    -----------------
Net income (loss) for the year                                             61                (10,088)                   485
                                                                ===================    ===================    =================

Basic and diluted earnings (loss) per share
  (Note 2j)                                                              0.01                 (1.47)                  0.07
                                                                ===================    ===================    =================
Weighted average number of shares used in
  computing basic and diluted earnings (loss)
  per share                                                         4,904,118              6,880,000              7,293,640
                                                                ===================    ===================    =================
</TABLE>

The accompanying notes are an integral part of the financial statements.


                                     F - 5
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                               Number of
                                                shares
                                              outstanding
                                             ------------                    Additional         Other
                                                Common        Share            paid-in      comprehensive         Retained       
                                                shares       capital           capital          income            earnings       
                                             ------------   ------------    ------------    ---------------    ----------------  
                                                             U.S. dollars in thousands
                                             ------------------------------------------------------------------------------------
<S>                                            <C>               <C>              <C>                <C>             <C>
Balance as of January 1, 1995                   4,110,801          671             2,174              (17)            (2,140)    
- - - - - - -----------------------------
Comprehensive income:
Net income for the year                                 -            -                 -                -                 61     
                                                                                                                                 
Other comprehensive income:
Foreign currency translation adjustments                -            -                 -               65                  -     
                                                                                                                                 
Comprehensive income                                    -            -                 -                -                  -     
                                                                                                                                 
Settlement of liability to a company
  under common control                                  -            -                 -                -                385     
Issuance of shares, net                         1,795,614          598             6,957                -                  -     
Debentures converted into shares                  973,585          324             2,559                -                  -     
Amortization of deferred compensation                   -            -               177                -                  -     
                                             ------------   ------------    ------------    ---------------    ----------------  
Balance as of December 31, 1995                 6,880,000        1,593            11,867               48             (1,694)    
- - - - - - -------------------------------

Comprehensive income:
Net loss for the year                                   -            -                 -                -            (10,088)    
                                                                                                                                 
Other comprehensive income:
Foreign currency translation adjustment                 -            -                 -               61                  -     
                                                                                                                                 
Comprehensive income                                    -            -                 -                -                  -     
                                                                                                                                 
Amortization of deferred compensation                   -            -                49                -                  -     
                                             ------------   ------------    ------------    ---------------    ----------------  
Balance as of December 31, 1996                 6,880,000        1,593            11,916              109            (11,782)    
- - - - - - -------------------------------

Comprehensive income:
Net income for the year                                 -            -                 -                -                485     
                                                                                                                                 
Other comprehensive income:
Foreign currency translation adjustment                 -            -                 -             (139)                 -     
                                                                                                                                 
Comprehensive income                                    -            -                 -                -                  -     
                                                                                                                                 
Issuance of shares, net                         4,000,000        1,136             2,376                -                  -     
Amortization of deferred compensation                   -            -                91                -                  -     
                                             ------------   ------------    ------------    ---------------    ----------------  
Balance as of December 31, 1997                10,880,000        2,729            14,383              (30)           (11,297)    
- - - - - - -------------------------------
                                             ============   ============    ============    ===============    ================  

<CAPTION>
                                                                         Total
                                              Comprehensive      shareholders'
                                                 income              equity
                                              ---------------    ---------------
                                                   U.S. dollars in thousands
                                              ----------------------------------
<S>                                                <C>                 <C>
Balance as of January 1, 1995                                              688
- - - - - - -----------------------------
Comprehensive income:
Net income for the year                                 61                  61
                                              ---------------
Other comprehensive income:
Foreign currency translation adjustments                65                  65
                                              ===============
Comprehensive income                                   126
                                              ===============
Settlement of liability to a company
  under common control                                                     385
Issuance of shares, net                                                  7,555
Debentures converted into shares                                         2,883
Amortization of deferred compensation                                      177
                                                                 ---------------
Balance as of December 31, 1995                                         11,814
- - - - - - -------------------------------

Comprehensive income:
Net loss for the year                              (10,088)            (10,088)
                                              ---------------
Other comprehensive income:
Foreign currency translation adjustment                 61                  61
                                              ---------------
Comprehensive income                               (10,027)                  -
                                              ===============
Amortization of deferred compensation                                       49
                                                                 ---------------
Balance as of December 31, 1996                                          1,836
- - - - - - -------------------------------

Comprehensive income:
Net income for the year                                485                 485
                                              ---------------
Other comprehensive income:
Foreign currency translation adjustment               (139)               (139)
                                              ---------------
Comprehensive income                                   346                   -
                                              ===============
Issuance of shares, net                                                  3,512
Amortization of deferred compensation                                       91
                                                                 ---------------
Balance as of December 31, 1997                                          5,785
- - - - - - -------------------------------
                                                                 ===============
</TABLE>

The accompanying notes are an integral part of the financial statements.


                                     F - 6
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
STATEMENTS OF CASH FLOWS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                   Year ended December 31,
                                                                ---------------------------------------------------------------
                                                                       1995                   1996                  1997
                                                                -------------------    -------------------    -----------------
                                                                   The Company            Consolidated          Consolidated
                                                                -------------------    -------------------    -----------------
                                                                                  U.S. dollars in thousands
                                                                ---------------------------------------------------------------
<S>                                                                    <C>                   <C>                     <C>
Cash flows from operating activities:

Net income (loss) for the year                                             61                (10,088)                   485
Adjustments to reconcile net income (loss) to net
  cash used in operating activities:

  Minority interest in earnings of subsidiary                               -                      -                     26
  Depreciation and amortization                                           189                    321                    644
  Loss (gain) from sale of property and equipment                           -                     (4)                     8
  Deferred taxes, net                                                     221                    400                     27
  Amortization of deferred compensation                                   177                     49                     91
  Equity in losses of a 50%-owned joint venture                         1,125                      -                      -
  Severance pay, net                                                     (136)                    83                    (18)
  Decrease in marketable securities                                       100                    490                      -
  Decrease (increase) in trade receivables                             (4,970)                 3,625                 (1,783)
  Decrease (increase) in other accounts receivable
    and prepaid expenses                                                 (355)                  (378)                    41
  Decrease (increase) in inventories                                      313                 (1,738)                   317
  Increase (decrease) in trade payables                                 1,463                  1,435                 (1,248)
  Increase in accrued expenses and
    other liabilities                                                     299                    224                    502
  Increase (decrease) in customer advances                                  -                  1,345                 (1,328)
                                                                -------------------    -------------------    -----------------

Net cash used in operating activities                                  (1,513)                (4,236)                (2,236)
                                                                -------------------    -------------------    -----------------
</TABLE>

The accompanying notes are an integral part of the financial statements.


                                     F - 7
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
STATEMENTS OF CASH FLOWS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                               Year ended December 31,
                                                         ---------------------------------------------------------------------
                                                                1995                  1996                     1997
                                                         -------------------   --------------------   ------------------------
                                                            The Company            Consolidated             Consolidated
                                                         -------------------    -------------------    -----------------------
                                                                              U.S. dollars in thousands
                                                        ---------------------------------------------------------------------
<S>                                                            <C>                   <C>                    <C>
Cash flows from investing activities:

  Purchase of a subsidiary (1)                                      -                     -                      -
  Loans to a subsidiary                                          (589)                    -                      -
  Proceeds from principal (repayment of
    principal) of short-term loans
    to affiliates and a shareholder                               268                   339                      -
  Long-term bank deposit                                         (400)                    -                      -
  Restricted long term bank deposit                                 -                     -                   (150)
  Proceeds from long-term bank deposit                              -                   400                      -
  Purchase of property and equipment                             (268)                 (230)                (1,479)
  Purchase of distribution rights                                (700)                    -                      -
  Proceeds from sale of property and equipment                     95                   393                     15
  Prepaid expenses                                                  -                  (368)                   231
                                                        -------------------   --------------------   ------------------------

Net cash provided by (used in) investing
  activities                                                   (1,594)                  534                 (1,383)
                                                        -------------------   --------------------   ------------------------

Cash flows from financing activities:

  Issuance of shares, net                                       6,855                     -                  3,512
  Short-term bank credit, net                                      (1)                1,424                   (810)
  Proceeds from principal of long-term
    bank loans                                                    430                     -                  1,263
  Repayment of principal of long-term
    bank loans                                                   (243)                 (355)                  (886)
                                                        -------------------   --------------------   ------------------------

Net cash provided by financing activities                       7,041                 1,069                  3,079
                                                        -------------------   --------------------   ------------------------

Effect of exchange rate changes on cash and
  cash equivalents                                                (63)                    6                     36
                                                        -------------------   --------------------   ------------------------
Increase (decrease) in cash and cash
  equivalents                                                   3,871                (2,627)                  (504)
Cash and cash equivalents at the
  beginning of the year                                           494                 4,365                  1,738
                                                        -------------------   --------------------   ------------------------
Cash and cash equivalents at the
  end of the year                                               4,365                 1,738                  1,234
                                                        ===================   ====================   ========================
</TABLE>

The accompanying notes are an integral part of the financial statements.


                                     F - 8
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
STATEMENTS OF CASH FLOWS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                 Year ended December 31,
                                                              ---------------------------------------------------------------
                                                                    1995                  1996                   1997
                                                              ------------------   -------------------   ---------------------
                                                                 The Company          Consolidated           Consolidated
                                                              ------------------   -------------------    --------------------
                                                                                U.S. dollars in thousands
                                                              ---------------------------------------------------------------
<S>                                                                  <C>                       <C>                <C>
(1)      Purchase of subsidiary:

      Estimated fair value of assets and liabilities acquired:

        Working capital                                                  -                       196                -
        Fixed assets                                                     -                      (585)               -
        Long-term loan                                                   -                       359                -
        Accrued severance pay                                            -                        30                -
                                                             -----------------    -------------------   --------------------

                                                                         -                         -                -
                                                             =================    ===================   ====================
      Supplemental disclosure of cash flow information:

        Cash paid during the year for:
          Interest                                                     206                       763              367
                                                             =================    ===================   ====================

          Income taxes                                                  32                        38               74
                                                             =================    ===================   ====================

      Non-cash financing information:

        Debentures converted into shares                             2,883                         -                -
                                                             =================    ===================   ====================

        Purchase of distribution rights against
          issuance of shares                                           700                         -                -
                                                             =================    ===================   ====================
</TABLE>

The accompanying notes are an integral part of the financial statements.


                                     F - 9
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------


NOTE 1:-  GENERAL

          a. Organization:

             1. Nur Macroprinters Ltd. (formerly: Nur Advanced Technologies
                Ltd.) ("the Company"), an Israeli Corporation, is an industrial
                company. The Company develops, manufactures and sells digital
                continuous ink-jet printing systems and related consumable
                products for large format printing. The Company maintains
                wholly-owned subsidiaries in Europe and United States for sales
                support and marketing. The Company's products are sold by a
                network of dealers and distributors. The principal markets of
                the Company are located in Europe and United States.

             2. Nur International S.A. ("Nur International"):

                   a) Purchase of distribution rights:

                      In May 1995, the Company, Shamrock Holdings of California
                      Inc. ("Shamrock") and Nur International entered into an
                      agreement, according to which the Company repurchased from
                      Nur International the distribution rights that had been
                      granted to Nur International. Pursuant to the new
                      agreement, Shamrock also agreed to exchange its loans to
                      Nur International totaling $ 1.4 million for 245,614
                      Common Shares of the Company. In addition, the Company was
                      given an option to purchase all Shamrock's shares in Nur
                      International for $ 0.5 million.

                      The distribution rights purchased from Nur International
                      are recorded as an asset at the purchase price less 50% of
                      unrealized intercompany profits, totaling $ 700 thousand,
                      and are being amortized over a period of five years. This
                      transaction also gives rise to a $ 700 thousand difference
                      between the Company's investment in Nur International and
                      its share in the underlying equity in Nur International.
                      After elimination of the negative goodwill, the balance
                      (approximately $ 300 thousand) is recorded as goodwill and
                      is also amortized over a period of five years.

                   b) Purchase of additional 50% of the shares:

                      The Company owned 50% of the shares of Nur International -
                      a corporate joint venture with Shamrock registered in
                      Belgium (see Note 23). Nur International and its
                      subsidiaries were engaged in selling and marketing
                      continuous ink jet printing systems and related consumable
                      products, printed materials produced by the Outboard
                      Printers and in establishing and operating billboard
                      advertising activities.


                                     F - 10
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

                      In May 1996, the Company and Shamrock signed an agreement
                      as follows:

                      (1) Shamrock will not be required to provide further
                          financing to Nur International in accordance with the
                          Subscription Agreement of February 3, 1994 (the "First
                          Agreement").

                      (2) The Company exercised the option provided, however,
                          instead of an exercise price of $ 0.5 million, the
                          Company purchased all of Shamrock's shares in Nur
                          International, free and clear of any liens,
                          encumbrances, etc., for a consideration of one dollar.

                      (3) Notwithstanding the above, for every year during which
                          Nur International's net income (after taxes) will
                          exceed $ 1 million, the Company will pay Shamrock a
                          sum equal to 10% of Nur International's net income, up
                          to a total of $ 0.5 million (accumulating from the
                          first payment). Nur International's net income shall
                          be as determined in its annual audited financial
                          statements. Shamrock's right to payments under this
                          section will expire upon the earlier of the payment of
                          the $ 0.5 million thereunder, or the end of the fiscal
                          year 2002. In 1996 and 1997, Nur International's net
                          income (after taxes) was less than $ 1, million.

                          The acquisition is accounted for on the basis of the
                          purchase method of accounting. Initial difference upon
                          acquisition totaling $ 923 thousand is netted from the
                          initial difference (negative goodwill) included in the
                          investment in Nur International totaling $ 293
                          thousand, and the balance totaling $ 630 thousand has
                          been written off at the acquisition date.

                          The Company recorded losses in 1995 in the amount of $
                          630 thousand in regard to the increase in equity since
                          the Company's loan to Nur International exceeds its
                          share in the losses of Nur International.

                          Commencing January 1996, the accounts of Nur
                          International are consolidated with those of the
                          Company.

                          Unaudited pro-forma data of the Company, as if the
                          acquisition of Nur International had been effected on
                          January 1, 1995, is as follows:

<TABLE>
<CAPTION>
                                                                       Year ended
                                                                      December 31,
                                                                          1995
                                                                    ------------------
                                                                     U.S. dollars in
                                                                        thousands
                                                                    ------------------
                          <S>                                              <C>   
                          Sales                                            15,785
                          Loss                                                (43)
                     
     Basic and dilutive loss per share                 (0.01)
</TABLE>


                                     F - 11
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

             3. Nur America Inc. ("Nur America"):

                In 1996, the Company established a wholly-owned subsidiary in
                the United States - Nur America, which is engaged in marketing
                the Company's products and related consumable products in South
                America and North America.

             4. Nur Advanced Technologies (Europe) S.A. ("Nur Europe"):

                In 1996, the Company established a wholly-owned subsidiary in
                Belgium - Nur Europe which is engaged in marketing the Company's
                products and related consumable products in Europe.

             5. Nur Marketing and Communication GmbH ("Nur Germany"):

                In December 1997, the Company purchased the shares of Nur
                Germany, a 84% owned subsidiary, that was held by Nur
                International. Nur Germany is engaged in selling and marketing
                consumable printed materials.

          b. Financial difficulties:

             During 1996, the Company encountered severe financial difficulties.
             The Company wrote off $ 3,757 thousand, of outstanding debts due to
             the Company from Moshe Nur, the Company's former Chairman of the
             Board of Directors and a former major shareholder, and from
             companies controlled by Moshe Nur, which are currently in
             bankruptcy proceedings (see also Notes 16, 18 and 22j).

          c. Investment in a private company:

             In December 1997, the Company signed an agreement with a private
             company which is engaged in research and development in fields
             related to the Company's activity. In accordance with the
             agreement, the Company will provide a loan in the amount of $ 300
             thousand to the private company.

             The loan is convertible to 26% of the share capital of the private
             Company. The loan is linked to dollar and bears interest of Libor +
             2.5%. The loan is repayable, under certain conditions, in one
             payment in 1999.

             Prior to December 31, 1997, the Company provided a loan of
             approximately $ 54 thousand. The Company recorded a provision in
             respect of the aforementioned amount since the private company is
             in the development stage, and there is an uncertainty regarding the
             private company's ability to repay the loan.


                                     F - 12
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 2:-  SIGNIFICANT ACCOUNTING POLICIES

          The Company's consolidated financial statements have been prepared in
          accordance with Generally Accepted Accounting Principles in Israel
          ("Israel GAAP"). Israel GAAP and Generally Accepted Accounting
          Principles in the United States ("U.S. GAAP") as applicable to the
          consolidated financial statements of the Company are identical in all
          material respects.

          The preparation of financial statements in conformity with generally
          accepted accounting principles requires management to make estimates
          and assumptions that affect the amounts reported in the financial
          statements and accompanying notes. Actual results could differ from
          those estimates.

          a. Financial statements in U.S. dollars:

             The accompanying consolidated financial statements have been
             prepared in U.S. dollars. The U.S. dollar is the currency of the
             primary economic environment in which the operations of the Company
             and Nur America are conducted. The U.S. dollar is the functional
             currency of the Company. The majority of sales are made in U.S.
             dollars and the majority of purchases of materials and components
             are invoiced and paid in U.S. dollars. In addition, a substantial
             number of other expenses are incurred outside Israel in U.S.
             dollars or paid in U.S. dollars or in New Israeli Shekels ("NIS")
             linked to the exchange rate of the U.S. dollar.

             The Company's transactions and balances denominated in U.S. dollars
             are presented at their original amounts. Non-dollar transactions
             and balances have been remeasured into U.S. dollars in accordance
             with Statement 52 of the Financial Accounting Standards Board
             ("FASB"). All transaction gains and losses from remeasurement of
             monetary balance sheet items denominated in non-dollar currencies
             are reflected in the statement of operations as financial income or
             expenses, as appropriate.

             The functional currencies of Nur International, Nur Europe, and Nur
             Germany are their local currencies. The balance sheets of these
             subsidiaries are translated into U.S. dollars at the exchange rate
             prevailing at balance sheet date. The statements of operations and
             cash flows are translated at weighted average exchange rates during
             each year presented. Translation adjustments are recorded in a
             separate component of shareholders' equity.

          b. Principles of consolidation:

             The consolidated financial statements include the accounts of the
             Company and its subsidiaries. Intercompany transactions and
             balances have been eliminated.

          c. Cash equivalents:

             Cash equivalents are short-term highly liquid investments that are
             readily convertible to cash with original maturities of three
             months or less.


                                     F - 13
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          d. Allowance for doubtful accounts:

             The allowance for doubtful accounts is determined with respect to
             specific debts doubtful of collection.

          e. Marketable securities:

             Management determines the appropriate classification of its
             investments in marketable securities at the time of purchase and
             reevaluated such determination at each balance sheet date.
             Marketable securities are accounted as trading securities for in
             accordance with the provisions of Statement No. 115 of the FASB.
             The marketable securities consist of debentures, mutual funds and
             other securities which are carried at their market value on balance
             sheet date. The change in the difference between the market value
             and cost of marketable securities is credited or charged to the
             statement of operations.

          f. Inventories:

             Inventories are stated at the lower of cost or market value. Cost
             is determined as follows:

             Raw materials - by the "first-in, first-out" method;
             work-in-progress and finished products - on the basis of computed
             manufacturing costs.

             The Company annually reviews the inventory for obsolescence, based
             on the sales activity of its products, and provides a reserve where
             appropriate.

          g. Restricted long term bank deposit:

             Restricted long term bank deposit is maintained with banks to
             secure leasing facilities for the company's customers. The Company
             is restricted from withdrawing any portion of the long term bank
             deposit at any time, until repayment of the loan by the customer.

          h. Property and equipment:

             These assets are stated at cost.

             Depreciation is computed using the straight-line method over the
             estimated useful lives of the assets.

             The annual depreciation rates are as follows:

<TABLE>
<CAPTION>
                                                                        %
                                                      -------------------------------------
<S>                                                   <C>                                  
                     Building                                          3%
                     Machinery and equipment                         10 - 33
                     Motor vehicles                                    15
                     Office furniture and equipment                  6 - 10
                     Leasehold improvements           over the term of the lease agreement
</TABLE>


                                     F - 14
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          i. Other assets:

             Patent rights are stated at cost. Amortization is computed using
             the straight-line method over the estimated useful life of five
             years.

          j. Deferred taxes:

             1. The Company follows the asset and liability method of accounting
                for income taxes in accordance with Israel GAAP. Under Israel
                GAAP, deferred taxes are provided for differences resulting from
                changes in the Israeli Consumer Price Index ("CPI") (the basis
                for the Company's tax reporting) and changes in the exchange
                rate of the NIS to the U.S. dollar. Statement 109 of the FASB,
                "Accounting for Income Taxes", does not allow deferred taxes to
                be recognized for this difference which, with respect to the
                Company's financial statements, is immaterial.

             2. The Company has permanently reinvested tax-exempt profits from
                its approved enterprise. Accordingly, no deferred taxes were
                recorded in respect of these profits. (see Note 20a).

             3. No provision has been recorded in the financial statements for
                capital tax gains which might be applicable upon sale of the
                Company's investment in its subsidiaries since the subsidiaries
                incurred losses.

          k. Earnings (loss) per share:

             Earnings (loss) per share are computed based on the weighted
             average number of Common Shares outstanding during each period.
             Diluted earnings per share also include share equivalents (stock
             options) which have a dilutive effect.

             In 1997, the Financial Accounting Standards Board issued Statement
             No. 128, "Earnings per Share". Statement 128 replaced the
             computation of primary and fully-diluted earnings per share with
             basic and diluted earnings per share. Unlike primary earnings per
             share, basic earnings per share excluded the dilutive effects of
             options, warrants and convertible securities. Diluted earnings per
             share is similar to the previously reported fully-diluted earnings
             per share. All earnings (loss) per share for all periods have been
             presented and, where appropriate, restated to conform to Statement
             128 requirements.


                                     F - 15
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          l. Accounting for stock-based compensation:

             The Company accounts for stock-based compensation in accordance
             with the requirements of Accounting Principles Board Opinion No. 25
             (APB 25) "Accounting for Stock Issued to Employees". Under APB 25
             when the exercise price of the Company's employee options is less
             then the fair value of the underlying Common Shares on the date of
             grant, compensation expense is recognized. Pro-forma information
             with respect to the fair value of the options is provided according
             to the requirements of FASB 123 "Accounting for Stock-Based
             Compensation".

             In accounting for options granted to persons other than employees,
             the provisions of Financial Accounting Standards Board Statement
             No. 123, "Accounting for Stock Based Compensation" were applied.
             According to FASB 123 the fair value of these options was estimated
             at the grant date using Black-Scholes option pricing model.

          m. Revenue recognition

             1. Revenues from sales of products are recognized upon shipment,
                when no significant vendor obligations remain and collection is
                deemed probable.

             2. Revenues from services are recognized upon the provision of the
                services.

             3. Estimated warranty costs, which to date have been insignificant,
                are accrued in the financial statements (in respect of most of
                these costs the Company has warranties from its suppliers).

          n. Royalty-bearing grants:

             Royalty-bearing grants from the Government of Israel for funding of
             approved research projects and for encouraging marketing activities
             are recognized at the later of the receipt of governmental approval
             for the project or the time the Company incurs the costs related to
             such grants, and are netted from such related costs in the
             statement of operations.

          o. Research and development:

             Research and development expenses are carried to the statement of
             operations as incurred.

             Grants are netted from research and development costs on an accrual
             basis as the related expenses are incurred.

          p. Advertising expenses:

             Advertising expenses are expensed as incurred.


                                     F - 16
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          q. Concentrations of credit risk:

             Financial instruments that potentially subject the Company to
             concentrations of credit risk consist principally of cash
             equivalents and trade receivables.

             The Company's cash and cash equivalents are invested in banks,
             either linked or unlinked to the U.S. dollar. Management believes
             that the financial institutions that hold the Company's investments
             are financially sound and, accordingly, minimal credit risk exists
             with respect to these investments.

             The Company generally does not require collateral from its
             customers; however, in certain circumstances, the Company may
             require letters of credit, other collateral or additional
             guarantees. The Company performs ongoing credit evaluations of its
             debtors. In management's estimations, the allowance for doubtful
             accounts adequately covers anticipated losses in respect of its
             accounts receivable credit risks.

             The Company purchase all of the ink and ink-jets used in its
             printers from one supplier while using the supplier's credit-terms.
             The Company's customers rely on the ink to operate their printers.
             Because the Company's business depends on the sale of its printers,
             a supply problem or a change in credit-terms could have a severe
             effect on the Company's financial results.

             The Company employs a limited number of unaffiliated subcontractors
             to manufacture components for its printers. The Company currently
             employs one independent sub-contractor to assemble the Blueboard
             printers. Because the Company relies on subcontractors, its
             business could suffer if the Company fails to maintain its
             relationships with its subcontractors or fails to develop
             alternative sources for its printer components.

          r. Fair value of financial instruments:

             The estimated fair value of financial instruments has been
             determined by the Company using available market information and
             valuation methodologies. Considerable judgment is required in
             estimating fair values. Accordingly, the estimates may not be
             indicative of the amounts the Company could realize in a current
             market exchange. The carrying amounts of cash and cash equivalents
             approximate and the Company's borrowings under its short-term
             credit agreements fair values, due to the short term maturities of
             these instruments.

             The fair value of the Company's long-term loan is estimated using
             discounted cash flow analyses, based on the Company's current
             increment borrowing rates for similar types of borrowing
             arrangements.


                                     F - 17
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

             The carrying amounts and fair values of the Company's financial
             instruments at December 31, 1997, are as follows (amounts in
             thousands):

<TABLE>
<CAPTION>
                                             Carrying amount             Fair value
                                             -------------------     --------------------
                                                    U.S. dollars in thousands
                                             --------------------------------------------

             <S>                                  <C>                        <C>  
             Cash and cash equivalents            1,738                      1,738
             Short term bank loans                  652                        652
             Long term loan                       1,076                      1,076
</TABLE>

          s. Impact of recently issued accounting standards:

             In June 1997, the FASB issued Statements of Financial Accounting
             Standards 131, "Disclosure About Segments of an Enterprise and
             Related Information". This statement is effective for fiscal years
             beginning after December 15, 1997. These statements do not have
             measurement effects on the financial statements, however, do
             require additional disclosure.

NOTE 3:- CASH AND CASH EQUIVALENTS

<TABLE>
<CAPTION>
                                                                                           December 31,
                                                 Linkage            Interest     --------------------------------
                                                  terms               rate           1996              1997
                                             -----------------    -------------  ------------    ----------------
                                                                       %             U.S. dollars in thousands
                                                                  -------------   --------------------------------
<S>                                            <C>                    <C>          <C>             <C>  
          Short-term bank deposits:
                                               U.S. dollars           5.1              1,659           1,031
                                                    FF                9.2                 74              61
                                                    DM                3.3                  -             135
          Cash in banks:
                                               Unlinked NIS            -                   5               7
                                                                                   ------------    ---------------
                                                                                       1,738           1,234
                                                                                   ============    ===============
</TABLE>


                                     F - 18
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 4:- TRADE RECEIVABLES

<TABLE>
<CAPTION>
                                                                                        December 31,
                                                                             ------------------------------------
                                                                                  1996                1997
                                                                             ----------------    ----------------
                                                                                  U.S. dollars in thousands
                                                                             ------------------------------------
          <S>                                                                <C>                 <C>
          Open accounts (1)                                                        4,819              6,340
          Notes receivable                                                             -                181
                                                                             ----------------    ----------------
                                                                                   4,819              6,521
          Less - allowance for doubtful accounts                                     606                540
                                                                             ----------------    ----------------
                                                                                   4,213              5,981
                                                                             ================    ================
</TABLE>

          (1)  Including receivables due from one customer in the amount of $
               784 thousand as of December 31, 1997 (December 31, 1996 -$212
               thousand).

NOTE 5:- OTHER ACCOUNTS RECEIVABLE AND
         PREPAID EXPENSES

<TABLE>
          <S>                                                                 <C>                <C>
          Government authorities                                                     621                321
          Participations and grants receivable                                       540                392
          Related parties                                                              4                146
          Deferred taxes                                                               -                  8
          Advances to suppliers                                                      189                353
          Prepaid expenses and other                                                 395                525
                                                                             ----------------    ----------------
                                                                                   1,749              1,745
                                                                             ================    ================
</TABLE>

                                     F - 19
<PAGE>

                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 6:-  INVENTORIES

<TABLE>
          <S>                                                                 <C>                 <C>  
          Raw materials                                                            945                 752
          Work-in-progress                                                         270                 277
          Finished products                                                      1,354               1,223
                                                                             ----------------     ---------------
                                                                                 2,569               2,252
                                                                             ================     ===============
</TABLE>

NOTE 7:-  LONG-TERM TRADE RECEIVABLES

          The long-term trade receivables bear interest at the rate of 9.5% and
          are repayable in 1998.

NOTE 8:-  PROPERTY AND EQUIPMENT

<TABLE>
<CAPTION>
                                                                              Office
                                              Machinery                      furniture       Building and
                                                and             Motor          and             leasehold
                                              equipment        vehicles      equipment        improvements       Total
                                            --------------    -----------   -------------    ---------------    ---------
                                                                         U.S. dollars in thousands
                                            -----------------------------------------------------------------------------
<S>                                         <C>               <C>            <C>              <C>               <C>  
          Cost as of January 1, 1997 *)              33           125               782                  84       1,024
             Additions                              280            64               301                 834       1,479
             Disposals                                -           (43)              (16)                  -         (59)
                                            --------------    ------------   -------------    --------------    ----------
          Balance as of
             December 31, 1997                      313           146             1,067                 918       2,444
                                            --------------    ------------   -------------    --------------    ----------

          Accumulated depreciation
             as of January 1, 1997 *)                12            50               259                  22         343
             Additions                              119            34               244                  99         496
             Disposals                                -           (20)              (16)                  -         (36)
                                            --------------    ------------   -------------    --------------    ----------
          Balance as of
             December 31, 1997                      131            64               487                 121         803
                                            --------------    ------------   -------------    --------------    ----------

          Depreciated cost as of
             December 31, 1997                      182            82               580                 797       1,641
                                            ==============    ============   =============    ==============    ==========
          Depreciated cost as of
             December 31, 1996  *)                   21            75               523                  62         681
                                            ==============    ============   =============    ==============    ==========
</TABLE>

           As for charges, see Note 17.

         *) Reclassified.


                                     F - 20
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 9:- OTHER ASSETS, NET

<TABLE>
<CAPTION>
                                                               December 31,
                                                    ------------------------------------
                                                        1996                1997
                                                    --------------    ------------------
                                                         U.S. dollars in thousands
                                                    ------------------------------------
          <S>                                       <C>               <C>
          Cost:
             Distribution rights                          700               700
             Patent rights                                 61                61
                                                    --------------    ------------------
                                                          761               761
                                                    --------------    ------------------
          Accumulated amortization:
             Distribution rights                          210               350
             Patent rights                                 22                30
                                                    --------------    ------------------
                                                          232               380
                                                    --------------    ------------------
          Depreciated cost                                529               381
                                                    ==============    ==================
</TABLE>

NOTE 10:- LEASES

          a. Nur America Inc. leases office space and warehouse facilities under
             a one-year operating lease agreement.

          b. Nur Germany leases office space for a period of 10 years ending in
             October 2006.

          c. The Company entered into a lease agreement with a former
             shareholder (Moshe Nur) according to which the Company leases two
             adjacent buildings each of approximately 6,500 square feet. The
             term of the lease is approximately 10 years from the date on which
             all the changes and improvements in the building required by the
             Company are completed.

             The lease agreement provides that the rental payment under the
             lease will be determined by an independent land assessor. The
             rental payments will be linked to the U.S. dollar and will increase
             every year by 5%. After five years, another independent land
             assessor may be appointed to reassess the rental payment. The Audit
             Committee may, at its discretion, appoint an additional land
             assessor, also to be approved by the shareholder. If the additional
             assessor is appointed, the amount of the rental payment will be the
             average of both assessments. If the Company is required to vacate
             the building or to cease using the entire or a portion of the
             building due to any suit filed relating to the use of the building,
             then, provided that the Company had used the building for its
             intended purposes, the term of the lease shall terminate
             immediately. If this occurs within the first five years of the
             lease, then the shareholder will agree to indemnify the Company for
             relocating expenses, fines levied on the Company, legal expenses
             and the carrying amount of the improvements made in the building at
             the Company's expense.


                                     F - 21
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

             During 1996 and 1997, the Company paid $ 545 thousand in respect of
             the erection of the building, on behalf of Moshe Nur. In 1997,
             Moshe Nur met financial difficulties, resulting in the filing of a
             petition in bankruptcy. The amounts paid were recorded as prepaid
             rent expenses as of December 31, 1996 and 1997.

             The Company's management and its Israeli legal consultants are of
             the opinion that, in accordance with the lease agreement, the
             Company is entitled to offset this amount against future rent
             payments. During 1997, the Company recorded $ 204 thousand as rent
             expenses in connection with such prepaid expenses.

             On April 29, 1997, the Company received a demand from the Otzar
             Hahayal Bank the holder of a mortgage lien on the premises to pay
             the bank the rental fees in respect of the aforementioned
             buildings.

             On February 4, 1998 in the context bankruptcy proceeding the
             special manager of Moshe Nur's properties filed an application to
             the court to compel the company to pay rental fees in respect of
             the buildings held by the Company or, alternatively, to issue an
             eviction order to remove the Company from the aforementioned
             premises.

             Future minimum rental payments as of December 31, 1997, under the
             aforementioned non cancelable leases, are as follows (U.S. dollars
             in thousands):

<TABLE>
             <S>                                 <C>
             1998                                        28
             1999                                       116
             2000                                        25
             2001                                        25
             2002                                        25
             Thereafter                                  95
                                                 ----------------
                                                        314
                                                 ================
</TABLE>

          d. Rental expenses were $ 42 thousand, $ 244 thousand and $ 350
             thousand for the years ended December 31, 1995, 1996 and 1997,
             respectively.

NOTE 11:- SHORT-TERM BANK LOANS

<TABLE>
<CAPTION>
                                                           Weighted average interest             December 31,
                                            Linkage      ------------------------------ -------------------------------
                                             terms            1996           1997            1996            1997
                                         --------------- --------------- -------------- --------------- ---------------
                                                                       %                  U.S. dollars in thousands
                                                         ------------------------------ -------------------------------

             <S>                          <C>                 <C>             <C>        <C>             <C>
             Revolving bank credit            NIS             17              17               1,462             160
             Short-term loans             U.S. dollar          -               7.3                 -             453
             Short-term loans                 NIS              -              17.7                 -              39
                                                                                         --------------  --------------

                                                                                               1,462             652
                                                                                         ==============  ==============
</TABLE>


                                     F - 22
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 12:- TRADE PAYABLES

<TABLE>
<CAPTION>
                                                                   December 31,
                                                          --------------------------------
                                                             1996              1997
                                                          ------------    ----------------
                                                             U.S. dollars in thousands
                                                          --------------------------------
          <S>                                             <C>             <C>  
          Open accounts                                         3,191           2,695
          Notes payable                                         1,246             521
                                                          ------------    ---------------
                                                                4,437           3,216
                                                          ============    ===============
</TABLE>

NOTE 13:- ACCRUED EXPENSES AND OTHER LIABILITIES

<TABLE>
<CAPTION>

                                                                   December 31,
                                                          --------------------------------
                                                              1996              1997
                                                          -------------    ---------------
                                                             U.S. dollars in thousands
                                                          --------------------------------
          <S>                                             <C>             <C>  
          Employees and payroll accruals                        577               585
          Royalties payable                                     241               390
          Deferred taxes                                         19                 -
          Other accrued expenses                                680             1,151
                                                          ---------------   -------------
                                                              1,517             2,126
                                                          ===============   =============
</TABLE>

NOTE 14:- LONG-TERM BANK LOANS, NET

          a. Composed as follows:

<TABLE>
<CAPTION>
                                                Linkage            Interest
                                                 terms               rate
                                              -------------     ---------------
                                                                      %
                                                                ---------------
             <S>                              <C>                 <C>              <C>               <C>
             From banks                       U.S. dollar         LIBOR
                                                                  +3.12                  971               289
             From leasing companies           U.S. dollar          6.2                   255             1,314
                                                                                   --------------    -------------
                                                                                       1,226             1,603
             Less - current maturities                                                   818               527
                                                                                   --------------    -------------
                                                                                         408             1,076
                                                                                   ==============    =============

          b. Aggregate maturities of long-term loans:

             First year (current maturities)                                             818               527
                                                                                   --------------    -------------
             Second year                                                                 388               190
             Third year                                                                   20               162
             Fourth year                                                                   -               139
             Fifth year and thereafter                                                     -               585
                                                                                   --------------    -------------
                                                                                         408             1,076
                                                                                   --------------    -------------
                                                                                       1,226             1,603
                                                                                   ==============    =============
</TABLE>


                                     F - 23
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 15:- SEVERANCE PAY, NET

          a. The Company's liability for severance pay, pursuant to Israeli law,
             is fully accrued. Employee insurance policies are purchased to
             cover a portion of this liability. Since these policies are owned
             by the Company, the cash value of these policies at each year end
             is recorded as an asset of the Company and included in severance
             pay funds in the Company's balance sheet.

             The Company has no liability for any pension payments to its
             employees.

<TABLE>
<CAPTION>
                                                                                Year ended December 31,
                                                             ---------------------------------------------------------------
                                                                   1995                 1996                   1997
                                                             -----------------    ------------------    --------------------
                                                               The Company          Consolidated           Consolidated
                                                             -----------------    ------------------    --------------------
                                                                               U.S. dollars in thousands
                                                             ---------------------------------------------------------------
          <S>                                                <C>                 <C>                    <C>
          b. Severance pay expense included in the 
             statements of operations                                162                217                    312
                                                             =================   ===================    ====================
</TABLE>

NOTE 16:- CONTINGENT LIABILITIES

          a. The Company entered into several project plans with the Chief
             Scientist of the Government of Israel regarding the development of
             the printers and the Mega Light, a discontinued product. The
             Company has an obligation to pay royalties at the rate of 2% - 3%
             of the sales derived from the applicable products developed within
             the framework of such research and development projects, up to an
             amount equal to 100% - 150% of the grant received, in NIS linked to
             the exchange rate of the U.S. dollar.

             The Company has no obligation to repay this amount if sales are not
             sufficient to satisfy the royalty obligations. As of December 31,
             1997, the Company has a contingent obligation to pay royalties in
             the amount of $ 993 thousand, excluding the discontinued Mega Light
             in respect to which there is no longer royalty obligation.

          b. The Company is required to pay royalties to the Fund for the
             Encouragement of Marketing Activity at the rate of 3% with respect
             to increases in export sales of products for which the Company
             received participations for its marketing activities, up to an
             amount equal to 100% of the grant received.

             The grant is repayable only in respect of sales of the related
             products, as a percentage of the growth in export sales.

             If there is no increase in export sales, or if the Company ceases
             producing the relevant products, the grant is not repayable. As of
             December 31, 1997, the Company has a contingent obligation to pay
             royalties in the amount of $ 129 thousand.


                                     F - 24
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          c. The Company is committed to pay royalties to the developer of the
             Outboard Printer at the rate of 4% of sales of these printers and
             accessory products, and at the rate of 12% of the gross margin of
             the sale of ink for printers. (See also note 16g).

          d. The Company has guaranteed to the lessor capital lease payments in
             the amount of $ 105 thousand for a printer that was leased by a
             subsidiary.

          e. In the course of the bankruptcy proceedings of Moshe Nur and the
             companies controlled by him, the Company may, in the future, be
             exposed to claims arising from the actions of Moshe Nur, the
             liability of which could be material.

          f. In 1997, claims and threats of claims were brought against the
             Company in the ordinary course of business in respect of various
             matters. The Company made a provision in the amount of $ 165
             thousand in respect of these claims and threats of claims based on
             the opinion of the Company's Israeli legal advisors. The Company's
             management believes that these provisions are adequate.

          g. On December 11, 1997, the Company filed a claim for monetary and
             other relief against the developer of the Outboard Printer and
             three companies which he controls ("Dochovna Group"). The claim
             primarily concerns the monetary damages which the developer and his
             companies caused to the Company over the course of the years in
             which they collaborated as well as the parallel and competitive
             activities carried out by the developer and his companies while
             infringing upon the Company's contractual and/or proprietary
             rights. Simultaneously with the claim letter, the Company also
             filed a request for temporary reliefs of which the most material
             concern is preventing the developer's competitive activities and
             the use he has made of the Company's commercial know-how.

             On January 18, 1998, in response, the developer of the Outboard
             Printer and two of the companies he controls filed a claim against
             the Company and five other parties (among them, the chief executive
             officer and the former Chief Executive Officer). Pursuant to the
             claim:

             1. The Company is indebted to the developer of the Outboard Printer
                or the companies which he controls the amount of $ 376 thousand
                in respect of printers supplied to the Company in the past which
                were not paid for.

             2. The Company is indebted to the developer of the Outboard
                Printers the amount of $ 1,063 thousand (subject to the
                presentation of invoices) in respect of an error in the
                calculation of royalties.

             3. The Company is prevented from manufacturing and marketing
                Blueboard printers as they are identical to the Wideboard
                printers which the Company is prohibited from manufacturing
                without the agreement of the developer of the Outboard Printer.

             Regarding the manufacture and marketing of the Blueboard printers,
             a temporary restraining order against the Company has been
             requested.


                                     F - 25
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

             According to the management opinion, and based on the opinion of
             its Israeli legal counsel, adequate provision was recorded in the
             books of the Company.

          h. In the context of the various proceedings under way regarding the
             dissolution of Nur Outdoor Advertising a company controlled by
             Moshe Nur, the receiver for Nur Outdoor Advertising claimed that
             the Company is bound to Nur Outdoor Advertising by an exclusivity
             agreement for the marketing of the Company's printers in Israel.

             Among others, it is claimed that the Company has breached the
             aforementioned agreement and is selling printers in Israel without
             paying the royalties due to Nur Outdoor Advertising pursuant to the
             aforementioned agreement.

             The Company notified Nur Outdoor Advertising's receiver in May
             1997, that the agreement at issue was breached by Nur Outdoor
             Advertising and, therefore, it was canceled by the Company and is
             null and void.

             In the opinion of the Company's Israeli legal counsel, a claim will
             be filed by the receiver of Nur Outdoor Advertising in respect of
             the printers the Company sold in Israel.

             The Company's management and its Israeli legal counsel are of the
             opinion that no amount will be required to be paid in regards to
             the abovementioned lawsuit.

NOTE 17:- CHARGES, GUARANTEES AND RESTRICTED LONG-TERM DEPOSIT

          a. As collateral for its liabilities to the banks, the Company granted
             an unlimited first priority lien on its machinery and equipment,
             vehicles, receivables from Scitex, major customer (hereinafter
             "Scitex"), a long-term bank deposit, and marketable securities, as
             well as a floating lien (a lien on the assets of the Company as
             they exist from time to time) on all its assets.

          b. The collateralized liabilities are as follows:

<TABLE>
<CAPTION>
                                                                December 31,
                                                    -------------------------------------
                                                         1996                1997
                                                    ---------------    ------------------
                                                         U.S. dollars in thousands
                                                    -------------------------------------

             <S>                                    <C>                <C>
             Short-term bank loan                         1,462                652
             Long-term liabilities,
                including current maturities              1,226              1,603
                                                    ---------------    ------------------

                                                          2,688              2,255
                                                    ===============    ==================
</TABLE>


                                     F - 26
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 18:- TRANSACTIONS AND BALANCES WITH RELATED PARTIES

          a. In March 1997, three companies in which Moshe Nur - a former
             shareholder - has holdings in various percentages, experienced
             financial difficulties and are in different stages of insolvency.
             These companies are Nur Outdoor Advertising (Manufacturing and
             Production) Ltd.("Nur Outdoor"), Nur Focus Assets and Investments
             Ltd. ("Nur Focus Assets") and Nur Focus Production (1995) Ltd.
             ("Nur Focus") Consequently, there is a considerable doubt as to
             whether these companies will continue as going concerns and whether
             the agreements entered with them will remain valid. As to the
             write-off of debts of related parties, see Note 22j.

             Agreements:

             1. Pursuant to an Israeli distribution agreement, the Company and
                Nur Outdoor entered into an ink supply agreement commencing
                October 1994. According to the ink supply agreement, the Company
                will supply Nur Outdoor with the ink for distribution in Israel.
                The price of the ink will be determined based upon the price for
                the ink paid by Scitex or any other distributor of the Company's
                products.

             2. The Company entered into maintenance and support agreements with
                Nur Outdoor and Nur Focus. According to the maintenance
                agreements, the Company undertook to provide Nur Outdoor and Nur
                Focus with maintenance and support services for the Outboard
                Printers bought by them in consideration for an annual payment
                to the Company of $ 25,000 per machine.

             3. In 1993, the Company entered into an Israeli Distribution
                Agreement for an indefinite period of time with Nur Outdoor and
                Nur Focus, affiliates of the Company. According to the terms of
                the agreement, Nur Outdoor was granted the exclusive rights to
                use, market and distribute the Outboard Printer in Israel. In
                addition, under this agreement, Nur Focus is entitled to
                purchase Outboard Printers from the Company for its own use.
                Pursuant to the Israeli Distribution Agreement, Nur Outdoor is
                entitled to purchase Outboard Printers from the Company on the
                same terms and conditions as Scitex.

                Pursuant to the agreement, Nur Outdoor has the exclusive right
                to use, market and distribute the MegaLight for the purpose of
                providing advertising media services to third parties in Israel.
                This right also extends to future developments of the MegaLight.
                Purchase of the MegaLight will be at cost plus 20%, and
                maintenance services and materials will be at market prices, but
                not less than those granted to I.E.M. International Media
                Electronic Ltd. ("IEM"), a subsidiary of Nur Outdoor.

                Nur Outdoor is entitled to royalties at the rate of 7% in
                respect of sales of electronic signs to others in Israel.


                                     F - 27
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

             4. In January 1993, the Company entered into an agreement with Nur
                Outdoor and Poster Media (Israel) Ltd. ("Poster Media"), an
                unrelated party, pursuant to which Nur Outdoor and Poster Media
                agreed to establish a joint venture, IEM. Under the agreement,
                the Company has agreed not to sell the MegaLight in Israel for
                indoor media services to any entity excluding IEM. In exchange,
                IEM has agreed to purchase the electronic media billboards only
                from the Company.

                In May 1995, the Company entered into an agreement with IEM.
                According to the agreement, the Company will supply IEM with
                editing and production services with respect to advertisements
                to be presented on the MegaLight. In consideration for such
                services, IEM will pay the Company a monthly payment in NIS
                equal to $ 1,500.

                Under a separate agreement, IEM leased from the Company three
                portable MegaLight boards. IEM will pay the Company
                consideration equal to half of IEM's revenues from the MegaLight
                during the lease period, less the direct expenses incurred by it
                during such period. In addition, IEM agreed to lease from the
                Company up to eight MegaLight boards for a short-term period and
                to pay for each MegaLight monthly payments in NIS equal to $
                300.

                In 1996, Nur Outdoor purchased the shares of Poster Media in
                IEM, and became a 100% shareholder of IEM.

             The Company terminated all of the aforementioned agreements in May
             1997 (see Note 16h).

          b. For a lease agreement with a former shareholder, see Note 10c.

          c. Between September and December 1997, the Company effected a private
             offering of its Common Shares in the United States (see also Note
             19a), for which the investment banking firm of Josephthal and Co.
             Inc. ("Josephthal") acted as exclusive placement agent. The
             chairman of Josephthal beneficially owns approximately 31.87% of
             the Company's Common Shares, and other individuals affiliated with
             Josephthal beneficially own approximately 39.51% of the Company's
             common Shares. In addition, three members of the Company's board of
             directors are affiliated with or employed by Josephthal and the
             chairman of Josephthal is the company's chairman. As compensation
             for its services as the Company's exclusive placement agent,
             Josephthal received fees of $439 thousand and warrants to purchase
             400,000 Common Shares at an exercise price of $1.00 per share.
             Finally an individual employed by Josephthal was the Company's
             acting Chief Financial Officer from April through October 1997 for
             which he received compensation of approximately $ 45 thousands.


                                     F - 28
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          d. Transactions with related parties:

<TABLE>
<CAPTION>
                                                                     Year ended December 31,
                                                   -------------------------------------------------------------
                                                         1995                  1996                 1997
                                                   -----------------    -------------------   ------------------
                                                     The Company          Consolidated          Consolidated
                                                   -----------------    ------------------    ------------------
                                                                    U.S. dollars in thousands
                                                   -------------------------------------------------------------
             <S>                                          <C>                       <C>                <C>
             Sales:
              Nur Outdoor                                 $1,625                    $485               $159
              Nur Focus                                      803                     113                 31
              IEM                                             38                       -                  -
              Nur International                               26                       -                  -
                                                     ---------------       ---------------    -------------------

                                                          $2,492                    $598               $190
                                                     ===============       ===============    ===================
             Cost of sales:
              Paid to:
              Nur Outdoor                                 $  283                    $511               $ 99
              Nur Focus                                      301                       7                 18
                                                     ---------------       ---------------    -------------------

                                                          $  584                    $518               $117
                                                     ===============       ===============    ===================
             Selling expenses:
              Nur Focus                                   $    1                    $130               $  -
              Participation from
              Nur International (1)                         (209)                      -                  -
              Participation in expenses of
                Nur International                            206                       -                  -
                                                     ---------------       ---------------    -------------------

                                                          $   (2)                   $130               $  -
                                                     ===============       ===============    ===================
</TABLE>

             (1)    Mainly reimbursement of direct salaries and
                    traveling expenses, which are netted against the
                    applicable expenses


                                     F - 29
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                               Year ended December 31,
                                                              -----------------------------------------------------------
                                                                     1995                1996                1997
                                                              -------------------    --------------    ------------------
                                                                  The Company          Consolidated        Consolidated
                                                              ------------------    -----------------    ---------------
                                                                              U.S. dollars in thousands
                                                              -----------------------------------------------------------
             <S>                                                        <C>                    <C>             <C>
             General and administrative expenses:
                Participation in salary, employee
                 benefits, maintenance and
                 bookkeeping to
                 Nur Outdoor (1)                                        $ 20                   $  -            $  -
                 Rent expenses                                             -                    153             204
                Salary and related benefits
                 paid to two shareholders (1997 -
                 three shareholders)                                      79                    244             261
                                                              -------------------    -----------------    ----------

                                                                        $ 99                   $397            $465
                                                              ===================    =================    ==========

                 Financial income:
                   Nur Focus                                            $155                   $107            $  -
                   Nur Outdoor                                           187                    182               -
                   Nur International                                     134                      -               -
                                                              -------------------    -----------------    ----------

                                                                        $476                   $289            $  -
                                                              ===================    =================    ==========
</TABLE>

             As to the write-off of debts of related parties, see Note 22j.

NOTE 19:- SHARE CAPITAL

          a. In October 1995, the Company effected a public offering of its
             securities in the United States, where its Common Shares are traded
             on the over-the-counter market. In the public offering, the Company
             issued 1,550,000 Common Shares.

             Following the initial public offering of the Company's shares in
             October 1995, the Company issued 155,000 warrants to Josephthal.
             These warrants are exercisable into 155,000 Common Shares of the
             Company at an exercise price of $ 7.20 per share, no later than
             October 2000.

             Between September and December 1997, the Company effected a private
             offering of its securities in the United States. In the private
             offering, the Company issued 4,000,000 Common Shares of NIS 1 par
             value each in consideration of $ 1 per common share.

             After the aforementioned transactions, the Company had 10,880,000
             Common Shares of NIS 1 par value each.


                                     F - 30
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          b. Stock Option Plan:

             In October 1995, the Company's Board of Directors adopted a
             Flexible Stock Incentive Plan (the "Stock Incentive Plan"). The
             Stock Incentive Plan provides for grants of stock options to
             employees of the Company. An aggregate amount of not more than
             500,000 stock options are available for grant under the Stock
             Incentive Plan. Of such amount, (i) not more than 414,768 options
             are available for grant as stock options on the basis of future
             services (such options, "Service Options"), (ii) not more than
             18,232 options may be granted as stock options on the basis of
             performance (such options, "Performance Options") and (iii) not
             more than 67,000 options may be granted as stock options to
             consultants on the basis of service or performance in respect of
             the public offering (such options, "Consultants Options").

             Compensation expenses, which comprise the excess of market value of
             stock of the Performance Options over the exercise price at grant
             date, are charged to income over the vesting period of ten years or
             on an accelerated basis, provided various performance targets are
             achieved.

             Compensation expenses, which comprise the excess of market value of
             stock of the Service Options over the exercise price at grant date,
             are charged to expenses over the vesting period of four years.

             In October 1997, the Company adopted an additional stock option
             plan. According to that option plan, 1,200,000 options will be
             granted to Company's employees, directors and consultants. During
             1997, the Company granted 825,000 options exercisable from date of
             grant (out of which 750,000 options were granted to the Chairman of
             the Board of Directors, two directors and to the Chief Executive
             Officer) at an exercise price between $ 1.00 to $ 1.50 per share.
             The aggregate amount of compensation related to the above options
             was $ 18,800 and was accounted for as compensation expense in the
             year ended December 31, 1997.

             As part of the private offering described in Note 19a above, the
             Company issued warrants to the placement agent, Josephthal to
             purchase 400,000 Common Shares of the Company at an exercise price
             of $ 1.00 per share, expiring in September 2002.


                                     F - 31
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

             The balance of the options at December 31, 1997 is as follows:

<TABLE>
<CAPTION>
                                                                                  Options outstanding
                                                                          -------------------------------------
                                                                                                    Weighted
                                                            Available       Number                   average
                                                               for            of       Exercise     exercise
                                                              grant        options       price        price
                                                           ------------   -----------  ----------  ------------
             <S>                                            <C>            <C>         <C>            <C>
             Balance as of January 1, 1995                         -             -         -            -
                Stock option plan                            500,000             -         -            -
                Options granted (9 employees and
                 consultants                                (189,526)      189,526      0.3-4.8       2.32
                                                           ------------   -----------  ----------  ------------
             Balance as of December 31, 1995                 310,474       189,526      0.3-1.8       2.32
                Options granted (1 employee)                 (18,232)       18,232        1.3         1.30
                Options expired                               87,987       (87,987)     1.3-4.8       2.37
                                                           ------------   -----------  ----------  ------------
             Balance as of December 31, 1996                 380,229       119,771      0.3-1.8       1.34
                Additional stock options plan              1,200,000             -         -            -
                Options granted (25 employees
                 and a vendor)                              (325,600)      325,600     0.3-1.75       1.33
                Options granted (2 employees and
                  3 directors)                              (825,000)      825,000        1-3         1.46
                                                           ------------   -----------  ----------  ------------
             Balance as of December 31, 1997                 429,629      1,270,371    0.3-1.75        1.3
                                                           ============   ===========  ==========  ============
</TABLE>

             The amount of options exercisable as of December 31, 1995, 1996 and
             1997 was 36,539, 54,771 and 849,921, respectively. The remaining
             contractual life of those options ranges between 1-4 years.

             The weighted average exercise price of options exercisable as of
             December 31, 1995, 1996 and 1997 is $ 0.31, $ 1.06 and $ 1.24,
             respectively.

             The options outstanding as of December 31, 1997 have been separated
             into ranges of exercise price, as follows:

<TABLE>
<CAPTION>
                                                         Options
                                                       outstanding               Weighted
                                                          as of                   average                Weighted
                                                       December 31,              remaining               average
             Exercise price                                1997              contractual life         exercise price
             --------------                         -------------------    ----------------------    -----------------
             <S>                                     <C>                          <C>                  <C>
             $ 0.3                                      36,539                    4                      0.3
             $ 1                                       100,000                    5                      1
             $ 1.25                                    500,000                    5                      1.25
             $ 1.3                                      18,232                    4                      1.3
             $ 1.4                                     360,600                    4                      1.4
             $ 1.5                                     225,000                    5                      1.5
             $ 1.75                                     30,000                    4                      1.75
                                                 -------------------                              -----------------
                                                     1,270,371                                         $ 1.3
                                                 ===================                              =================
</TABLE>


                                     F - 32
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          c. The Company has elected to follow Accounting Principles Board
             Opinion 25, "Accounting for Stock Issued to Employees" (APB 25) and
             related interpretations for its employee stock options. As
             discussed below, the alternative fair value provided for under FASB
             Statement No. 123, "Accounting for Stock-Based Compensation" (FASB
             123), requires the use of option valuation models that were not
             developed for use in valuating employee stock options. Where the
             exercise price equals the market price of the underlying stock on
             the grant date, no compensation expense is recognized under APB 25.

          d. In January 1997, the Company granted to its Israeli counsel an
             option to purchase 30,000 shares at an exercise price of $1.75 per
             share. The fair market value of these options was estimated
             according to FASB-123 at the grant date using Black-Scholes value
             option pricing model was immaterial.

          e. Pro-forma information regarding net income and earnings per share
             is required by FASB 123, and has been determined as if the Company
             has accounted for its employee stock options under the fair value
             method of that Statement. The fair value for these options was
             estimated at the grant date using the Black-Scholes option pricing
             model with the following weighted-average assumptions for 1995,
             1996 and 1997: risk-free interest rates of 7%, 7% and 6.3%
             respectively, dividend yields of 0% volatility factors of the
             expected market price of the Company's Common Shares of 1.3, 1.75
             and 1.25, respectively, and a weighted average expected life of the
             option of 3 years.

             The Black-Scholes model was developed for use in estimating the
             fair value of traded options which have no vesting restrictions and
             are fully transferable. In addition, option valuation models
             require the input of highly subjective assumptions including the
             expected share price volatility. Because the Company's employee
             stock options have characteristics significantly different from
             those of traded options, and because changes in the subjective
             input assumptions can materially affect the fair value estimate, in
             management's opinion, the existing models do not necessarily
             provide a reliable single measure of the value of its employee
             stock options. For purposes of pro-forma disclosures, the estimated
             fair value of the options is amortized to expense over the options
             vesting period.

             The weighted average fair value of the options at their grant dates
             in 1995, 1996 and 1997 was $ 0.65, $ 0.86 and $ 0.42, respectively.

             For purposes of pro forma disclosure, the estimated fair value of
             the options is amortized to expense over the options vesting
             period. Because SFAS 123 is applicable only to options granted
             subsequent to December 31, 1994, its pro forma effect will not be
             fully reflected until the year 1999.

             The total compensation expense included in the statements of
             operations for 1995, 1996 and 1997 is $ 177 thousand, $ 49 thousand
             and $ 91 thousand, respectively.


                                     F - 33
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

              Pro-forma information is as follows

<TABLE>
<CAPTION>
                                                                       Year ended December 31,
                                                     -------------------------------------------------------------
                                                           1995                  1996                  1997
                                                     ------------------    ------------------    -----------------
                                                        The Company           Consolidated          Consolidated
                                                     -------------------    ------------------    -----------------
                                                          U. S. dollars in thousands except per share amount
                                                     -------------------------------------------------------------
<S>                                                  <C>                   <C>                    <C>
             Net income (loss), as reported                         61               (10,088)            485
                                                     ==================    ===================    =================
             Pro forma net income (loss)                            53               (10,142)            129
                                                     ==================    ===================    =================
             Pro forma basic earnings
                (loss) per share                                  0.01                 (1.47)            0.02
                                                     ==================    ===================    =================
             Pro forma diluted earnings
                (loss) per share                                  0.01                 (1.47)            0.02
                                                     ==================    ===================    =================
</TABLE>

          f. Dividends:

             Dividends if any, will be paid in NIS. Dividends paid to
             shareholders outside Israel will be converted into U.S. dollars on
             the basis of the exchange rate prevailing at the date of payment.


                                     F - 34
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 20:- TAXES ON INCOME

          a. Tax benefits under the Law for the Encouragement of Capital
             Investments, 1959 (the "law"):

             Certain of the Company's production facilities have been granted
             the status of "approved enterprise" under the law, under two
             separate investment plans.

             The implementation of the investments under the first plan was
             finalized in 1993. The implementation of the second plan is
             expected to be finalized in 1998.

             According to the provisions of this law, the Company chose to enjoy
             "alternative benefits" which provide tax exemption in exchange for
             waiver of grants. Accordingly, the Company's income from the
             approved enterprise will be tax-exempt for a period of two and four
             years for the first and second plan, respectively, commencing with
             the year it first earns taxable income, and subject to corporate
             tax at the rate of 25%, for additional periods of five and three
             years, for the first and second plan, respectively.

             The period of tax benefits detailed above is subject to limits of
             12 years from the commencement of production, or 14 years from
             receiving the approval, whichever is earlier. Given the
             abovementioned conditions, the period of benefits for the first
             plan commenced in 1994 and will terminate in 2000. The period of
             benefits for the second plan has not yet commenced.

             The tax-exempt profits earned by the Company's "approved
             enterprise" can be distributed to shareholders without subjecting
             the Company to taxes only upon the complete liquidation of the
             Company. If these retained tax-exempt profits are distributed in a
             manner other than upon the complete liquidation of the Company,
             they would be taxed at the corporate tax rate applicable to such
             profits as if the Company had not chosen the alternative tax
             benefits (currently - 25% for an "approved enterprise") and an
             income tax liability of approximately $ 415 would be incurred.

             Income from sources other than the "approved enterprise" during the
             periods of benefits, will be taxable at regular tax rate of 36%.

             The law also entitles the Company to claim accelerated rates of
             depreciation on equipment used by the "approved enterprise" during
             five tax years.

          b. Measurement of results for tax purposes:

             Results for tax purposes are measured in terms of earnings in NIS
             after certain adjustments for increases in the Israeli CPI. As
             explained in Note 2a, the financial statements are prepared in
             dollars. The difference between the annual change in the Israeli
             CPI and in the NIS/dollar exchange rate causes a difference between
             taxable income and the income in dollars as reflected in the
             financial statements.


                                     F - 35
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          c. Tax benefits under the Law for the Encouragement of Industry
             (Taxation), 1969:

             The Company is an "industrial company" under the above law and as
             such is entitled to claim accelerated rates of depreciation, in
             accordance with regulations published under the inflationary
             adjustments law.

             The Company is also entitled to deduct the offering expenses from
             its taxable income in three equal annual payments.

          d. A reconciliation of the theoretical tax expense, assuming all
             income is taxed at the regular statutory rate applied to
             corporations in Israel up to December 31, 1997, and the actual tax
             expense, is as follows:

<TABLE>
<CAPTION>
                                                                                Year ended December 31,
                                                              -------------------------------------------------------------
                                                                    1995                  1996                  1997
                                                              ------------------    ------------------    -----------------
                                                                 The Company          Consolidated          Consolidated
                                                              -------------------   ------------------    -----------------
                                                                               U.S. dollars in thousands
                                                              -------------------------------------------------------------
<S>                                                                  <C>                  <C>                     <C>
             Theoretical tax expense (benefit)
                computed at the rate of 36%
                (1995 - 37%)                                           520                (3,624)                  208
             Increase (decrease) in taxes:
                Effect of certain adjustments on
                 the results for tax purposes and
                 the Israeli CPI                                        76                    49                    61
                Effect of tax-exempt income
                 during the benefit period (see a.
                 above) and other, net                                (375)                    -                     -
                Deferred income taxes resulting
                 from carryforward losses for which
                 valuation allowance was recorded                        -                 3,975                     -
                Utilization of deferred taxes in
                 respect of carryforward losses                          -                     -                  (202)
                                                              ------------------    ------------------    -----------------
             Actual tax expense                                        221                   400                    67
                                                              ==================    ==================    =================
             Increase in earnings per share
                due to tax-exempt income                             0.08                      -                     -
                                                              ==================    ==================    =================
          e. The provision for taxes is comprised as follows:

             Deferred taxes                                           221                    400                   (27)
             Current taxes                                             -                      -                    94
                                                               ------------------     ------------------    -----------------
                                                                      221                    400                    67
                                                               ==================     ==================    =================
</TABLE>


                                     F - 36
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          f. Deferred taxes:
<TABLE>
<CAPTION>

                                                                               Year ended December 31,
                                                           ----------------------------------------------------------------
                                                                  1995                   1996                   1997
                                                           -------------------    -------------------     -----------------
                                                               The Company           Consolidated           Consolidated
                                                           --------------------    ------------------     -----------------
                                                                              U.S. dollars in thousands
                                                           ----------------------------------------------------------------
             <S>                                                         <C>                  <C>               <C>
             Deferred tax assets (liabilities) are 
               comprised of the following:

             Provisions for severance pay                                  26                     76                34
             Deductible public offering
               expenses                                                   390                    195                 -
             Others (mainly capitalized
               royalties)                                                 387                    326               120
             Net operating loss carryforward                                -                  3,539             3,337
                                                           -------------------    -------------------    ------------------

             Gross deferred tax assets                                    803                  4,136             3,491
                                                           -------------------    -------------------    ------------------

             Fixed assets                                                 (32)                   (52)              (64)
             Inventories                                                    -                      -               (12)
                                                           -------------------    -------------------    ------------------

             Gross deferred tax liabilities                               (32)                   (52)              (76)
                                                           -------------------    -------------------    ------------------

             Valuation allowance (1)                                     (390)                (4,103)           (3,407)
                                                           -------------------    -------------------    ------------------

             Net deferred tax assets (liabilities)                        381                    (19)                8
                                                           ===================    ===================    ==================

             Presented as follows:

             Current assets                                                81                      -                 8
             Long-term assets                                             300                      -                 -
             Current liabilities                                            -                    (19)                -
                                                           -------------------    -------------------    ------------------

                                                                          381                    (19)                8
                                                           ===================    ===================    ==================
</TABLE>

               (1)  The company has provided valuation allowances against the
                    deferred tax assets in respect of tax loss carryforward and
                    other temporary differences and history of losses and
                    current uncertainty concerning its ability to realize these
                    deferred tax assets in the future.


                                     F - 37
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          g. Income tax assessments, losses and deductions carried forward to
             future years:

             Final tax assessments have not been received by the Company since
             its incorporation. At December 31, 1997, the Company had available
             carryforward losses (excluding capital losses totaling $ 2,363
             thousand) and deductions aggregating $ 6,286 thousand. Carryforward
             losses for tax purposes in the Company are not limited in time.

             Nur America, Nur International and Nur Europe had available
             carryforward losses aggregating $ 82 thousand, $ 1,372 thousand and
             $ 150 thousand, respectively.

             The Company has valuation allowances against amounts of the tax
             benefits in the accompanying consolidated financial statements due
             to its accumulated deficit and the uncertainty as to when these
             benefits will be utilized.

          h. Income (loss) before income taxes consisted of the following:

<TABLE>
<CAPTION>
                                                                    Year ended December 31,
                                                 --------------------------------------------------------------
                                                       1995                   1996                  1997
                                                 ------------------     ------------------    -----------------
                                                      Company                        Consolidated
                                                 -------------------    ---------------------------------------
                                                                   U.S. dollars in thousands
                                                 --------------------------------------------------------------
             <S>                                        <C>                  <C>                    <C>
             Domestic                                   $1,407               $(8,947)               $1,156
             Foreign                                         -                  (741)                 (578)
                                                 ------------------    -------------------   ------------------
                                                        $1,407               $(9,688)               $  578
                                                 ==================    ===================   ==================
</TABLE>


                                     F - 38
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 21:- LINKAGE TERMS OF MONETARY BALANCES

          The following tables reflect the linkage terms of monetary balances at
          each balance sheet date:

<TABLE>
<CAPTION>
                                                                              December 31, 1997
                                                  ----------------------------------------------------------------------
                                                                                  In other
                                                                                   foreign
                                                                  In U.S.$        currency
                                                   Linked to      or linked       or linked
                                                  Israeli CPI      thereto         thereto       Unlinked        Total
                                                  -------------   -----------    ------------   ------------    ---------
                                                                          U.S. dollars in thousands
                                                  ----------------------------------------------------------------------
          <S>                                     <C>             <C>            <C>            <C>             <C>  
          Assets:
             Cash and cash equivalents                  -           1,031             196              7           1,234
             Trade receivables                          -           2,671           3,021            289           5,981
             Other accounts receivable
              and prepaid expenses                    312             391               -          1,034           1,737
             Restricted long-term deposit               -             150               -              -             150
             Prepaid expenses                           -               -               -            137             137
                                                  -------------   -----------    ------------   ------------    ---------
                                                      312           4,243          3,217           1,467           9,239
                                                  =============   ===========    ============   ============    =========
          Liabilities:
             Short-term bank loans                      -             453               -            199             652
             Trade payables                             -             154             766          2,296           3,216
             Accrued expenses and
              other liabilities                         -             512               -          1,614           2,126
             Customer advances                          -              17               -              -              17
             Long-term bank loans,
              including current maturities              -           1,603               -              -           1,603
                                                  -------------   -----------    ------------   ------------    ---------
                                                        -           2,739             766          4,109           7,614
                                                  =============   ===========    ============   ============    =========
</TABLE>


                                     F - 39
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                        December 31, 1996
                                              ---------------------------------------------------------------------------
                                                                              In other
                                                                               foreign
                                                               In U.S.$        currency
                                               Linked to       or linked       or linked
                                              Israeli CPI       thereto         thereto        Unlinked         Total
                                              ------------    ------------    ------------    -----------    ------------
                                                                         U.S. dollars in thousands
                                              ---------------------------------------------------------------------------
          <S>                                 <C>             <C>            <C>             <C>            <C>  
          Assets:
             Cash and cash equivalents              -           1,659              74               5          1,738
             Trade receivables                      -           3,658             514              41          4,213
             Other accounts receivable
              and prepaid expenses                621             539               -             589          1,749
             Long-term trade receivables            -              90               -               -             90
             Prepaid expenses                       -               -               -             368            368
                                              ------------    -----------    ------------    -----------    -----------
                                                  621           5,946            588            1,003          8,158
                                              ============    ===========    ============    ===========    ===========
          Liabilities:
             Short-term bank loans                  -               -               -           1,462          1,462
             Trade payables                         -           1,443           1,542           1,452          4,437
             Accrued expenses and
              other liabilities                     -             212               -           1,305          1,517
             Customer advances                      -           1,345               -               -          1,345
             Long-term bank loans,
              including current maturities          -           1,226               -               -          1,226
                                              ------------    -----------    ------------    -----------    -----------
                                                    -           4,226           1,542           4,219          9,987
                                              ============    ===========    ============    ===========    ===========
</TABLE>


                                     F - 40
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 22:- SELECTED STATEMENTS OF OPERATIONS DATA

<TABLE>
<CAPTION>
                                                                           Year ended December 31,
                                                           --------------------------------------------------------
                                                                 1995                 1996               1997
                                                           ------------------    ---------------    ----------------
                                                              The Company         Consolidated       Consolidated
                                                           ------------------    ---------------    ----------------
                                                                          U.S. dollars in thousands
                                                           --------------------------------------------------------
          <S>                                                  <C>                   <C>               <C>
          a. Major customer data:
             Sales to customer A                               8,171                 7,665              2,455
                                                           ==================    ===============    ===============
             Percentage of total sales                         59.1%                 46.1%             11.18%
                                                           ==================    ===============    ===============
             Sales to customer B                               1,625                   485                159
                                                           ==================    ===============    ===============
             Percentage of total sales                         11.8%                  2.9%               0.7%
                                                           ==================    ===============    ===============
</TABLE>

          b. Information regarding Company operations in different geographical
             areas:

             Inter-segment sales are accounted for at prices comparable to
             unaffiliated customer sales.

<TABLE>
<CAPTION>
                                                                  Year ended December 31, 1997
                                          --------------------------------------------------------------------------
                                                                                    Adjustments
                                                                       United           and
                                           Israel        Europe        States      eliminations       Consolidated
                                          ----------    ---------     ---------    --------------    ----------------
                                                                   U.S. dollars in thousands
                                          --------------------------------------------------------------------------
             <S>                            <C>         <C>             <C>            <C>               <C>
             Sales to unaffiliated
               customers                     3,049      11,849          7,061                -           21,959
             Transfers between
               geographic areas             13,250                          -          (13,250)               -
                                          ----------    ---------     ---------    --------------    ----------------
             Total sales                    16,299      11,849          7,061          (13,250)          21,959
                                          ==========    =========     =========    ==============    ================
             Operating income (loss)         1,204         199           (195)            (302)             906
                                          ==========    =========     =========    ==============
             Financial expenses, net                                                                       (320)
             Other expenses, net                                                                             (8)
                                                                                                     ----------------
             Income before taxes on
               income                                                                                       578
                                                                                                     ================
             Identifiable assets as
               of December 31, 1997         11,315       2,518          1,353           (1,403)          13,783
                                          ==========    =========     =========    ==============    ================
</TABLE>


                                     F - 41
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                               Year ended December 31, 1996
                                          --------------------------------------------------------------------------
                                                                                    Adjustments
                                                                       United           and
                                           Israel        Europe        States      eliminations       Consolidated
                                          ----------    ---------     ---------    --------------    ----------------
                                                                U.S. dollars in thousands
                                          --------------------------------------------------------------------------
             <S>                          <C>            <C>            <C>             <C>              <C>
             Sales to unaffiliated
               customers                   7,724         7,373          1,540                -           16,637
             Transfers between
               geographic areas            4,398             -              -           (4,398)               -
                                          ----------    ---------     ---------    --------------    ----------------

             Total sales                  12,122         7,373          1,540           (4,398)          16,637
                                          ==========    =========     =========    ==============    ================

             Operating loss               (8,995)          (74)          (128)               -           (9,197)
                                          ==========    =========     =========    ==============

             Financial expenses, net                                                                       (589)
             Gain on marketable
               securities                                                                                    22
             Other income, net                                                                               76
                                                                                                     ----------------

             Loss before taxes on
               income                                                                                    (9,688)
                                                                                                     ================

             Identifiable assets as
               of December 31, 1996        9,532         4,670          1,208           (3,249)          12,161
                                          ==========    =========     =========    ==============    ================
</TABLE>


                                     F - 42
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                  Year ended December 31,
                                                                ------------------------------------------------------------
                                                                       1995                  1996                1997
                                                                --------------------    ---------------    -----------------
                                                                    The Company          Consolidated        Consolidated
                                                                --------------------    ---------------    -----------------
                                                                                 U.S. dollars in thousands
                                                                ------------------------------------------------------------
          <S>                                                            <C>                   <C>                    <C>
          c. Sales from Israel classified by
               geographical destinations:

                    Local:
                      Israel                                              2,774                   780                   679
                    Export (1):
                      Europe                                              5,684                 3,957                 1,325
                      U.S.A.                                              2,564                 2,325                   907
                      Others                                              2,802                   662                   138
                                                                --------------------    ---------------    -----------------

                                                                         13,824                 7,724                 3,049
                                                                ====================    ===============    =================
             (1)   Including indirect export
                     sales to distributor, which
                     are presented in accordance
                     with the geographical
                     location of the end customer.

          d. Cost of sales of printers and
               related products:

                    Materials consumed                                    6,666                10,986                 8,554
                    Salaries, wages and employee
                      benefits                                              379                   627                   352
                    Subcontractors                                        1,494                   526                    52
                    Other manufacturing costs                               301                   541                   542
                    Depreciation and amortization                            13                    34                     3
                                                                --------------------    ---------------    -----------------

                                                                          8,853                12,714                 9,503
                    Less (add) decrease (increase) in
                      inventories of finished products
                      and work-in-progress                                  521                (1,186)                  124
                                                                --------------------    ---------------    -----------------

                                                                          9,374                11,528                 9,627
                                                                ====================    ===============    =================

          e. Cost of sales of printed materials:

                    Materials consumed                                        -                 1,650                 1,358
                    Subcontractors                                            -                   358                   326
                                                                --------------------    ---------------    -----------------

                                                                              -                 2,008                 1,684
                                                                ====================    ===============    =================
</TABLE>


                                     F - 43
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                  Year ended December 31,
                                                                ------------------------------------------------------------
                                                                       1995                  1996                1997
                                                                --------------------    ---------------    -----------------
                                                                    The Company          Consolidated        Consolidated
                                                                --------------------    ---------------    -----------------
                                                                                 U.S. dollars in thousands
                                                                ------------------------------------------------------------
          <S>                                                          <C>                 <C>                     <C>
          f. Research and development expenses:

             Salaries, wages and employee
               benefits                                                  561                 898                   1,119
             Materials and subcontractors                                351                 529                     154
             Other costs                                                 128                 103                     453
                                                                --------------------    ---------------    -----------------

                                                                       1,040               1,530                   1,726
                                                                ====================    ===============    =================

          g. Selling and marketing expenses, net (1):

             Salaries, wages and employee
               benefits                                                  181               1,603                   1,562
             Commissions                                                 409                 437                     247
             Traveling                                                   185                 503                     570
             Advertising                                                 240                 652                     738
             Bad debts                                                   132                 509                     448
             Other costs                                                 145               1,119                   1,255
                                                                --------------------    ---------------    -----------------

                                                                       1,292               4,823                   4,820
             Less - participation of the
               Fund for the Encouragement of
               Marketing Activity                                        253                   -                     200
                                                                --------------------    ---------------    -----------------

                                                                       1,039               4,823                   4,620
                                                                ====================    ===============    =================
             (1)   Net of participation
                     from Nur International of
                     $ 209 thousand in 1995.

          h. General and administrative expenses:

             Salaries, wages and employee
               benefits                                                  463                 914                   1,048
             Office maintenance                                          300                 702                     909
             Other costs                                                 424                 944                   1,482
                                                                --------------------    ---------------    -----------------

                                                                       1,187               2,560                   3,439
                                                                ====================    ===============    =================
</TABLE>


                                     F - 44
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                  Year ended December 31,
                                                                ------------------------------------------------------------
                                                                       1995                  1996                1997
                                                                --------------------    ---------------    -----------------
                                                                    The Company          Consolidated        Consolidated
                                                                --------------------    ---------------    -----------------
                                                                                 U.S. dollars in thousands
                                                                ------------------------------------------------------------
          <S>                                                   <C>                     <C>                <C>
          i. Financial expenses, net:

             Expenses:
               Interest
                 On short-term credit                                  152                  682               390
                 On long-term loans                                    123                   72               193
               Loss arising from foreign
                 currency transactions                                 351                  154                 -
                                                                --------------------    ---------------    -----------------

                                                                       626                  908               583
                                                                --------------------    ---------------    -----------------
             Income:
               Interest                                                421                  319               234
               Gain arising from foreign
                 currency transactions                                   -                    -                29
                                                                --------------------    ---------------    -----------------

                                                                       421                  319               263
                                                                --------------------    ---------------    -----------------

                                                                       205                  589               320
                                                                ====================    ===============    =================
</TABLE>


                                     F - 45
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          j. Write-off of debts of related parties:

             In March 1997, three companies in which Moshe Nur - a former
             shareholder - has holdings in various percentages, experienced
             financial difficulties (see also Note 18a). The debts stem from the
             purchases of printers, spare parts and ink and cash transfers from
             the Company.

             The management of the company believes that the company will not be
             able to collect the debts of these companies and therefore it was
             decided to write-off the debts totaling $ 3,757 thousand, comprised
             as follows:

<TABLE>
<CAPTION>
                                                                                                 Year ended
                                                                                             December 31, 1996
                                                                                           -----------------------
                                                                                               U.S. dollars
                                                                                                in thousands
                                                                                           -----------------------
             <S>                                                                                      <C>
             Nur Outdoor Advertising
                 (Manufacturing and Production) Ltd.                                                    994
             Nur Focus Assets and Investments Ltd.                                                    2,117
             Nur Focus Production (1995) Ltd.                                                           646
                                                                                           -----------------------

                                                                                                      3,757
                                                                                           =======================
</TABLE>


          k. Equity in losses of a 50%-owned joint venture:

<TABLE>
<CAPTION>
                                                                          Year ended December 31,
                                                         -----------------------------------------------------------
                                                               1995                 1996                 1997
                                                         -----------------     ----------------     ----------------
                                                           The Company          Consolidated         Consolidated
                                                         -----------------     ----------------     ----------------
                                                                         U.S. dollars in thousands
                                                         -----------------------------------------------------------
             <S>                                              <C>                           <C>                <C>
             Equity in post-acquisition losses                  (593)                       -                  -
             Losses from increase in equity of
               joint venture                                    (630)                       -                  -
             Less - amortization of negative
               goodwill                                           98                        -                  -
                                                         -----------------     ----------------     ----------------

                                                              (1,125)                       -                  -

                                                         =================     ================     ================
</TABLE>


                                     F - 46
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

NOTE 23:-     INVESTEES


<TABLE>
<CAPTION>
                                                                                          Percentage of (1)
                                                                                 -------------------------------------
                               Name of the Company                                 Ownership              Control
          ---------------------------------------------------------------        --------------        ---------------
                                                                                                  %
                                                                                 -------------------------------------
          <S>                                                                        <C>                   <C>
          a. Subsidiaries outside Israel:

             Active:

             Nur International S.A. ("Nur International")                            100                   100

             Nur Advanced Technologies (Europe) S.A.
               ("Nur Europe")                                                        100                   100

             Nur America Inc. ("Nur America")                                        100                   100

             Nur Marketing and Communication GmbH
               ("Nur Germany")                                                        84                    84

             Inactive:

             Nur Hungaria KFT ("Nur Hungary") (1)                                    100                   100

             Good-Lux S.A. ("Nur Luxembourg") (1)                                    100                   100

          b. Subsidiaries in Israel:

             Inactive:

             M.B.T. (Nur) Industries Ltd. ("M.B.T.")                                 100                   100

             Nur Print Technologies (1993) Ltd. ("Nur Print")                        100                   100

             N.A.T. Holdings and Investments (1997) Ltd.                             100                   100
</TABLE>


          (1)   Represents the percentages of ownership of Nur International in
                these subsidiaries. The shares of some of these subsidiaries are
                held in custody by the Company.


                                     F - 47
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
CONSOLIDATED BALANCE SHEETS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                           June 30,
                                                                                             1998
                                                                                       ------------------
                                                                                           Unaudited
                                                                                       ------------------
                                                                                        U.S. dollars in
                                                                                           thousands
                                                                                       ------------------
<S>                                                                                    <C>
    ASSETS

CURRENT ASSETS
  Cash and cash equivalents                                                                    2,082
  Marketable securities                                                                           63
  Trade receivables                                                                            6,823
  Other accounts receivable and prepaid expenses                                               1,632
  Inventories                                                                                  3,049
                                                                                       ------------------

Total current assets                                                                          13,649
                                                                                       ------------------

LONG-TERM INVESTMENTS:
  Restricted long term bank deposit                                                              382
  Prepaid expenses                                                                                24
  Severance pay funds                                                                            317
                                                                                       ------------------

Total long-term investments                                                                      723
                                                                                       ------------------

PROPERTY AND EQUIPMENT:
  Cost                                                                                         3,207
  Less - accumulated depreciation                                                                887
                                                                                       ------------------

                                                                                               2,320
                                                                                       ------------------

OTHER ASSETS, net                                                                                308
                                                                                       ------------------

Total assets                                                                                  17,000
                                                                                       ==================
</TABLE>


The accompanying notes are an integral part of the consolidated financial
statements.


                                     F - 48
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
CONSOLIDATED BALANCE SHEETS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                              June 30,
                                                                                           ----------------
                                                                                                1998
                                                                                           ----------------
                                                                                              Unaudited
                                                                                           ----------------
                                                                                            U.S. dollars
                                                                                            in thousands
                                                                                           ----------------
<S>                                                                                        <C>
    LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
  Short-term bank loans                                                                              530
  Current maturities of long-term bank loans                                                         462
  Trade payables                                                                                   5,175
  Accrued expenses and other liabilities                                                           2,664
  Customer advances                                                                                    -
                                                                                           ----------------

Total current liabilities                                                                          8,831
                                                                                           ----------------

LONG-TERM LIABILITIES:
  Long-term bank loans, net                                                                        1,080
  Accrued severance pay                                                                              438
                                                                                           ----------------

Total long-term liabilities                                                                        1,518
                                                                                           ----------------

MINORITY INTEREST                                                                                     39
                                                                                           ----------------

SHAREHOLDERS' EQUITY:
  Share capital:
    Common Shares of NIS 1 per nominal value:
      Authorized: 20,000,000
      Issued and outstanding: 6,880,000 Common Shares
      as of June, 1997; 10,880,000 Common Shares
      as of June 30, 1998                                                                          2,729
  Additional paid-in capital                                                                      14,350
  Other comprehensive income                                                                        (151)
  Accumulated deficit                                                                            (10,316)
                                                                                           ----------------

Total shareholders' equity                                                                         6,612
                                                                                           ----------------

Total liabilities and shareholders' equity                                                        17,000
                                                                                           ================
</TABLE>


The accompanying notes are an integral part of the consolidated financial
statements.


                                     F - 49
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
CONSOLIDATED STATEMENTS OF OPERATIONS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                                 Six months ended
                                                                                                     June 30,
                                                                                        ------------------------------------
                                                                                             1997                1998
                                                                                        ---------------    -----------------
                                                                                                     Unaudited
                                                                                        ------------------------------------
                                                                                            U.S. dollars in thousands,
                                                                                             except per share amounts
                                                                                        ------------------------------------
<S>                                                                                     <C>                <C>
Revenues
  Sales of printers and related products                                                        7,909             14,233
  Sales of printed materials                                                                    1,304              1,621
                                                                                        ---------------    -----------------

                                                                                                9,213             15,854
                                                                                        ---------------    -----------------
Cost of revenues:
  Cost of sales of printers and related products                                                4,213              6,862
  Cost of sales of printed materials                                                              711                993
                                                                                        ---------------    -----------------

                                                                                                4,924              7,855
                                                                                        ---------------    -----------------

Gross profit                                                                                    4,289              7,999
                                                                                        ---------------    -----------------

Research and development expenses                                                                 756              1,591
Less - royalty-bearing grants                                                                     127                310
                                                                                        ---------------    -----------------

Research and development expenses, net                                                            629              1,281
                                                                                        ---------------    -----------------

Selling and marketing expenses, net                                                             1,891              2,844
General and administrative expenses                                                             1,662              2,358
Write-off of debts of related parties                                                              99                  -
                                                                                        ---------------    -----------------

                                                                                                3,652              5,202
                                                                                        ---------------    -----------------

Operating income (loss)                                                                             8              1,516
Financial expenses, net                                                                           286                319
Loss on marketable securities                                                                       -                 91
                                                                                        ---------------    -----------------

Income (loss) before taxes on income                                                             (278)             1,106
Taxes on income                                                                                     -                112
                                                                                        ---------------    -----------------

Income (loss) after taxes on income                                                              (278)               994
Minority interest in losses of subsidiary                                                           -                 13
                                                                                        ---------------    -----------------

Net income (loss) for the period                                                                 (278)               981
                                                                                        ===============    =================

Basic and diluted earnings (loss) per share (Note 2j)                                           (0.04)              0.09
                                                                                        ===============    =================
Weighted average number of shares used in
  computing basic and diluted earnings (loss) per share                                     6,880,000         10,880,000
                                                                                        ===============    =================
</TABLE>


The accompanying notes are an integral part of the consolidated financial
statements.


                                     F - 50
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                  Six months ended June 30, 1997
                                               ---------------------------------------------------------------------
                                                 Number of
                                                  shares
                                                outstanding
                                               --------------                       Additional           Other
                                                  Common             Share            paid-in        comprehensive  
                                                  shares            capital           capital            income     
                                               --------------    --------------    --------------    ---------------
                                                                     U.S. dollars in thousands
                                               ---------------------------------------------------------------------
<S>                                            <C>               <C>               <C>               <C>
Balance as of January 1, 1997                     6,880,000             1,593            11,916                109  
- - - - - - -----------------------------

Comprehensive income:
  Net loss for the period                                 -                 -                 -                  -  
                                                                                                                    
Other comprehensive income:
  Foreign currency translation adjustment                 -                 -                 -                116  
                                                                                                                    
                                                                                                                    
Comprehensive income                                      -                 -                 -                  -  
                                                                                                                    
Amortization of deferred compensation                     -                 -                57                  -  
                                               --------------    --------------    --------------    ---------------

Balance as of June 30, 1997                       6,880,000             1,593            11,973                225  
- - - - - - ---------------------------
                                               ==============    ==============    ==============    ===============

<CAPTION>
                                                                  Six months ended June 30, 1998
                                               ---------------------------------------------------------------------
<S>                                            <C>               <C>               <C>               <C>
Balance as of January 1, 1998                    10,880,000             2,729            14,383                (30) 
- - - - - - -----------------------------

Comprehensive income:
  Net loss for the period                                 -                 -                 -                  -  
                                                                                                                    
Other comprehensive income:
  Foreign currency translation adjustment                 -                 -                 -                  -  
                                                                                                                    
Comprehensive income                                      -                 -                 -                  -  
                                                                                                                    
Share capital issuance expenses                           -                 -               (47)                 -  
Amortization of deferred compensation                     -                 -                14                  -  
                                               --------------    --------------    --------------    ---------------

Balance as of June 30, 1998                      10,880,000             2,729            14,350               (151) 
- - - - - - ---------------------------
                                               ==============    ==============    ==============    ===============

<CAPTION>
                                                            Six months ended June 30, 1997
                                               ------------------------------------------------------
                                               
                                               
                                               
                                                                                          Total
                                                  Retained         Comprehensive      shareholders'
                                                  earnings            income              equity
                                               ----------------   ----------------    ---------------
                                                               U.S. dollars in thousands
                                               ------------------------------------------------------
<S>                                                  <C>                   <C>                <C>
Balance as of January 1, 1997                        (11,782)                                 1,836
- - - - - - -----------------------------

Comprehensive income:
  Net loss for the period                               (278)              (278)               (278)
                                                                  ----------------
Other comprehensive income:
  Foreign currency translation adjustment                  -                116                 116
                                                                  ----------------
Comprehensive income                                       -               (162)                  -
                                                                  ================
Amortization of deferred compensation                      -                                     57
                                               ----------------                       ---------------

Balance as of June 30, 1997                          (12,060)                                 1,731
- - - - - - ---------------------------
                                               ================                       ===============

<CAPTION>
                                                            Six months ended June 30, 1998
                                               ------------------------------------------------------
<S>                                                  <C>                   <C>                <C>
Balance as of January 1, 1998                        (11,297)                                 5,785
- - - - - - -----------------------------

Comprehensive income:
  Net loss for the period                                981                981                 981
                                                                  ----------------
Other comprehensive income:
  Foreign currency translation adjustment                  -               (121)               (121)
                                                                  ----------------
Comprehensive income                                       -                860                   -
                                                                  ================
Share capital issuance expenses                            -                  -                 (47)
Amortization of deferred compensation                      -                  -                  14
                                               ----------------                       ---------------

Balance as of June 30, 1998                          (10,316)                                 6,612
- - - - - - ---------------------------
                                               ================                       ===============
</TABLE>


The accompanying notes are an integral part of the consolidated financial
statements.


                                     F - 51
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
CONSOLIDATED STATEMENTS OF CASH FLOWS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                                 Six months ended
                                                                                                     June 30,
                                                                                        ------------------------------------
                                                                                             1997                1998
                                                                                        ---------------    -----------------
                                                                                                     Unaudited
                                                                                        ------------------------------------
                                                                                             U.S. dollars in thousands
                                                                                        ------------------------------------
<S>                                                                                     <C>                <C>
Cash flows from operating activities:

Net income (loss) for the period                                                                 (278)               981
Adjustments to reconcile net income (loss) to net
  cash used in operating activities:

  Minority interest in earnings of subsidiary                                                       -                 13
  Depreciation and amortization                                                                   218                384
  Deferred taxes, net                                                                             (27)                 8
  Amortization of deferred compensation                                                            57                 14
  Severance pay, net                                                                               15                 25
  Decrease in marketable securities                                                                 -                (63)
  Increase in trade receivables                                                                   (54)              (855)
  Decrease in other accounts receivable
    and prepaid expenses                                                                        1,150                179
  Decrease (increase) in inventories                                                              323               (797)
  Increase (decrease) in trade payables                                                          (813)             1,936
  Increase in accrued expenses and other liabilities                                              574                461
  Decrease in customer advances                                                                (1,345)               (17)
                                                                                        ---------------    -----------------

Net cash provided by (used in) operating activities                                              (180)             2,269
                                                                                        ---------------    -----------------
</TABLE>


The accompanying notes are an integral part of the consolidated financial
statements.


                                     F - 52
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
CONSOLIDATED STATEMENTS OF CASH FLOWS
- - - - - - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                                 Six months ended
                                                                                                     June 30,
                                                                                        ------------------------------------
                                                                                             1997                1998
                                                                                        ---------------    -----------------
                                                                                                     Unaudited
                                                                                        ------------------------------------
                                                                                             U.S. dollars in thousands
                                                                                        ------------------------------------
<S>                                                                                     <C>                <C>
Cash flows from investing activities:

  Restricted long-term bank deposit                                                                 -               (232)
  Purchase of property and equipment                                                           (1,032)              (990)
                                                                                        ---------------    -----------------

Net cash provided by (used in) investing activities                                            (1,032)            (1,222)
                                                                                        ---------------    -----------------

Cash flows from financing activities:

  Share capital issuance expenses                                                                   -                (47)
  Short-term bank credit, net                                                                    (607)              (122)
  Proceeds from principal of long-term bank loans                                               1,169                231
  Repayment of principal of long-term bank loans                                                 (154)              (292)
                                                                                        ---------------    -----------------

Net cash provided by financing activities                                                         408               (230)
                                                                                        ---------------    -----------------

Effect of exchange rate changes on cash and cash equivalents                                        -                 31
                                                                                        ---------------    -----------------

Increase (decrease) in cash and cash equivalents                                                 (804)               848
Cash and cash equivalents at the beginning of the period                                        1,738              1,234
                                                                                        ---------------    -----------------

Cash and cash equivalents at the end of the period                                                934              2,082
                                                                                        ===============    =================
</TABLE>


The accompanying notes are an integral part of the consolidated financial
statements.


                                     F - 53
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------


NOTE 1:-  GENERAL

          The Company develops, manufactures and sells digital continuous
          ink-jet printing systems and related consumable products for large
          format printing.

          These financial statements have been prepared as of June 30, 1998 and
          for the six months then ended.

          These financial statement are to be read in conjunction with the
          annual financial statements of the Company as of December 31, 1997 and
          their accompanying notes.


NOTE 2:-  SIGNIFICANT ACCOUNTING POLICIES

          The significant accounting policies applied in the annual financial
          statements of the Company as of December 31, 1997 are applied
          consistently in these financial statements.


NOTE 3:-  FINANCIAL STATEMENTS IN U.S. DOLLARS

          The accompanying audited condensed consolidated financial statements
          have been prepared in accordance with generally accepted accounting
          principles for interim financial information. Accordingly, they do not
          include all the information and footnotes required by generally
          accepted accounting principles for complete financial statements. In
          the opinion of management, all adjustments (consisting of normal
          requiring accruals) considered necessary for a fair presentation have
          been included. Operating results for the six-months period ended June
          30, 1998 are not necessarily indicative of the results that may be
          expected for the year ended December 31, 1998.

NOTE 4:-  SUBSEQUENT EVENTS

          a. In September 1998, the Company acquired from Meital all rights
             (including all related assets) to Meital's piezo DoD inkjet
             technologies for application in wide format digital printers for
             approximately $ 3.0 million, consisting of an up-front payment of
             $ 750,000, the assumption of certain liabilities and future sales
             based royalties. The Meital acquisition is expected to result in
             the recognition by NUR of a one-time charge involving a write-off
             assigned to in-process research and development in the amount of
             $ 1,600,000. In addition, the Company has future royalty
             obligations, during the next three years, which will not exceed $
             1.3 million. This charge will be taken in the third quarter of
              1998.


                                     F - 54
<PAGE>


                                                          NUR MACROPRINTERS LTD.
                                      (Formerly: Nur Advanced Technologies Ltd.)
NOTES TO FINANCIAL STATEMENTS
- - - - - - --------------------------------------------------------------------------------

          b. During September, 1998 the district court of Tel Aviv approved
             several settlement agreements among the Company, the special
             manager for Moshe Nur's assets in his bankruptcy proceedings, Moshe
             Nur and other of his family members, two Israeli banks, and the
             temporary receiver of Nur Outdoor Advertising Ltd. (a company
             formerly affiliated with Mr. Nur).
             According to the agreements, all material claims against the
             Company relating to the lease of its offices (including
             confirmation of the Company's pre-payment of lease until July
             2000), alleged breach of contracts and alleged debts owed to any
             of the above mentioned parties were dismissed.

             As part of the various settlement agreements, the Company will pay
             an aggregate of $100 thousand.

          c. In connection with a claim (see note 16g) a partial settlement was
             reached between the Company and the Dochovna Group, according to
             which all parties shall not apply for interim remedies or
             attachments against each other or against companies controlled by
             the parties, in Israel or abroad.

          d. In June 1998, Quantum Securities Ltd. ("Quantum") filed a suit
             against the Company claiming that the Company breached an alleged
             investor relations agreement between Quantum and the Company. In
             the suit Quantum claims $33,380 in monetary damages and the right
             to Ordinary Share purchase warrants to purchase 100,000 Ordinary
             Shares of the Company at $1.75 per share and 100,000 Ordinary
             Shares of the Company at $2.00 per share. The Company has denied
             that such an agreement with Quantum exists with the Company and
             plans to defend itself vigorously. The Company has also
             counterclaimed for reimbursement of approximately $17,000 paid to
             Quantum in the past.


                               - - - - - - - - - -


                                     F - 55
<PAGE>


      We have not authorized any dealer, salesperson or other person to give any
information or represent anything not contained in this Prospectus. You must not
rely on any unauthorized information. This Prospectus does not offer to sell or
buy any shares in any jurisdiction where it is unlawful. The information in this
Prospectus is current as of __________, 1998.

                                -----------------


                 TABLE OF CONTENTS
                                                 Page
Prospectus Summary..................................3
Risk Factors........................................8
Use of Proceeds....................................18
Market for Common Equity...........................18
Dividend Policy....................................19
Capitalization.....................................19
Selected Consolidated Financial Data...............20
Management's Discussion and Analysis of Financial
     Condition and Results of Operations...........22
Business...........................................34
Management.........................................48
Principal Shareholders.............................54
Selling Shareholders...............................55
Certain Transactions...............................59
Description of Ordinary Securities.................59
Commission Position on Indemnification
     for Securities Act Liabilities................61
Shares Eligible for Future Sale....................61
Exchange Controls and Other Limitations
     Affecting Security Holdings...................61
Israeli Taxation and Foreign Exchange
     Regulations...................................62
US Tax Considerations Regarding
     Ordinary Shares...............................66
Plan of Distribution...............................70
Legal Matters......................................72
Experts............................................72
Additional Information.............................72
ISA Exemption .....................................72
Index to Financial Statements.....................F-1


                                5,897,339 SHARES

                                     [LOGO]



                             NUR MACROPRINTERS LTD.






                                 ORDINARY SHARES



                                 ---------------

                                   PROSPECTUS
                                 ---------------












                             _________________, 1998

<PAGE>

                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

Item 13.  Other Expenses of Issuance and Distribution

      The following table sets forth an estimate (except for the Securities and
Exchange Commission registration fee, the NASD filing fee and the Nasdaq fee) of
the fees and expenses expected to be incurred by the Company on behalf of the
Selling Shareholders in connection with the issuance and distribution of the
securities being registered under the Registration Statement:

                                                                       Amount
                                                                     to be Paid
                                                                     -----------
      Securities and Exchange Commission registration fee........    $  3,893.72
      NASD filing fee............................................       1,900.62
      Nasdaq fee.................................................       8,000.00
      Printing and engraving expenses............................      70,000.00
      Legal fees and expenses....................................     130,000.00
      Accounting fees and expenses...............................      30,000.00
      Miscellaneous expenses.....................................      10,000.00
                                                                     -----------
                                                                 
               Total.............................................    $253,794.34
                                                                     ===========
                                                               
Item 14.  Indemnification of Directors and Officers

      Pursuant to the Registrant's Articles of Association, the Registrant may
indemnify its Office Holders, as defined in the Israeli Companies Ordinance (New
Version), 1983 (the "Israeli Companies Ordinance") for (a) any monetary
obligation imposed upon them for the benefit of a third party by a judgment,
including a settlement approved by the Registrant or an arbitration decision
certified by court, as a result of an act or omission of such person in his
capacity as an Office Holder and (b) reasonable litigation expenses, including
legal fees, incurred by such Office Holder or which he is obligated to pay, in
proceedings brought against him by or on behalf of the Registrant or by others,
or in connection with criminal proceedings in which he was acquitted, in each
case relating to acts or omissions of such person in his capacity of Office
Holder of the Registrant. The Israeli Companies Ordinance defines "Office
Holder" to include directors, managing director, general manager, chief
executive officer, executive vice president, vice president, other manager
directly subordinate to the managing director and any person assuming the
responsibilities of the foregoing positions without regard to such person's
title.

      In addition, pursuant to the Israeli Companies Ordinance, indemnification
of, and procurement of insurance coverage for, an Office Holder of the
Registrant is permitted if it is permitted by the Registrant's Articles of
Association and if it is approved by the Registrant's Audit Committee and Board
of Directors. The Registrant's Articles of Association permit such
indemnification and procurement of insurance coverage. In certain circumstances,
the Israeli Companies Ordinance also requires approval of such indemnification
and insurance by the Registrant's shareholders. The approval of indemnification
agreements and procurement of 

                                      
<PAGE>

insurance for all of the Registrant's directors will require shareholder
approval. In addition, the approval of indemnification and procurement of
insurance for certain directors who may be deemed to hold 25% or more of the
share capital of the Registrant requires the consent of disinterested
shareholders subject and pursuant to the Israeli Companies Ordinance.

      The Registrant intends to purchase a directors' and officers' liability
insurance policy insuring its Office Holders with respect to those matters
permitted by the Israeli Companies Ordinance.

Item 15.  Recent Sales of Unregistered Securities

      During the past three years, the Registrant made the following sales of
its unregistered securities.

      Between September and December 1997, the Registrant effected a private
offering of its Ordinary Shares in the United States, for which Josephthal & Co.
Inc. ("Josephthal") acted as exclusive placement agent. See "Certain
Transactions." The private placement was exempt from the registration
requirements of the Securities Act of 1933 pursuant to Section 4(2) thereof. As
compensation for its services as the Registrant's exclusive placement agent,
Josephthal received fees of $339,000 and warrants to purchase 400,000 Ordinary
Shares at an exercise price of $1.00 per share. Payment to Josephthal in
consideration for the banking services rendered by Josephthal to the Registrant
has been approved by the Registrant's shareholders.

Item 16.  Exhibits and Financial Statement Schedules.

    (a)   Exhibits

Exhibit      Description
Number

     3.1     Memorandum of Association of the Registrant, in Hebrew with a
             translation to English.*

     3.2     Articles of Association of the Registrant.*

     3.3     Certificate of Name Change.**

     4.1     Specimen Certificate for Ordinary Shares.*

     5.1     Opinion of Shimonov Barnea & Co. (to be filed by amendment)

    10.1     A Private Investment Agreement between the Registrant and certain
             Private Investors dated October 5, 1993, in Hebrew with translation
             to English.*

    10.3     Registration Rights Agreement between the Registrant and certain
             Private Investors.*

    10.4     Assignment Agreement between Nur Focus Advertising Products Ltd.***
             and the Registrant dated October 4, 1993, in Hebrew with a
             translation to English.*

    10.5     Royalties Agreement between Nur Focus Advertising Products Ltd.***
             and the Registrant dated May 23, 1995, in Hebrew with a translation
             to English.*
<PAGE>

    10.6     Share Subscription Agreement between the Registrant, Nur
             International, S.A. and Shamrock Holding of California, Inc. dated
             February 3, 1994.*

    10.7     Agreement between the Registrant, Nur International, S.A. and
             Shamrock Holding of California, Inc. dated May 5, 1995.*

    10.8     Distribution Agreement between Scitex Corporation Ltd. and the
             Registrant dated June 10, 1992, in Hebrew with a translation to
             English.*+

    10.9     Agreement between the Registrant, Nur Outdoor Advertising
             (Manufacturing and Production) Ltd. and Nur Focus Advertising
             Products Ltd.*** dated 1994, in Hebrew with a translation to
             English.*

   10.10     Registrant's 1995 Stock Option/Stock Purchase Plan.*

   10.11     Registrant's 1997 Stock Option Plan.****

   10.12     Lease Agreement between the Registrant and Mr. Moshe Nur dated
             October 4, 1993, as amended on May 29, 1995, in Hebrew with a
             translation to English.*

   10.13     Order Agreement between the Registrant and Matan Systems (1991)
             Ltd. dated August 3, 1994, as amended on January 26, 1995 and as
             further amended on October 16, 1995 and Assignment Letter dated
             March 6, 1995, in Hebrew with a translation to English.*+

   10.14     Voting Agreement between Moshe Nur and Yoram Ben-Porat dated
             January 1, 1992.*

   10.15     Agreement between Imaje S.A. and the registrant dated as of October
             16, 1995.*

   10.16     Marketing and Sales Support Agreement between the Registrant and
             Scitex Europe, S.A., dated as of October 18, 1995.*

   10.17     Agreement between the Registrant and Matan Systems (1991) Ltd.
             dated October 16, 1995.*

   14.1      Material Foreign Patents.*

   21.1      List of Subsidiaries of the Registrant.*****

   23.1      Consent of Krost Forer & Gabbay

   23.2      Consent of Shimonov Barnea & Co. (included in Exhibit 5.1)

   24.1      Power of Attorney (included on the signature page hereto)

   27.1      Financial Data Schedule for the year ended December 31, 1995.*****

   27.2      Financial Data Schedule for the year ended December 31, 1996.*****

   27.3      Financial Data Schedule for the year ended December 31, 1997.*****

   27.4      Financial Data Schedule for the six months ended June 30, 1997.

   27.5      Financial Data Schedule for the six months ended June 30, 1998.

- - - - - - -------------

*     Previously filed with the Company's Registration Statement on Form F-1
      Registration No. 33-93160 and incorporated by reference herein.
<PAGE>

**    Previously filed with the Company's 6-K dated January 7, 1998 and
      incorporated by reference herein.

***   Subsequently changed its name to Nur Focus Assets and Investments, Ltd.

****  Previously filed with the Company's Form 6-K dated October 14, 1997 and
      incorporated by reference herein.

***** Previously filed with the Company's Form 20-F for the year ended December
      31, 1997 and incorporated by reference herein. 

+     Confidential treatment granted as to portions of the agreement.

   (b) Financial Statement Schedules

      All schedules have been omitted as the required information is either not
applicable or presented in the financial statements or notes thereto.

Item 17.  Undertakings

      Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.

      The undersigned Registrant hereby undertakes that:

      (1)   To file, during any period in which offers or sales are being made,
            a post-effective amendment to this registration statement;

            (i)   To include any prospectus required by Section 10(a)(3) of the
                  Securities Act

            (ii)  To reflect in the prospectus any facts or events arising after
                  the effective date of the registration statement (or the most
                  recent post-effective amendment thereof) which individually or
                  in the aggregate, represent a fundamental change in the
                  information set forth in the registration statement.
                  Notwithstanding the foregoing, any increase or decrease in
                  volume of securities offered (if the total dollar value of
                  securities offered would not exceed that which was registered)
                  and any deviation from the low or high end of the estimated
                  maximum offering range may be reflected in the form of
                  prospectus filed with the Commission pursuant to Rule 424(b)
                  if, in the aggregate, the changes in volume and price
                  represent no more than a 20 percent change in the maximum
                  aggregate offering price set forth in the "Calculation of
                  Registration Fee" table in the effective registration
                  statement.

            (iii) To include any material information with respect to the plan
                  of distribution not previously disclosed in the registration
                  statement or any material change to such information in the
                  registration statement.

      (2)   That, for the purpose of determining any liability under the
            Securities Act of 1933, each such post-effective amendment shall be
            deemed to be a new registration statement relating to the securities
            offered therein, and the offering of such securities at that time
            shall be deemed to be the initial bona fide offering thereof.

      (3)   To remove from registration by means of a post-effective amendment
            any of the securities being registered which remain unsold at the
            termination of the offering.
<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Act of 1933, as amended,
the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form F-1, and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in The State of Israel, on October 26, 1998.

                                      NUR MACROPRINTERS LTD.
                                      By: /s/ Erez Shachar
                                          ---------------------------------
                                          Erez Shachar
                                          President and Chief Executive Officer

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below
hereby constitutes and appoints Erez Shachar and Eitan Padan, and each of them,
his or her true and lawful agent, proxy and attorney-in-fact, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to (i) act on, sign and file with the Securities and
Exchange Commission any and all amendments (including post-effective amendments)
to this Registration Statement together with all schedules and exhibits thereto,
(ii) act on, sign and file with the Securities and Exchange Commission any
registration statement relating to this Offering that is to be effective upon
filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended,
(iii) act on, sign and file with the Securities and Exchange Commission any
exhibits to such registration statement or pre-effective or post-effective
amendments, (iv) act on, sign and file such certificates, instruments,
agreements and other documents as may be necessary or appropriate in connection
therewith, (v) act on and file any supplement to any prospectus included in this
registration statement or any such amendment and (vi) take any and all actions
which may be necessary or appropriate in connection therewith, granting unto
such agents, proxies and attorneys-in-fact, and each of them, full power and
authority to do and perform each and every act and thing necessary or
appropriate to be done (including any prospectus included in this registration
statement), as fully for all intents and purposes as he or she might or could do
in person, hereby approving, ratifying and confirming all that such agents,
proxies and attorneys-in-fact, any of them or any of his, her or their
substitute or substitutes may lawfully do or cause to be done by virtue hereof

      Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on the dates indicated.

      Signature                  Title of Capacities                 Date
      ---------                  -------------------                 ----

/s/ Dan Purjes            Chairman of the Board of Directors    October 26, 1998
- - - - - - -----------------------
Dan Purjes
                       
/s/ Erez Shachar          President and Chief Executive         October 26, 1998
- - - - - - -----------------------     Officer and Director                            
Erez Shachar           
                          
/s/ Eitan Padan           Chief Financial Officer,              October 26, 1998
- - - - - - -----------------------     Vice President of Finance                           
Eitan Padan                 and Secretary                                       

                          
/s/ Roni Ferber                      Director                   October 26, 1998
- - - - - - -----------------------                                                         
Roni Ferber                                                                     
                                                                                
/s/ Yoram Ben-Porat                  Director                   October 26, 1998
- - - - - - -----------------------                                                         
Yoram Ben-Porat                                                                 
                                                                                
/s/ Robert L. Berenson               Director                   October 26, 1998
- - - - - - -----------------------                                                         
Robert L. Berenson
                                                                                
/s/ Robert Hussey                    Director                   October 26, 1998
- - - - - - -----------------------                              
Robert Hussey                                      
<PAGE>

                                  EXHIBIT INDEX

Exhibit      Description
Number
     3.1     Memorandum of Association of the Registrant, in Hebrew with a
             translation to English.*

     3.2     Articles of Association of the Registrant.*

     3.3     Certificate of Name Change.**

     4.1     Specimen Certificate for Ordinary Shares.*

     5.1     Opinion of Shimonov Barnea & Co. (to be filed by amendment)

    10.1     A Private Investment Agreement between the Registrant and certain
             Private Investors dated October 5, 1993, in Hebrew with translation
             to English.*

    10.3     Registration Rights Agreement between the Registrant and certain
             Private Investors.*

    10.4     Assignment Agreement between Nur Focus Advertising Products Ltd.***
             and the Registrant dated October 4, 1993, in Hebrew with a
             translation to English.*

    10.5     Royalties Agreement between Nur Focus Advertising Products Ltd.***
             and the Registrant dated May 23, 1995, in Hebrew with a translation
             to English.*

    10.6     Share Subscription Agreement between the Registrant, Nur
             International, S.A. and Shamrock Holding of California, Inc. dated
             February 3, 1994.*

    10.7     Agreement between the Registrant, Nur International, S.A. and
             Shamrock Holding of California, Inc. dated May 5, 1995.*

    10.8     Distribution Agreement between Scitex Corporation Ltd. and the
             Registrant dated June 10, 1992, in Hebrew with a translation to
             English.* +

    10.9     Agreement between the Registrant, Nur Outdoor Advertising
             (Manufacturing and Production) Ltd. and Nur Focus Advertising
             Products Ltd.*** dated 1994, in Hebrew with a translation to
             English.*

   10.10     Registrant's 1995 Stock Option/Stock Purchase Plan.*

   10.11     Registrant's 1997 Stock Option Plan.****

   10.12     Lease Agreement between the Registrant and Mr. Moshe Nur dated
             October 4, 1993, as amended on May 29, 1995, in Hebrew with a
             translation to English.*

   10.13     Order Agreement between the Registrant and Matan Systems (1991)
             Ltd. dated August 3, 1994, as amended on January 26, 1995 and as
             further amended on October 16, 1995 and Assignment Letter dated
             March 6, 1995, in Hebrew with a translation to English.* +

   10.14     Voting Agreement between Moshe Nur and Yoram Ben-Porat dated
             January 1, 1992.*

   10.15     Agreement between Imaje S.A. and the registrant dated as of October
             16, 1995.*

   10.16     Marketing and Sales Support Agreement between the Registrant and
             Scitex Europe, 
<PAGE>

             S.A., dated as of October 18, 1995.*

   10.17     Agreement between the Registrant and Matan Systems (1991) Ltd.
             dated October 16, 1995.*

   14.1      Material Foreign Patents.*

   21.1      List of Subsidiaries of the Registrant.*****

   23.1      Consent of Krost Forer & Gabbay

   23.2      Consent of Shimonov Barnea & Co. (included in Exhibit 5.1)

   24.1      Power of Attorney (included on the signature page hereto)

   27.1      Financial Data Schedule for the year ended December 31, 1995.*****

   27.2      Financial Data Schedule for the year ended December 31, 1996.*****

   27.3      Financial Data Schedule for the year ended December 31, 1997.*****

   27.4      Financial Data Schedule for the six months ended June 30, 1997.

   27.5      Financial Data Schedule for the six months ended June 30, 1998.

- - - - - - -------------

*     Previously filed with the Company's Registration Statement on Form F-1
      Registration No. 33-93160 and incorporated by reference herein.

**    Previously filed with the Company's 6-K dated January 7, 1998 and
      incorporated by reference herein.

***   Subsequently changed its name to Nur Focus Assets and Investments, Ltd.

****  Previously filed with the Company's Form 6-K dated October 14, 1997 and
      incorporated by reference herein.

***** Previously filed with the Company's Form 20-F for the year ended December
      31, 1997 and incorporated by reference herein.

+     Confidential treatment granted as to portions of the agreement.

                                                                        Ex. 23.1
                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

We consent to the reference to our firm under the caption "Experts" and to the
use of our report dated March 9, 1998, except for comprehensive data included in
the statements of changes in shareholders' equity for which date is October 20,
1998, in the Registration Statements Form F-1 and relatd Prospectus of Nur
Macroprinters Ltd. for the registration of 5,897,339 shares of its common stock
(underlying 4,000,000 common shares, 1,342,339 stock options and 555,000
warrants).


Tel Aviv, Israel
October 22, 1998

                                       Yours truly,
                                       /s/ Kost, Forer and Gabbay
                                       -------------------------------------
                                       KOST, FORER and GABBAY
                                       Certified Public Accountants (Israel)

<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
                              THIS SCHEDULE CONTAINS SUMMARY FINANCIAL 
                              INFORMATION EXTRACTED FROM THE COMPANY'S FINANCIAL
                              STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
                              REFERENCE TO SUCH FINANCIAL STATEMENTS INCLUDED
                              AS A PART OF THIS FORM F-1
</LEGEND>
<MULTIPLIER>                                     1,000     
<CURRENCY>                                           $     
       
<S>                                             <C>
<PERIOD-TYPE>                                         6-MOS
<FISCAL-YEAR-END>                               DEC-31-1997
<PERIOD-START>                                  JAN-01-1997
<PERIOD-END>                                    JUN-30-1997
<EXCHANGE-RATE>                                           1
<CASH>                                                  934
<SECURITIES>                                              0
<RECEIVABLES>                                         6,095
<ALLOWANCES>                                            628
<INVENTORY>                                           2,246
<CURRENT-ASSETS>                                      8,647
<PP&E>                                                2,056
<DEPRECIATION>                                          487
<TOTAL-ASSETS>                                       10,908
<CURRENT-LIABILITIES>                                 7,337
<BONDS>                                                   0
                                     0
                                               0
<COMMON>                                              1,593
<OTHER-SE>                                            1,978
<TOTAL-LIABILITY-AND-EQUITY>                         10,908
<SALES>                                               9,213
<TOTAL-REVENUES>                                      9,213
<CGS>                                                 4,924
<TOTAL-COSTS>                                         3,653
<OTHER-EXPENSES>                                          0
<LOSS-PROVISION>                                        628
<INTEREST-EXPENSE>                                      286
<INCOME-PRETAX>                                        (278)
<INCOME-TAX>                                              0
<INCOME-CONTINUING>                                    (278)
<DISCONTINUED>                                            0
<EXTRAORDINARY>                                           0
<CHANGES>                                                 0
<NET-INCOME>                                           (278)
<EPS-PRIMARY>                                         (0.04)
<EPS-DILUTED>                                         (0.04)
        

</TABLE>

<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
                              THIS SCHEDULE CONTAINS SUMMARY FINANCIAL 
                              INFORMATION EXTRACTED FROM THE COMPANY'S FINANCIAL
                              STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
                              REFERENCE TO SUCH FINANCIAL STATEMENTS INCLUDED
                              AS A PART OF THIS FORM F-1

</LEGEND>
<MULTIPLIER>                                           1,000      
<CURRENCY>                                             $          
       
<S>                                                    <C>
<PERIOD-TYPE>                                                6-MOS
<FISCAL-YEAR-END>                                      DEC-31-1998
<PERIOD-START>                                         JAN-01-1998
<PERIOD-END>                                           JUN-30-1998
<EXCHANGE-RATE>                                                  1
<CASH>                                                       2,082
<SECURITIES>                                                    63
<RECEIVABLES>                                                8,735
<ALLOWANCES>                                                   280
<INVENTORY>                                                  3,049
<CURRENT-ASSETS>                                            13,649
<PP&E>                                                       3,207
<DEPRECIATION>                                                 887
<TOTAL-ASSETS>                                              17,000
<CURRENT-LIABILITIES>                                        8,831
<BONDS>                                                          0
                                            0
                                                      0
<COMMON>                                                     2,729
<OTHER-SE>                                                   5,440
<TOTAL-LIABILITY-AND-EQUITY>                                17,000
<SALES>                                                     15,854
<TOTAL-REVENUES>                                            15,854
<CGS>                                                        7,855
<TOTAL-COSTS>                                                6,294
<OTHER-EXPENSES>                                                 0
<LOSS-PROVISION>                                               280
<INTEREST-EXPENSE>                                             319
<INCOME-PRETAX>                                              1,106
<INCOME-TAX>                                                   112
<INCOME-CONTINUING>                                            994
<DISCONTINUED>                                                   0
<EXTRAORDINARY>                                                 13
<CHANGES>                                                        0
<NET-INCOME>                                                   981
<EPS-PRIMARY>                                                 0.09
<EPS-DILUTED>                                                 0.09
                                                                  

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission